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 Sexual contact networks containing persons diagnosed with HIV and/or syphilis are 
efficient platforms for delivery of enhanced HIV treatment support to persons living with HIV 
(PLWH) and prevention resources to HIV-negative persons. We conducted three inter-related 
studies among men who have sex with men (MSM) in North Carolina (NC) to assess the 
potential for network-based interventions to reduce HIV transmission. 
 We first generated independent and combined HIV and syphilis networks using contact 
tracing data for all MSM diagnosed with HIV or syphilis 2015-2017 in NC. We identified network 
communities, or clusters of densely connected nodes, in the combined network and evaluated 
interconnectivity between the syphilis and HIV networks by community. Heightened 
interconnectivity was associated with younger median age; higher proportions of persons self-
identifying as Black, non-Hispanic; and higher proportions of syphilis cases diagnosed at sexually 
transmitted disease clinics.  
 Next, we used NC surveillance data to identify two types of qualifying “network events” 
among MSM in NC 01/2013-06/2017: being diagnosed with early syphilis or being named as a 
recent sexual contact of a person diagnosed with HIV or early syphilis. We estimated prevalent 
and incident viral suppression among previously diagnosed PLWH at and after network events 
(52.6% and 35.4%, respectively) and assessed the effect of contact tracing services on incident 
viral suppression. The six-month cumulative incidence of reported viral suppression was 13.1 
(95% CI: 8.9, 17.4) percentage points higher after events among persons reached vs. not 
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reached by these services. Using linked insurance claims data, we also evaluated prevalent and 
incident pre-exposure prophylaxis (PrEP) use among HIV-negative network members (5.4% and 
4.1%, respectively). 
 Finally, we generated static contact networks with community structure drawn from the 
combined HIV/syphilis network described above and varied endemic HIV prevalence across 
network communities. We applied a stochastic transmission model to simulate HIV spread, 
evaluated community-level HIV incidence rates by endemic community-level HIV prevalence, 
and modeled the efficiency of community-prevalence-based vs. randomly allocated interventions. 
PrEP interventions were most efficient when preferentially deployed to susceptible persons in 
communities with higher endemic HIV prevalences, while viral suppression intervention efficiency 
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CHAPTER ONE:  SPECIFIC AIMS 
 
 Despite the development of highly effective human immunodeficiency virus (HIV) 
prevention modalities, HIV incidence is steady or increasing in many populations.1 Available 
interventions, including antiretroviral therapy (ART) as treatment among PLWH and PrEP for 
prevention among HIV-negative persons, substantially reduce HIV transmission.2-5 However, 
ART and PrEP uptake and adherence are widely suboptimal,6,7 preventing these interventions 
from reaching their full potentials at the population level. New strategies are needed to increase 
ART and PrEP use for improved clinical and prevention outcomes in the modern epidemic era.  
 Sexual contact networks containing persons diagnosed with HIV and/or syphilis are 
efficient platforms for delivery of HIV interventions for both epidemiological and practical 
reasons. HIV and syphilis are syndemic, particularly among MSM, and primarily affect the same 
populations in the United States (US).8 HIV-uninfected HIV/syphilis network members 
experience heightened HIV risk,9,10 and among previously diagnosed, unsuppressed PLWH, 
being newly diagnosed with syphilis or named as a sexual contact of someone diagnosed with 
HIV or syphilis suggests potential for ongoing HIV transmission.10 As contact tracing for HIV and 
syphilis is routine in the US,11 existing public health infrastructure can serve as a conduit to 
reach HIV-negative and HIV-positive network members with PrEP and ART, respectively.  
 Network-focused HIV prevention efforts will require improved understanding of the 
relationship between HIV and syphilis contact networks and up-to-date knowledge of PrEP and 
viral suppression use and coverage gaps within these networks. Identification of network 




connected to the remainder of the network,12 may provide a novel means of identifying 
populations at greatest risk of HIV acquisition and allocating interventions within the 
interconnected HIV/syphilis network.13,14 Network community structure impacts disease 
transmission across networks,13,14 and tailored interventions could harness this effect to 
maximize the HIV prevention benefits of limited public health resources. 
 We conducted a detailed investigation of HIV and syphilis contract tracing networks 
among MSM in NC, a state with a large HIV epidemic that serves as a useful representation of 
HIV in the American South.15 We applied social network analysis, descriptive and causal 
inference epidemiological methods, and network transmission modeling using public health 
surveillance and insurance claims data to: 
(1) Evaluate interconnectivity of HIV and syphilis sexual contact networks among MSM in 
NC. Using contact tracing data, we generated independent and combined HIV and syphilis 
networks for all MSM diagnosed with HIV or early syphilis, respectively, in North Carolina 
between 2015 and 2017. We treated the independent networks as layers and identified 
network communities, or clusters of densely connected nodes, in the two-layer network. We 
assessed interconnectivity by comparing the mean node degree among syphilis network 
members in the syphilis network alone vs. in the combined HIV/syphilis network, both overall 
and by community. 
Hypotheses: HIV and syphilis sexual contact networks among MSM in NC are 
interconnected and network interconnectivity differs by network community.  
Justification: The biological underpinnings of the HIV/syphilis syndemic have been 
comprehensively described,8 but the syndemic has never been evaluated using a network 
approach. Using a simple measure that we devised to assess interconnectivity of the 
syphilis network with the HIV network, we aim to identify populations within the syphilis 




(2) Assess viral suppression and PrEP use among MSM members of the HIV/syphilis 
sexual contact network in NC. We used surveillance data to identify two types of qualifying 
“network events” occurring 01/2013-06/2017 among MSM in NC: being diagnosed with early 
syphilis, or being named as a recent sexual partner of a person diagnosed with HIV or early 
syphilis. We estimated prevalent and incident viral suppression among previously diagnosed 
PLWH at and after the network event, and we assessed the effect of contact tracing 
services on six-month cumulative incidence of viral suppression. Using linked prescription 
claims data, we also evaluated prevalent and incident PrEP use among HIV-negative 
network members. 
Hypotheses: Six-month cumulative incidence of viral suppression is heightened among 
viremic, previously diagnosed PLWH interviewed by Disease Intervention Specialists (DIS) 
during contact tracing. Prevalent and incident PrEP use are low among HIV-negative 
network members, despite high frequency of PrEP indication in this population.  
Justification: The NC DPH is strengthening efforts to expand PrEP use and increase viral 
suppression under their emergent “Ending the HIV Epidemic” campaign. Identification of 
gaps in current intervention coverage and resource needs among known HIV/syphilis 
network members may assist NC DPH in development of effective intervention strategies to 
reach this critical population.  
(3) Model the impact of HIV prevention interventions in modular networks with 
differential endemic HIV prevalence across network communities. We generated static 
contact networks with community structure drawn from the combined HIV/syphilis network 
generated in Aim 1 and varied endemic HIV prevalence within communities. We applied a 
simple, stochastic transmission model to simulate HIV spread over these networks. We 
evaluated community-level HIV incidence rates by endemic community-level HIV prevalence 




allocated ART and PrEP interventions on overall HIV incidence rates at a range of endemic 
overall network HIV prevalences and intervention coverage levels. 
Hypotheses: PrEP interventions may be most efficient when preferentially allocated to 
persons in high-prevalence vs. low-prevalence communities because each susceptible 
person has a higher probability of HIV exposure via membership in a discordant dyad in a 
high-prevalence community. ART interventions may be most efficient when preferentially 
allocated to persons in low-prevalence vs. high-prevalence communities because viral 
suppression of PLWH may largely insulate susceptible persons in a low-prevalence 
community from HIV exposure. 
Justification: Prior studies of the impact of network community structure on infection 
transmission have assessed only newly introduced infections,13,14 a scenario that is not 
relevant to the current context of endemic HIV. We aim to elucidate the contribution of 
community structure to endemic infection transmission and test intervention allocation 
strategies that leverage heterogeneous infection distribution across network communities as 












CHAPTER TWO: BACKGROUND 
 
A.   HIV Epidemiology 
 Despite great advances in HIV treatment and prevention in recent years,16,17 estimated 
HIV incidence is steady or increasing in many key populations.1,17 Estimated global HIV 
incidence has declined dramatically in the era of widespread ART and improved testing and 
prevention interventions.16,17 However, only very gradual declines in incidence have been 
estimated in most global regions since 2010, while large increases have been estimated in 
eastern Europe and central Asia.17 In the US, over one million people are living with HIV and an 
estimated 40,000 become newly infected each year.18 Estimated HIV incidence remains flat 
among Black MSM and is rising among Hispanic and Latino MSM, contrary to decreasing 
estimated incidence among all other demographic groups in the US.1,19 There is a pressing 
need for novel intervention strategies to build upon current successes in HIV treatment and 
control, and to extend these successes to the most vulnerable populations. 
HIV in the Southern United States 
 The South is the core of the modern US HIV epidemic.20 Southern states, as well as the 
District of Columbia, contain just 38% of the national population but host approximately half of 
all new HIV diagnoses.20 In 2018, the South experienced an HIV diagnosis rate of 15.7/100,000 
population.18 This rate eclipses those observed in other regions: 10.0/100,000 in the Northeast, 
9.3/100,000 in the West, and 7.2/100,000 in the Midwest.18 Although HIV incidence is 
heterogeneous across the region, eight of the ten states and all of the ten metropolitan 




As in other regions of the US, HIV in the South primarily affects disadvantaged populations.20 In 
2018, African American and Hispanic and/or Latino populations accounted for 52% and 22% of 
new diagnoses in the South, respectively.18 Self-identified Black and Hispanic and/or Latino 
MSM comprise 48% of all new diagnoses in the South, while Black women comprise 69% of 
new diagnoses among women.20  
 Access to health services, including HIV care, primary care, mental health treatment, 
and addiction services, is a critical component of effective HIV prevention and treatment. 
However, southern states have higher average uninsured rates than states in other regions, 
which can impede regular care.21,22 High uninsured rates in the South are attributed to 
comparatively depressed average economic conditions,20 lower availability of employer-based 
health insurance coverage,20 and failure of many southern states to expand Medicaid following 
the 2010 Patient Protection and Affordable Care Act.21-23 Only seven of sixteen southern states, 
and the District of Columbia, have expanded Medicaid as of January 2020.23 Medicaid 
expansion was associated with a significant increase in HIV testing rates for individuals below 
the expansion income cutoff from 2010-2017, with the largest impacts among older Black and 
rural testers.24 Failure to expand Medicaid in many southern states may contribute to higher 
proportions of PLWH who are undiagnosed in the South compared to PLWH in other regions of 
the country.20 As a consequence of delayed diagnosis, PLWH in the South, particularly non-
white PLWH, are more likely to experience HIV-related morbidity.20 
 High levels of HIV-related stigma, including internalized, perceived, and experienced 
stigma, may also contribute to heightened HIV incidence and poorer health outcomes among 
PLWH in the South.25 Persistent HIV-related stigma in the South is associated with poor ART 
adherence, increased depressive symptoms, and increased substance use, each of which can 
complicate effective HIV care. Stigma may also prevent patients from accessing HIV testing and 
decrease HIV status disclosure to sexual partners, increasing the likelihood of transmission. 




rurality, substance use, and socioeconomic status can further inhibit formation of the social 
support systems that are critical for successful HIV care.25  
 HIV control in the South is complicated by the relative rurality of the epidemic. HIV is a 
primarily urban epidemic in the US, with newly diagnosed HIV infections in rural and suburban 
areas comprising only 23%-32% of all infections.26,27 The South contains a disproportionate 
percentage of both rural and urban populations of PLWH.26,28,29 Approximately two-thirds of 
PLWH in rural regions of the US live in the South,28,30 and the HIV incidence rate within rural 
areas in the southeast is three times the overall US rural incidence rate.29 Barriers to successful 
HIV care associated with rurality include increased distance to specialized medical facilities and 
personnel, a shortage of qualified medical and mental health professionals in rural regions, a 
lack of personal or public transportation to travel to HIV care and testing, and increased 
perceived stigma towards PLWH in rural communities.30-32 In particular, HIV-related stigma may 
be magnified in rural areas because of a perceived lack of privacy in small communities.32,33  
HIV in North Carolina 
 NC hosts a large HIV epidemic with an epidemiology reasonably representative of trends 
across the American South, allowing it to serve as an effective laboratory for new intervention 
development. In 2018, approximately 35,000 PLWH resided in NC and 1,218 persons were 
newly diagnosed with HIV (13.9 diagnoses/100,000 population over 13 years old),15 a slight 
decline from 2017 (15.1/100,000). NC ranked 13th in rate of new HIV diagnoses and 7th in 
absolute new HIV diagnoses among all US states and Washington D.C in 2018.18 A majority of 
newly diagnosed PLWH in NC self-identify as MSM (53%) and 3% self-identify as people who 
inject drugs (PWID); 2% identify as both MSM and PWID.15 Approximately three-fourths of 
newly diagnosed PLWH in NC self-identify as Black (63%) or Hispanic/Latino (10%).15  
 As observed across the South, vulnerable populations are disproportionately affected by 




estimated rates of 1,908 and 845 diagnoses/100,000 population in 2018, respectively, 
compared to 200 diagnoses/100,000 population among White MSM.15 Adult and adolescent 
Black women experienced a new diagnosis rate of 15 diagnoses/100,000 population, compared 
to 1.4 diagnoses/100,000 population among White women in NC.15 HIV in NC also 
predominately affects young persons. The highest new diagnosis rates are observed among 
persons ages 20-29 and 46% of all newly diagnosed PLWH in 2018 were <30 years of age at 
diagnosis.15  
 Inconsistent access to health care and barriers to care associated with rurality and 
poverty also contribute to HIV transmission in NC. Like many other southern states, NC has not 
yet moved to expand Medicaid;25 11% of NC residents remain uninsured and may experience 
difficulty accessing health care, including preventative services that can reduce HIV incidence.15 
NC also hosts the third highest proportion of newly diagnosed PLWH residing in rural areas, 
following only Mississippi and South Carolina. Nearly 20% of all newly diagnosed PLWH in NC 
live in rural counties, compared to 9% across the US.29 Persons living in NC census tracts with 
higher proportions of persons living below the federal poverty line, including many rural areas, 
also experienced higher rates of HIV and STI diagnoses in 2018.15  
B.   Pre-Exposure Prophylaxis and Antiretroviral Therapy 
 Available interventions, including ART as treatment for PLWH2,3 and PrEP for prevention 
of HIV among HIV-negative persons,4,5 substantially reduce HIV transmission. However, ART6 
and PrEP7 uptake and adherence are widely suboptimal, preventing these interventions from 
reaching their full potentials at the population level. Failures in uptake and adherence for each 
intervention have been visualized as continuums through which a patient may progress.34,35 
Although some patients move quickly through the HIV PrEP or care continuums, many patients 
stall at one stage, drop backward to an earlier stage, or cycle through continuum stages multiple 




adherence.35 These three processes are divided into nine discrete stages, including 1) 
identifying individuals at highest risk for HIV infection; 2) increasing HIV risk awareness; 3) 
enhancing PrEP awareness; 4) facilitating PrEP access; 5) linking to PrEP care; 6) prescribing 
PrEP; 7) initiating PrEP; 8) adhering to PrEP; and 9) retaining patients in PrEP care.35 The HIV 
care continuum [Figure 2.2] spans 1) HIV infection; 2) HIV diagnosis; 3) HIV care engagement; 
4) ART prescription; and 5) viral suppression.34 Brief overviews of PrEP and ART, including 
challenges that impede regular progression through each continuum and existing interventions 
to address these challenges, are presented below. 
Pre-Exposure Prophylaxis 
 Daily PrEP for HIV prevention, also known as Truvada, was approved by the FDA in 
2012.37 Truvada, oral combination emtricitabine/tenofovir disoproxil fumarate (FTC/TDF), 
contributes to the HIV prevention arsenal as a biomedical prevention option for HIV-negative 
persons who are at risk for HIV infection.37 Individual-level HIV risk reduction may be as great 
as 99% with full PrEP adherence.38 To date, only a handful of confirmed PrEP failures under full 
adherence have been reported worldwide, and several of these cases acquired drug-resistant 
strains of HIV not susceptible to Truvada.39-42 PrEP also offers population-level benefits. From 
2012 through 2016, increased rates of PrEP uptake in US states were associated with 
significant declines in new HIV diagnoses.43 Similar results were observed in New South Wales, 
Australia following a pilot intervention targeting MSM indicated for PrEP; rapid PrEP roll-out was 
associated with a 35% decline in HIV diagnoses among all MSM in New South Wales.44 
Mathematical models have demonstrated that PrEP may be a cost-effective use of public health 
resources, in comparison to other prevention interventions, when adherence is high and 
individuals at greatest risk of HIV acquisition are prioritized for uptake.45-48 
 In addition to prevention of HIV infection, PrEP use may also increase frequency of 




for safer conception by serodiscordant couples,50,53 and decrease HIV stigma.50,52 The US 
Centers for Disease Control and Prevention (CDC) recommends that persons using PrEP be 
tested for HIV every three months and for bacterial STIs every three to six months, with testing 
typically occurring at each prescribing visit.54 The frequent STI testing required for PrEP 
prescription maintenance may have downstream effects on STI incidence. One modeling study 
estimated a 42% reduction in gonorrhea incidence and 40% reduction in chlamydia incidence 
over ten years among US MSM with uptake of PrEP by 40% of MSM and 40% risk 
compensation.49 Risk compensation is an increase in transmission-associated sexual behaviors, 
such as declines in condom use or increases in number of condomless sexual partners, 
because of perceived HIV risk reduction with PrEP.49 In this model, risk compensation of nearly 
100% among persons using PrEP was required to fully negate the benefits of increased STI 
screening frequency and early STI treatment.49 
 The benefits of PrEP use are partially counterweighted by negative effects at the 
individual and population levels. Small amounts of risk compensation following PrEP uptake 
have been observed, particularly among MSM who used condoms inconsistently prior to PrEP 
initiation.55 Significant increases in STI diagnoses among persons using PrEP have also been 
identified. However, it is unclear if detected increases in diagnoses can be attributed to 
increases in STI incidence subsequent to increased risk compensation or to increased coverage 
and frequency of STI testing.55 Antiretroviral resistance as a result of PrEP use during acute, 
undiagnosed HIV infection has been highlighted as another potential drawback to widespread 
PrEP uptake but remains a chiefly theoretical concern because of strict screening for acute HIV 
infection during initial PrEP prescription.56-58 PrEP use may also cause serious adverse events 
including declines in bone mineral density and renal disfunction.59-61 Poor adherence among 
some recipients is currently the largest barrier to successful PrEP use following uptake, 




 Although PrEP indications encompass a large population, uptake has been low. HIV-
negative, adult MSM who report any male sex partners in the past six months and are not in a 
monogamous partnership with a recently tested, HIV-negative partner are partially indicated for 
PrEP. MSM must also fulfil at least one of the following criteria for indication: 1) report any 
condomless anal intercourse (CAI) in the past six months; 2) have been diagnosed with or 
reported a bacterial STI in the past six months; or 3) are in an ongoing sexual relationship with 
an HIV-positive male partner.54 Other adult men and women who experience substantial risk of 
HIV acquisition, including PWID, may also be indicated.54 Adolescents who weigh a minimum of 
77 pounds and meet other indication criteria in any category are further eligible to receive 
PrEP.54 PrEP uptake has been slower than anticipated; an estimated 1.2 million persons in the 
US, including 492,000 MSM, 115,000 PWID, and 624,000 non-MSM/non-PWID are indicated for 
PrEP,64 but only an estimated 18% of these persons were prescribed PrEP in 2018.7 In NC, just 
an estimated 2,500 persons were prescribed PrEP in 2018.65 
 PrEP is underused by some populations, including persons under age 25,66,67 Black and 
Hispanic and/or Latino men and women,68,69 low-income persons,68 women,67 and persons with 
a high school education or less.68 Uptake has also been disproportionately low in the South and 
Midwest.67,70,71 Unfortunately, many of the populations least likely to utilize PrEP experience the 
greatest HIV risks.71,72 This reality is demonstrated by lower PrEP-to-need ratios (PnR), or ratios 
of the number of persons prescribed PrEP to the number of new HIV diagnoses in a given 
population. Persons under age 25 (PnR = 0.9) and residents of the South (PnR = 1.0) display 
lower PnRs than the US population as a whole (PnR = 1.8).67 PrEP access is also highly 
variable by geographic location; PrEP providers in NC are largely located in urban areas and 
approximately two-thirds of NC counties do not have a PrEP provider.73 TelePrEP has also been 
successfully piloted in Iowa as an alternative option for rural clients to address this barrier to 





 Pilot programs offering full service PrEP care or PrEP referrals out of select county 
health departments in NC are underway,75-78 exploring the potential for these existing providers 
to reach currently underserved populations and address financial barriers to care. Although 
Gilead’s copay and medication assistance programs reduce the cost of Truvada for 
underinsured and uninsured patients, respectively, these programs do not cover the cost of 
provider care and laboratory tests at prescribing and follow-up visits, leaving a coverage gap 
that can be addressed by county health departments with established STI testing 
programming.79 NC counties have taken multiple approaches to PrEP provision, including low-
cost direct PrEP prescriptions and follow-up at the Orange County and Cabarrus County Health 
Departments,75,76 referrals to free PrEP care out of the Mecklenburg County Health 
Department,77 and referrals to internal and external PrEP clinics at the Durham County Health 
Department.78 These pilot programs may serve as a foundation for wider health department 
PrEP distribution programs across the state. For instance, Florida introduced a program in 2018 
offering PrEP through all 67 county health departments in the state and offers sliding scale 
provider and laboratory costs.80 This approach ensures that PrEP is accessible to all patients, 
regardless of distance to a conventional PrEP provider or insurance coverage for PrEP-related 
costs. 
Antiretroviral Therapy 
 Widespread ART has changed clinical outcomes for millions of PLWH by allowing 
treatment of HIV as a chronic condition and preventing the onset of AIDS.16,17,81 ART has 
radically improved since the introduction of Zidovudine (AZT) monotherapy in 1987.81 Modern 
antiretroviral agents belong to one of five drug classes: entry inhibitors, including CCR5 binding 
and fusion inhibitors, reverse transcription inhibitors, including nucleoside reverse transcription 
inhibitors (NRTI) and non-nucleoside reverse transcription inhibitors (NNRTI), integration 




Triple-drug combination therapy is standard of care for all PLWH worldwide and safely 
suppresses HIV replication below detectable viral loads in most patients.81 Standard treatment 
in the US is a backbone composed of two NRTIs and a PI/NNRTI/INSTI base.82 This 
combination may be altered to account for viral drug resistance, interactions with therapies for 
co-morbidities, adverse events, or medication availability in resource-limited settings.82,83 
Immediate ART initiation following diagnosis for all PLWH is recommended by the US 
Department of Health and Human Services84 and the World Health Organization (WHO).83 
 ART also provides transmission prevention benefits; the landmark HPTN 052 trial 
demonstrated in 2011 that suppressive ART in PLWH prevents sexual HIV transmission to 
uninfected partners.85 This study, as well as the supporting PARTNER 1 and 2 and Opposites 
Attract trials, identified zero transmissions from study participants with fully suppressed viral 
loads to an enrolled partner.85-88 This evidence sparked the re-conceptualization of ART as 
“treatment as prevention” (TAP).89 Modeling studies have shown that a TAP approach to HIV 
control has the potential to substantially reduce population-level HIV incidence.2 Recently, this 
paradigm has been rephrased for the public in the “U=U” campaign, designed to communicate 
that HIV infection in PLWH with undetectable viral loads is untransmissible.90 
 ART use is increasing rapidly but falls short of coverage goals. Globally, 62% of PLWH 
were receiving ART and 53% were virally suppressed by the end of 2018.91 The UNAIDS 90-90-
90 goals call for 90% of all PLWH to be diagnosed, 90% of diagnosed PLWH to be receiving 
ART, and 90% of those on ART to be virally suppressed. In 2018, 78% of diagnosed PLWH 
globally were prescribed ART and 86% of those on ART were virally suppressed, demonstrating 
substantial progress toward the 90-90-90 goals.91 However, some global regions have markedly 
lower coverage. In 2018, just 33% of PLWH in the Middle East/North Africa were receiving ART, 
indicating large gaps in diagnoses and care. In Eastern Europe/Central Asia and 




 ART coverage in the US, and specifically in North Carolina, also shows room for 
improvement. In NC, an estimated 68% of PLWH were retained in care in 2018, a proxy for ART 
use, and 62% were virally suppressed.15 Viral suppression in NC is similar to that observed 
across the US and is higher among newly diagnosed PLWH, demonstrating improvements in 
care linkage and maintenance in recent years.92,93 Viral suppression in NC is lowest among 
patients ages 18-24 years at diagnosis, Black and Hispanic/Latino patients, and PWID.92 In 
2016, 55% of PLWH ages 18-24 years at diagnosis in NC were singly virally suppressed, 
compared to 76% of PLWH aged ≥55 years at diagnosis.94 Disparities in durable viral 
suppression were even greater; just 42% of PLWH ages 18-24 years at diagnosis showed 
durable viral suppression, compared to 68% of PLWH aged ≥55 years.94 A significant increase 
in viral suppression by age at diagnosis was observed across all race/ethnicity strata.94 Self-
identified Hispanic/Latino PLWH were less likely to be singly virally suppressed (60%) 
compared to Black, non-Hispanic (63%) and White, non-Hispanic (72%) PLWH in NC.94 
 PLWH engaged in care encounter four possible failure points preventing successful 
treatment with ART: 1) delay in initiation or failure to initiate ART; 2) discontinuation of ART; 3) 
poor adherence to ART; and 4) viral resistance to ART.95 Although the HIV Medication 
Assistance Program and the Ryan White HIV/AIDS Program offer low-income NC residents 
financial support for HIV care and medication,96 many patients face additional barriers that can 
lead to failure to initiate, continue, or adhere to ART. Barriers to successful treatment with ART 
encompass structural issues, including lack of health insurance, inconsistent housing or 
transportation, few nearby care facilities, inconvenient clinic hours and appointment availability, 
and culturally-insensitive medical care, as well as intra-and inter-personal issues, including low 
socioeconomic status (SES), substance use, mental illness, perceived stigma, and insufficient 
social support systems97-99 Engagement in HIV care and adherence to ART are also fluid over 
time, and PLWH may require a range of interventions to support consistent treatment as 




 NC offers targeted support for HIV care engagement through State Bridge Counselors 
(SBC), or case managers who have also undergone field intervention training.100,101 SBC 
operate under the Data to Care framework, which leverages HIV surveillance data to support 
progression through the HIV care continuum.102 SBC receive a list of diagnosed PLWH without 
a recent HIV care visit documented in NC HIV surveillance data each month. They then attempt 
to contact these individuals, identify those who are truly not engaged in care, and support their 
linkage or re-linkage to care. SBC provide individualized services to as many PLWH as 
possible, including assistance scheduling provider visits, support with financial assistance 
applications and insurance plan enrollment, referrals for mental health and substance abuse 
counseling, and aid with housing and transportation, language barriers, and childcare.100,101  
C.   HIV/Syphilis Syndemic 
The interacting HIV and syphilis epidemics among MSM exacerbate the impact of the 
other to form a syndemic.8,103 In the US, HIV,103-105 syphilis,103-105 and HIV-syphilis 
coinfections104,106-108 are concentrated among MSM, particularly among young MSM of 
color.107,108 Nationwide, approximately 53% of MSM newly diagnosed with early syphilis were 
coinfected with HIV in 2013.107 The high prevalence of co-infections is tied to an increase in 
syphilis infections among MSM over the last two decades.109 Although syphilis diagnosis rates 
fell sharply in the late 1990s, spurring calls for syphilis elimination, the epidemic resurged in the 
2000s among MSM.109 This resurgence is attributed to reductions in perceptions of HIV risk 
following the introduction of ART, leading to reductions in condom use.103,109 Serosorting, or 
selection of sexual partners by shared perceived HIV infection status, also allowed increased 
opportunities for STI transmission in the absence of condom use.103,109 Syphilis rapidly shifted 
from primarily affecting heterosexual populations to predominately affecting MSM.110 From 2000 




7% to 62%.110 This trend was replicated across high-income nations globally, with syphilis 
diagnoses among MSM increasing from 27% to 55% from 2000 through 2013.111 
 The HIV/syphilis syndemic is highly observable in NC. Much like other states in the 
American Southeast, NC experiences higher HIV and syphilis incidence than the national 
average.15,112 NC also showed the highest rate of primary and secondary syphilis diagnosis 
among MSM of all states in 2015.113 In 2018, NC reported 1,914 new early syphilis diagnoses 
(18.4/100,000 population), of which approximately 55% occurred among self-identified MSM.114 
Dramatic increases in detected HIV-syphilis coinfection in NC have also been observed in 
recent years; approximately 45% of persons diagnosed with syphilis were coinfected with HIV in 
2014, compared to 6% in 2002.115 HIV/syphilis coinfections in NC are largely concentrated 
among MSM, and particularly among Black MSM.115 Further, both HIV and syphilis contact 
tracing investigations yield new HIV diagnoses. Nationally, an estimated 1.3-100 HIV cases 
must be interviewed to yield one new HIV case among named contacts.116 In NC, 41 syphilis 
cases must be interviewed to yield one new HIV case, demonstrating substantial undiagnosed 
HIV prevalence within the known syphilis contact network.116 
Syphilis infection increases both susceptibility to HIV among HIV-negative patients and 
transmissibility of HIV from coinfected patients.103,117 Syphilis is an ulcerative condition that 
decreases mucosal integrity in the genital tract. Syphilitic lesions recruit activated CD4+ T cells 
and dendritic cells. Increased concentrations of these immune cells then heighten direct 
infection of CD4+ T cells at the site of the lesion and amplify dendritic presentation of virions to 
CD4+ T cells in regional lymph nodes for indirect infection.117,118 Syphilis infection in co-infected 
patients also upregulates HIV gene expression via increased binding of nuclear factor (NF)-κB 
to the promoter region of the HIV provirus117,118 and induces generation of pro-inflammatory 





A syphilis or HIV diagnosis is a strong indicator of generalized STI risk and offers 
opportunities for prevention and screening for the other infection. Syphilis infection predicts HIV 
diagnosis among MSM in longitudinal studies9,119,120 and HIV diagnosis is approximately three 
times as high among MSM recently diagnosed with syphilis compared to HIV-negative MSM not 
recently diagnosed with syphilis, even following effective treatment of the syphilis infection.121 It 
is recommended that all persons diagnosed with HIV or syphilis be screened at diagnosis or 
entry to care for the other infection and that contacts of both HIV and early syphilis cases be 
screened for both infections.11 PLWH are also encouraged to test at least annually for syphilis 
coinfection.104 
D.   Contact Tracing for HIV and STI control 
 Contact tracing, also termed partner notification in the STI domain, has long served as 
an integral component of infectious disease control. Mandatory contact tracing was first 
implemented with the passage of the Contagious Disease Act of 1864 in Great Britain to combat 
the spread of venereal disease among military members.122 Contact tracing procedures have 
since been refined to carefully balance the privacy interests of index cases, individual health 
interests of named contacts, and public health interests of the state.123 Contact tracing aims to 
detect previously undiagnosed infection to reduce morbidity and mortality among infected 
persons and prevent onward transmission of infection via treatment and behavior change.124 
First, persons newly diagnosed with the infection of interest are interviewed to elicit recent 
sexual, social, and/or injection drug use (IDU) contacts, depending on the mechanism(s) of 
transmission for the relevant infection. Named contacts are then informed of potential exposure 
to a transmissible infection and provided testing, prevention counseling, and when applicable, 
access to treatment.124  
 Contact tracing is widely utilized in both domestic and global settings. Although used in 




income nations as well.125 In 2016, the WHO issued a new recommendation that voluntary, 
assisted partner notification services should be offered to all newly diagnosed PLWH.125 
Globally, sixty-seven nations practice contact tracing or partner notification and twenty-one 
nations require some form of mandatory notification. State law in much of the US, including NC, 
mandates contact tracing and infection screening for contacts of persons diagnosed with HIV 
and early syphilis.126-128 In NC, DIS are automatically notified when a patient is diagnosed with 
HIV or early syphilis and attempt to interview all new cases to elicit information about recent 
contacts. DIS then attempt to reach these named contacts to provide HIV and syphilis testing 
and prevention counseling.129  
 Contact tracing efforts also offer opportunities to intervene at several stages in the HIV 
PrEP and care continuums. A systematic review evaluating the effectiveness of HIV contact 
tracing programs found a range of one to eight sexual or IDU contacts named per index case.130 
Although only approximately two-thirds of named contacts were identified with sufficient 
information to begin an investigation, and only 63% of those persons consented to be tested for 
HIV, a mean of 20% of named contacts tested were newly diagnosed with HIV.130 Contact 
tracing programs for HIV and syphilis effectively identify a population with a high prevalence of 
undiagnosed infection that may benefit from testing. Of the estimated 1.1 million PLWH in the 
US in 2015, approximately 14.5% remained undiagnosed.131 Contact tracing efforts may allow 
for earlier diagnosis of HIV than would have otherwise been observed in this population, 
triggering changes in behavior and allowing for treatment with ART to reduce the likelihood of 
onward transmission.  
 Syphilis diagnosis and contact tracing for HIV or syphilis may also serve as cues to 
action within the Health Belief Model and trigger acceptance of PrEP or ART uptake among 
previously reluctant or unaware individuals. The Health Belief Model was developed in the early 
1950s by the US Public Health Service to describe why some preventative measures and 




related behaviors were dependent on two primary factors: (1) desire to avoid illness; and (2) 
belief that a health action effectively prevents or treats illness. The model has been further 
developed into six subcategories: (1) perceived susceptibility to illness; (2) perceived severity of 
illness; (3) perceived benefits of a recommended health action; (4) perceived barriers to uptake 
or maintain the recommended health action; (5) cues to action; and (6) self-efficacy.132 A cue to 
action is a stimulus needed to trigger a decision-making process to accept a recommended 
health action and can be internal or external.132 Syphilis diagnosis or being named as a contact 
of a person diagnosed with HIV or syphilis could serve this function as stimuli for PrEP or ART 
uptake. 
  NC and several other jurisdictions have recently expanded HIV prevention services to 
include referrals for PrEP by DIS during contact tracing133-135 because the behaviors and sexual 
partnerships of persons diagnosed with syphilis or named as contacts of persons diagnosed 
with HIV or syphilis place them at substantial HIV risk.14,15 A recent study of a sexual network in 
NC found that one-quarter of HIV-negative named contacts of persons diagnosed with HIV or 
syphilis were diagnosed with HIV within three years.136 Contact tracing also offers an opportunity 
to intervene on the first five stages of the HIV PrEP continuum [Figure 2.1], allowing for PrEP 
awareness building and support for PrEP uptake among indicated persons.35 Although several 
studies are currently assessing the potential for contact tracing services to identify and connect 
eligible PrEP users to providers, as well as interventions to support PrEP linkage and retention 
among this population,135,137 the size of the populations indicated for PrEP and currently using 
PrEP within the HIV/syphilis contact tracing network are unknown.  
 Previously diagnosed PLWH identified in the HIV/syphilis contact tracing network may 
show continued behaviors that allow for ongoing HIV transmission in the absence of viral 
suppression.10 These PLWH may be prime beneficiaries of intensified care engagement 
interventions by DIS and SBC. One recent study reported that 20% of newly diagnosed PLWH 




network members often rejoined the same sexual contact network from which they had acquired 
infection following HIV diagnosis.136 An estimated 70% of HIV transmissions in the US138 (and 
77% in NC)139 arise from contact with previously diagnosed PLWH, highlighting the importance 
of reaching this population with suppressive ART for both clinical and public health benefits. 
However, limited resources often force prioritization of persons newly diagnosed with HIV or 
diagnosed with syphilis, and particularly acute/recent HIV cases and symptomatic early syphilis 
cases, over non-symptomatic, previously diagnosed PLWH by DIS and SBC. Presentation of 
viremic previously diagnosed PLWH in the network may be a missed opportunity to identify 
persons at high risk of HIV transmission and to assist them with care engagement or re-
engagement [Figure 2.2].140 
E.   Network Epidemiology 
 Modern network analysis is rooted in sociometry, or the study of relationships within 
small groups of individuals. Sociometry was first applied to evaluate group structure and 
individuals’ positions within those structures in 1932.141 The field rapidly expanded, now 
encompassing computational, biological, neural, and social networks and methodologies to 
analyze these networks.142 In network analyses involving relationships of any form between 
individuals, individuals are represented as nodes and relevant connections between individuals 
are documented as edges.143 There are two primary types of network analysis: egocentric and 
sociometric. Egocentric analyses evaluate the personal networks of a sample of nodes from the 
population of interest, including just the nodes that are connected to the sample nodes and the 
edges that connect them. Sociometric analyses evaluate the complete network of nodes and 
edges in a set population.143 
 Network analyses are critical components of infectious disease control, particularly 
public health efforts to minimize the transmission of HIV and STIs. In the 1930s, patients at 




ascertain common sources of infection, allowing for the first visualizations of sexual contact 
networks.144 Sexual contact network analyses in the mid-1980s then demonstrated connections 
between early AIDS cases among MSM in New York City, Los Angeles, and San Francisco, 
supporting the hypothesis that AIDS was caused by an infectious agent transmitted via sexual 
activity.145,146 HIV and STI sexual contact networks have since been repeatedly characterized in 
efforts to halt outbreaks and improve targeting of prevention and treatment 
interventions.142,147,148 
 Network features, including density, concurrency, and mixing patterns, heavily influence 
infection transmission within a network.142,147,148 Infection diffuses more quickly over dense 
networks, or networks with a greater proportion of potential connections between nodes fulfilled, 
than over sparse networks with fewer edges per node.142 Infection diffusion also increases with 
concurrency.149-151 Concurrent partnerships overlap in time, where one or more additional 
partnerships begin before the first terminates.142 Independent of network density, increased 
concurrency creates greater network connectivity, exposing larger portions of the network to 
infection.149-151 Sexual networks typically demonstrate fairly assortative mixing, with the 
exception of dissortative mixing by sex in heterosexual networks.152,153 Assortative mixing, also 
termed homophily, occurs when individuals partner with those who share an attribute, such as 
age, race, socioeconomic status, or number of partners.152,153 Homophily may allow for 
differential infection incidence within network sub-populations. Several studies have illustrated 
the role of racial homophily, alongside existing racial and ethnic disparities in HIV prevalence 
and treatment, in perpetuating heightened HIV incidence among Black MSM.154,155  
 Underlying social and cultural forces drive network features.142 Social norms impact 
partner selection, including the number of lifetime partnerships and length of partnerships, 
creating higher or lower levels of density within a network.142 These norms also control the 
acceptability of concurrent partnerships and the tendency towards homophilous sexual 




where individuals meet sexual partners, may enforce or circumvent existing social norms.142 
Dating websites and mobile applications can expose individuals to a wider pool of potential 
sexual partners than they might otherwise encounter and increase opportunities for sexual 
partnerships, particularly among LGBTQ individuals.156,157 Conversely, physical spaces such as 
bars and nightclubs tend to host a smaller, more homogenous pool of prospective partners 
because they cater to specific demographic and geographic populations.158 
 Network factors are associated with HIV acquisition and transmission risk. Following an 
HIV outbreak in a population of PWID in Brooklyn, New York, several network factors were 
identified as significant predictors of HIV infection.159,160 One significant predictor was 
membership in a large, connected component, or a group of persons in which each person is 
connected to at least one additional person within the group. Component membership exposes 
each person to a potential transmission chain from any infected person in the component.159 A 
recent study in NC combined demographic characteristics, HIV/STI testing history, and 
sociosexual network data to develop a risk score algorithm for future indicators of transmission 
risk behavior among newly diagnosed PLWH.10 A model including network features correctly 
classified a greater percentage of PLWH than a model including only individual-level data.10 
Finally, although concurrency does not increase an individual’s HIV/STI acquisition risk 
independent of number of partners, it is associated with increased acquisition risk among the 
concurrent partners161 and increased population-level HIV prevalence.150 Augmentation of 
traditional individual-based analyses with network-based factors may improve evaluation of HIV 
acquisition and transmission risk. 
Limitations of Contact Tracing Network Data 
 Contact tracing data has inherent biases and limitations stemming from non-randomly 
missing data.151,162-165 First, the contact tracing network is identified with selection on infection or 




results are implicitly non-generalizable to the full population from which cases and contacts are 
drawn. As only persons diagnosed with HIV or early syphilis are queried for contacts, analyses 
of these data are restricted to egocentric network analysis methods against the sporadically 
interconnected local networks of each diagnosed person. Analyses may also treat the resulting 
network as a sparse, non-random sample from the underlying sociometric network. 
 Contact tracing is unable to reach all newly diagnosed persons and their contacts. In 
NC, approximately 20% of persons diagnosed with HIV or early syphilis are not reached by DIS 
for interview or do not agree to name partners when reached for interview.10 Further, in one 
meta-analysis of US contact tracing programs with reported data, 33% of all persons named as 
contacts of persons diagnosed with HIV or early syphilis were not reached by public health 
personnel.130 Analyses of network populations identified via contact tracing may thus be subject 
to an additional source of selection bias.163 Contact tracing data are also self-reported and can 
be plagued by incomplete reporting and poor recall.166-168 Persons may additionally fail to name 
contacts because of stigma towards MSM/PWID and PLWH, anonymous partnerships, and 
infidelity,162,163 creating a substantial amount of missing data that may bias network analyses by 
reducing observed density and connectivity.163,165  
Combined HIV and Syphilis Networks 
 Few analyses have generated combined networks containing persons diagnosed with 
HIV or syphilis and their sexual contacts.10,136,169,170 The first combined network study visualized 
persons diagnosed with HIV or syphilis in Colorado Springs from 1985 through 1999 and 
described the structure of the resulting network.169 Subsequent studies have added to our 
understanding of how these networks intersect. One study assessed the combination of HIV 
and syphilis networks in a single NC county, concluding that contemporaneous HIV and syphilis 
transmission persists among MSM in NC.170 This study identified two distinct, large network 




and syphilis, while the second was largely composed of older MSM diagnosed with syphilis and 
their named contacts, with higher proportions of persons who reported engaging in transactional 
sex.170 Another recent study generated a combined HIV/syphilis network seeded by two young, 
Black MSM diagnosed with acute HIV infection in NC.136 Following HIV diagnosis, 21% of 
PLWH in the network were later diagnosed with an incident STI. Conversely, 25% of HIV-
negative named contacts of persons diagnosed with HIV or syphilis were newly diagnosed with 
HIV within three years.136 Finally, a combined HIV/syphilis network generated within one NC 
region demonstrated bridging between HIV contact network components by persons diagnosed 
with early syphilis and their named contacts.10 
 This literature illuminates a relationship between HIV and syphilis networks among 
MSM. However, each of the prior studies evaluating combined HIV/syphilis networks have 
focused on small sub-populations of interest and have largely evaluated the combined network 
as a single network, rather than specifically interrogating how the two networks 
inteconnect.10,136,169,170 A statewide HIV/syphilis contact network has never been characterized, 
and independent HIV and syphilis networks within a single population have never been 
compared. There is a need for a more nuanced understanding of how HIV and syphilis networks 
overlap and diverge if the HIV/syphilis syndemic among MSM is to be effectively addressed.  
Network Systems 
 Many approaches have been proposed to illuminate the complex relationships between 
networks.171 The simplest approach to comparison of two networks is to assess network 
overlap, or the presence of shared nodes and edges between two or more networks. The 
Jaccard node similarity quantifies overlap between two networks as the number of nodes 
belonging to both independent networks, or the intersection, divided by the number in the 
combined network, or the union.172 The Jaccard edge similarity is the number of edges in the 




both measures, a value of 1 represents complete overlap and a value of 0 represents no 
overlap.172 Overlap may be measured between separate networks or between layers of a 
network system. Other approaches treat the networks as interacting or interdependent, but 
distinct, where nodes and edges are not present in multiple networks, but edges may connect 
nodes in network A to nodes in network B. Information, infection, or activity can pass from one 
network to another over these edges.171 
 Interconnected or interconnecting networks have been conceptualized in several ways 
but are broadly defined as network systems in which nodes in network A may be connected 
both to other nodes in network A via intra-network edges, as well as to nodes in network B via 
inter-network edges. Inter-network edges may occur between shared nodes in both networks or 
between distinct nodes across the two networks.171 One proposed measure of interconnectivity 
between networks assesses the change in node degree distributions from the independent 
networks to the combined network in coupled, disjoint network systems.173 These network 
systems require that each node in network A is connected to a node in network B (coupled), but 
that no nodes are present in both networks (disjoint). This measure distinguishes between 
strongly and weakly coupled network systems, where disease or information diffuses over a 
strongly coupled network system as if it were a single network. However, this measure requires 
that all networks demonstrate an internal scale, which is violated by scale-free networks, such 
as most sexual networks, and that the networks be disjoint.173 No measure has been previously 
proposed to quantify interconnectivity between two overlapping, or non-disjoint, networks with 
some proportion of shared nodes and edges. 
F.   Network Community Structure 
 Network community structure is the presence of clusters of nodes that are densely 
connected to each other and sparsely connected to the remainder of the network.12 Community 




networks, including epidemiological contact networks for directly-transmitted infections in human 
and animal populations.13,174,175 However, few studies have been conducted evaluating 
community structure in sexual contact networks. In one such analysis, strong network 
community structure characterized by homogeneity of HIV transmission risk group within 
communities was identified in a sexual contact network of persons diagnosed with HIV and their 
named contacts in Cuba.176 Community detection may be applied to identify community 
structure within multipartite, multiplex, directed or undirected, and weighted or unweighted 
networks, or most combinations of network types.12,177 
 One major school of community detection methodologies is modularity optimization.12 
This approach identifies an approximation of the strongest partition, or division of a network into 
communities with the greatest edge density within communities and least edge density between 
communities. Modularity optimization applies an algorithm, or quality function, that counts the 
number of edges observed within a community, minus the number of edges that would have 
been expected to occur within the same group of nodes under a null model with only randomly 
occurring community structure.12 The quality function is calculated for potential partitions, where 
the partition with the highest value for the quality function displays the strongest community 
structure. As modularity optimization is NP-hard, or likely cannot be solved in polynomial time 
under most algorithms, the strongest partition identified may be one of multiple optimal 
partitions.12 This heuristic may be particularly relevant for identification of network communities 
to inform the design of network-focused transmission prevention interventions because it 
optimizes edge density within communities. As transmissions occur over network edges, most 
transmissions must occur over dense intracommunity edges and few transmissions may occur 
over sparse intercommunity edges in networks with strong community structure. Thus, 
modularity optimization allows for identification of network subgroups or clusters within which 




 Community structure impacts epidemic features, including size, duration, and peak 
prevalence, independent of other network parameters.13,14 In a network with strong community 
structure, infection is more likely to spread within communities than between communities 
because of higher edge density within communities.13 Early outbreaks may die out within the 
initial community or spread serially through sparse edges between communities. Thus, 
outbreaks in networks with strong community structure tend to exhibit greater variance in final 
incidence and duration than those in networks with weak community structure, which typically 
experience more explosive outbreaks.13 Overall community structure also appears to play a 
larger role in infection diffusion over networks than the precise internal structure of communities. 
This phenomenon has been attributed to the relative density of within-community edges 
compared to between-community edges.14 
 The study of infection transmission over networks with community structure was a 
byproduct of the study of information diffusion over networks with community structure, and 
thus, all analyses to date have been limited to transmission of newly introduced infections over 
naïve networks with community structure.14 The effect of community structure on the spread of 
an endemic infection, such as HIV, through a network population has not been assessed. 
Further, the effect of community structure on transmission when infection is unevenly distributed 
across communities is unknown, as are the corresponding relationships among community 
infection prevalence, intervention type, intervention allocation approach, and intervention 
impacts. Identification of network communities may provide a novel means of identifying 
populations at greatest infection risk and allocating network-based interventions. 
G.   Summary  
 The ongoing burden of the HIV epidemic among MSM, particularly among young MSM 
of color in the American South, highlights the need for improved interventions to reduce HIV 




population may be valuable in the design of effective ART and PrEP interventions that can be 
deployed through known sexual contact networks. Insights into how network community 
structure impacts infection transmission over these networks may also aid in precise delivery of 
these interventions for maximum prevention benefits. In addition, up-to-date knowledge of PrEP 
and viral suppression levels within these networks is required to assess resource needs and 
current intervention coverage gaps. In an era where “Ending the HIV Epidemic” (EHE) 
campaigns are being mounted across the US,178 findings from this dissertation may be helpful in 
the design and deployment of EHE-backed interventions against persistent HIV incidence in 





















Figure 2.1 HIV pre-exposure prophylaxis (PrEP) care continuum 
 


















































































CHAPTER THREE: DATA SOURCES AND EXTENDED METHODS 
 
A. Overview of Data Sources 
North Carolina Electronic Disease Surveillance System (NC EDSS) 
 NC EDSS is a secure, integrated system for monitoring of all reportable communicable 
infections in NC, including HIV and syphilis.179 This system is used by NC DPH, all 86 local and 
multi-county health departments in NC, and eight regional HIV/STI offices. Individuals are 
assigned unique identifiers upon diagnosis or interaction with NC DPH related to one of the 
infections included in NC EDSS. This identifier is then used to follow the individual over time 
and to link reports across disease fields, enabling longitudinal evaluation at the individual level. 
Reporting of HIV and early syphilis diagnoses to NC EDSS is mandated by NC law, as is 
reporting of all CD4 counts, viral loads, and viral sequences performed for PLWH. The rich 
information managed in NC EDSS allows for study of individuals over time as they experience 
HIV and STI diagnoses, are named as contacts, engage in HIV care, and disengage from HIV 
care.179 
 As described in Chapter 2, NC law mandates DIS contact tracing for named contacts of 
HIV and early syphilis cases. Early syphilis comprises three infection stages – primary, 
secondary, and early latent – approximately corresponding to the first three, six, and twelve 
months of infection, respectively.104 DIS attempt to interview all persons newly diagnosed with 
HIV and persons diagnosed with early syphilis to identify recent sexual and IDU contacts, as 
appropriate. Sexual and IDU contacts are elicited for the twelve months prior to DIS interview for 




three months prior to symptom onset for persons diagnosed with early latent, secondary, and 
primary syphilis, respectively [Figure 3.1].128 DIS then attempt to trace and screen these named 
contacts, and a subsequent round of contact tracing is initiated when a contact is newly 
diagnosed with HIV or diagnosed with early syphilis. This process produces exponential 
discriminative snowball sampling of the underlying contact network.180  
 SBC assist persons newly diagnosed with HIV with linkage to HIV treatment to expedite 
ART initiation.100,101 SBC also identify previously diagnosed PLWH who are not receiving regular 
HIV care and are not virally suppressed through frequent record evaluations, provider reports, 
and DIS report following early syphilis diagnoses or identification of these persons as contacts 
of persons diagnosed with HIV or early syphilis. SBC then provide support for care linkage or re-
linkage. All DIS and SBC interviews are documented in NC EDSS.100,101 
 Information on persons diagnosed with HIV and early syphilis and their named sexual 
and injection drug use contacts available in NC EDSS include: 
1. HIV and STI diagnosis information, including dates, tests, results, providers, and 
locations, as well as self-reported STI diagnoses; and 
2. Laboratory and medical information, including HIV viral loads, CD4 counts, and viral 
sequences, as well as the associated dates, providers, and locations; and 
3. Demographic information, including age, sex, self-identified gender identity, and self-
identified race and ethnicity; and 
4. Behavioral information, including self-identification as MSM or PWID, condom use, 
and substance use behaviors; and 
5. Contact information, including names of contacts, type of contact (sexual, injection 
drug use, or social), contact duration (start and end dates or start date to current), 
and frequency of sexual or injection-related acts; and 
6. Geographic information, including residential and clinic location at diagnosis and/or 




 All data were originally collected for public health surveillance purposes and no further 
contact was made with study participants on behalf of this study. A Data Use Agreement with 
the Communicable Disease Branch of the NC DPH governing data collection, use, and 
publication was executed prior to data extraction from NC EDSS.  
Blue Cross Blue Shield of North Carolina (BCBS NC) 
 BCBS NC data contain insurance claims from insured groups, administrative services 
only groups, and individual market and Affordable Care Act Exchange groups.181 These data 
cover approximately 3.6 million NC residents:182 35% of the NC population,183,184 50% of the 
non-Medicare/Medicaid insured population,182,184,185 and 60% of the privately insured 
population.186 BCBS NC data are housed at the Cecil G. Sheps Center for Health Services 
Research at the University of North Carolina at Chapel Hill (UNC-CH). Available data include: 
1. Insurance claims information, including provider visits, inpatient and outpatient care, 
prescription medications, charge amounts, dates of service, diagnoses, and 
procedures; and 
2. Provider information, including specialty and location; and 
3. Member information, including age, self-identified gender, and county/ZIP code of 
residence; and 
4. Plan information, including dates of enrollment in BCBS NC, type of insurance plan, 
pharmacy coverage, and relationship to BCBS NC subscriber.181  
These data do not include State Employee’s Health Plan subscribers, which is also 
administered by BCBS NC. A Data Use Agreement with BCBS NC governing data access, use, 






B. Linkage of Data Sources  
 A subset of persons present in NC EDSS (described below in Aim 2 Extended Methods) 
were linked to BCBS NC insurance claims data for analyses in Aim 2 by an honest broker at the 
Cecil G. Sheps Center for Health Services Research at UNC-CH. Individually identifiable health 
information (IIHI) and dummy identifiers, stripped of all health-related information, were provided 
by both NC EDSS and BCBS NC for data linkage [Figure 3.2].  
 Linkages occurred on the Sheps Center’s secure server using an iterative set of three 
matching algorithms [Table 3.1]. Before matching, names were stripped of all blanks, periods, 
dashes, commas, apostrophes, and suffixes. A strict deterministic match on first and last name, 
date of birth, self-identified gender, and ZIP code was applied as the first pass, followed by 
subsequent passes using subsets of these fields. Matched persons were removed after each 
pass. Persons in NC EDSS who matched to multiple BCBS NC IDs in any of the three matching 
passes (multiple matches) were cross-checked against a table of persons known to have 
multiple BCBS NC IDs and data were condensed across all matched IDs. Multiple matches not 
previously known to Sheps Center staff were manually resolved and samplings of high 
confidence matches were reviewed for verification. 
 Access to IIHI data was restricted to the honest broker who performed matching and 
data linkage work. IIHI were stored in an encrypted form while at rest and destroyed as soon as 
linkage was completed. Dummy identifiers were then used to merge health-related information 
from both sources. The linked dataset containing BCBS NC and NC EDSS data was stored on 







C. Aim 1 Extended Methods 
Study Design 
 Using contact tracing data, we generated independent and combined HIV and syphilis 
networks for all MSM diagnosed with HIV or early syphilis, respectively, in North Carolina 
between 2015 and 2017. We treated the independent networks as layers and identified network 
communities, or groups of densely connected people, in the two-layer network. We assessed 
interconnectivity of the syphilis network with the HIV network by comparing the mean node 
degree among syphilis network members in the syphilis network alone vs. the combined 
HIV/syphilis network, both overall and by community. All analyses were conducted in R v. 
3.5.0187 and MATLAB 9.3 (The MathWorks Inc., Natick, MA).  
Study Population and Data Extraction 
 We defined a network event as receiving an HIV or early syphilis diagnosis between 
2015 and 2017, or being named as a sexual contact by someone receiving one of these new 
diagnoses. Each network event was assigned a network event status: HIV diagnosis, early 
syphilis diagnosis, HIV contact, or early syphilis contact.   
 All new HIV and early syphilis diagnoses among persons diagnosed in NC between 
2015 and 2017 who self-identified as cisgender MSM aged ≥ 18 years were included as HIV 
and syphilis diagnosis events, respectively. Adult, cisgender men named as sexual contacts at 
these diagnosis events were included as experiencing HIV and early syphilis contact events, 
respectively. Some persons experienced multiple or repeat network events during the study 
period; all such events were included for network generation. We excluded diagnosis events 
among newly diagnosed persons not reached for – or not willing to provide information about 
recent contacts in – DIS interview, as the absence of information about contacts precludes any 




named no sexual contacts during the relevant time frame were included as isolates. Events 
among self-identified transgender persons were excluded because gender identity was not 
collected for persons diagnosed with early syphilis during the study time frame, preventing 
analyses specific to this vulnerable population. 
 Data extracted from NC EDSS for diagnosis and contact events included dummy 
identifiers, demographic information, geographic information, diagnosis dates, locations, and 
statuses through December 31, 2018, laboratory confirmed and self-reported STI history 
through December 31, 2018, contact tracing dates and statuses through December 31, 2018, 
HIV viral loads through December 31, 2018 for all PLWH, and self-reported HIV transmission 
risk factors. Data were extracted using SAS 9.4 (SAS Institute Inc., Cary, NC) from a copy of 
NC EDSS data current through December 31, 2018.  
Network Generation and Description 
 In social network analysis, persons are represented as nodes and relevant connections 
between persons are included as edges.143 We generated an independent HIV network 
comprising persons diagnosed with HIV and their contacts, with sexual relationships reported 
during HIV contact tracing between these persons as edges. We generated an analogous 
independent syphilis network comprising persons diagnosed with syphilis and their contacts, 
linked by edges denoting sexual relationships reported during syphilis contact tracing. Finally, 
we generated a combined HIV/syphilis network comprising all persons and edges from both 
independent networks.   
 We calculated descriptive statistics for the combined network population and by network 
event status, summarizing the number and percentage of network events according to age and 
self-identified race/ethnicity. We also described the diagnostic site for persons diagnosed with 
early syphilis, categorizing sites as 1) primary care physician’s office or health maintenance 




health departments; 3) other clinics; 4) emergency department; and 5) other (inpatient care, 
correctional facility, blood bank, etc.). 
 Next, we calculated standard network parameters for the combined and independent 
networks. In network analysis, a component is a group of two or more nodes, where each node 
is connected by an edge to at least one other node in the component. An isolate is a node that 
is not connected by an edge to any other node.143 We identified isolates, calculated the largest 
component size for each network, and characterized the corresponding component size 
distributions as the number and percentage of components in each network that were dyads (2 
nodes), and small (3-9 nodes), medium (10-29 nodes), and large components (≥ 30 nodes). 
One network characteristic of particular interest was the size of the largest connected 
component in each network. The largest connected component is the largest group of persons 
within a network within which each person is connected to at least one other person within the 
group. An increase in the percentage of persons included in the largest connected component 
from the independent networks to the combined network demonstrates bridging by nodes and 
edges in each of the independent networks between disconnected components in the other 
network. 
 We calculated node degree as the number of nodes to whom each node was connected 
by an edge143 and estimated the mean and 95% confidence intervals in each network 
population. Homophily (assortative mixing) by age and self-identified race/ethnicity for pairs of 
diagnosis nodes and their sexual contacts were characterized for each network. Homophily by 
age was calculated as the median absolute difference in diagnosis-contact ages at the time of 
the network event. Homophily by race/ethnicity was evaluated via mean homophilic 
preference,188 or the proportion of edges within diagnosis-contact pairs with concordant self-
identified race/ethnicity classifications (Black, non-Hispanic; White, non-Hispanic; Hispanic; 
Asian, non-Hispanic; or other/multiracial). Pairs in which either partner was missing self-




Network Overlap and Interconnectivity 
 We used a traditional measure of network overlap, the Jaccard node similarity, to 
quantify direct overlap between the independent HIV and syphilis networks. We calculated this 
measure as the number of nodes belonging to both independent networks (intersection) divided 
by the number in the combined network (union).172 We calculated the Jaccard edge similarity 
analogously as the number of edges in the intersection divided by the number in the union. For 
both measures, a value of 1 represents complete overlap and a value of 0 represents no 
overlap.  
 The Jaccard node and edge similarities do not fully describe the potential for HIV to 
propagate across the syphilis network, as opportunities for transmission of HIV through the 
syphilis network are dependent not only on the amount, but also the distribution, of overlap 
[Figure 3.3]. If the HIV network overlaps with only a distinct segment of the syphilis network, 
limited numbers of persons within the syphilis network are directly connected to the HIV 
network. However, if the HIV and syphilis networks are more widely interwoven, a larger 
proportion of syphilis network members may be directly connected to the HIV network. To reflect 
this phenomenon, we devised a simple measure of interconnectivity that accounts for both the 
proportion of overlapping nodes and the distribution of this overlap.  
 More specifically, we conceptualized interconnectivity as the relative percentage 
increase in mean node degree (mean number of persons to whom each person is connected by 
an edge) following combination of an index network with a second network. To estimate 
interconnectivity of the syphilis network with the HIV network, we thus compared the mean node 
degree among syphilis network members in the independent syphilis vs. combined HIV/syphilis 
networks. If there were no interconnectivity between the syphilis network and the HIV network, 
we would expect to observe no increase in mean node degree; higher relative increases 




Dickison et al.173 for evaluation of coupled, disjoint network systems, but our simpler measure 
allows for nodes and edges to be shared between networks. Further, our measure does not 
require that networks’ degree distributions demonstrate an internal scale, a requirement is 
violated by scale-free networks, including many sexual contact networks. 
Community Detection 
 Community detection identifies clusters of nodes within a network that are more densely 
connected to each other than to the remainder of the network.12 We employed community 
detection to identify clusters of persons within the combined HIV/syphilis network among whom 
the syphilis network was highly interconnected with the HIV network, suggesting greater 
potential for exogenous HIV entry into the syphilis network. We applied a generalized Louvain 
method for community detection, including the independent HIV and syphilis networks as 
distinct network layers.177 This method maximizes a quality function Q, also termed the 
modularity of the network, to identify the set of community assignments that produces the 
highest concentration of edges within network communities. Larger values of Q (maximum 
possible value = 1) indicate that more edges occur within communities (rather than between 
communities), while Q = 0 indicates that edge occurrence is uncorrelated with community 
labels. Community detection analyses were restricted to the largest connected component in the 
combined network to ensure sufficient network density. 
 The generalized Louvain method for community detection maximizes a quality function 
Q that sums intra-community edge weights within layers, less the edge weight expected under a 
null model where nodes are linked randomly within layers.177 Nodes in each layer are connected 
to their corresponding node in each other layer in which they are present under an interlayer 
coupling parameter ꙍ = 1 [Figure 3.4]. Interlayer coupling with ꙍ = 1 ensures that each node is 
identified in only one community across all layers. However, not all nodes are required to be 
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 This function sums the total edge weight observed, less the edges expected within 
layers in a null model under the set resolution parameter, within communities. The sum is then 
divided by the total edge weight observed within the network. Adjacencies 𝐴𝑖𝑗𝑠 denote edges 
within a layer s between nodes i and j, and inter-layer couplings 𝐶𝑗𝑠𝑟 denote edges between 
node j in layer s to itself in layer r. The total edge strength for each node j within a single layer is 
𝑘𝑗𝑠 =  ∑ 𝐴𝑖𝑗𝑠𝑖  and the total edge strength across layers is 𝑐𝑗𝑠 =  ∑ 𝐶𝑗𝑠𝑟𝑟 . The multilayer edge 
strength for node j in layer s is defined as κ𝑗𝑠 =  𝑘𝑗𝑠 + 𝑐𝑗𝑠. The total weight of all edges within a 
layer is 2𝑚𝑠 and the total weight of all edges in the network is 2μ =  ∑ κjrjr . The parameters 
𝛿𝑠𝑟 , 𝛿𝑖𝑗 , and 𝛿(𝑔𝑖𝑠, 𝑔𝑗𝑟) are Kronecker deltas: 𝛿𝑠𝑟 = 1 if the layers s and r are the same layer and 
0 if different layers, 𝛿𝑖𝑗 = 1 if nodes i and j are the same node in different layers and 0 if different 
nodes, and 𝛿(𝑔𝑖𝑠, 𝑔𝑗𝑟) = 1 if the community assignments 𝑔𝑖𝑠 and 𝑔𝑗𝑟 of nodes i and j in layers s 
and r are the same and 0 if they differ.177 The resolution parameter 𝛾 is adjusted to modify 
community size. 
 We applied the Convex Hull of Admissible Modularity Partitions (CHAMP) algorithm to 
our network189 to identify domains of potentially optimal resolution parameters within the range 
[0, 10] for both 𝛾 and ꙍ. Pairs of (𝛾, ꙍ) parameter selections within any single domain produce 
community assignments with similar numbers of communities and modularity (Q). After setting 
ꙍ = 1, CHAMP identified a domain over 𝛾 = [0.2, 1.2] within which all possible parameter 
assignments should produce similar community assignments.   
 We then applied a modified version of the iterated generalized Louvain algorithm for 
community detection within categorical, multilayer networks available at 
http://netwiki.amath.unc.edu/GenLouvain190 and discussed above, adapting the script to allow 




tested 𝛾 were identified as the community assignments for each node that maximized the quality 
function Q in the highest modularity partition of 1,000 non-deterministic runs.177 We compared 
identified communities across a subset of the 𝛾 = [0.2, 1.2] domain with ꙍ = 1 and selected 𝛾 = 
0.25 as the final parameter assignment because it minimized the number of individuals in small 
communities excluded from interconnectivity analyses. 𝛾 = 0.2-0.3 produced very similar 
community assignments and required exclusion of the same number of nodes due to 
membership in communities containing <30 members of the syphilis network [Table 3.2]. 
Network community membership was visualized using an adaptation of the code available at 
http://netwiki.amath.unc.edu/VisComms/VisComms.191 
Comparison to Modularity of Random Networks 
 Large, sparse networks naturally tend to have high modularity, so for comparison we 
assessed modularity of the largest connected component of the same size and density of 
random multilayer networks generated from an Erdos-Renyi model. These networks showed 
modularity (Q) = 0.954 (± SD: 0.0032). Although the absolute difference in modularity is slight, 
given the small available range between the modularity expected by chance and the maximum 
value of Q = 1, our empirical network does display significantly higher modularity.  
Heterogeneity of Syphilis/HIV Network Interconnectivity by Community 
 We repeated our analysis of syphilis network interconnectivity with the HIV network in 
each community to assess heterogeneity of interconnectivity. As the distribution of node degree 
increases was non-normal within communities, we restricted this analysis to network 
communities containing ≥30 members of the syphilis network to allow for reliable estimates of 
the mean percentage increase in node degree under the central limit theorem.192 
 To characterize potentially distinguishing features of highly interconnected communities 




models to assess the unadjusted associations between community membership characteristics 
and community-level interconnectivity (relative percentage increase in node degree following 
combination of the syphilis network with the HIV network). Independent variables included 
median age of community members at first network event; proportion of community members 
who self-identified as Black, non-Hispanic; proportion of persons with syphilis diagnoses who 
received their diagnoses at STD clinics in each community; and proportion of community 
members who were members of both the HIV and syphilis networks. Each independent variable 
was assessed in a distinct regression model. With the exception of syphilis diagnosis site, we 
included all members of each community in the calculation of these community descriptors 
because understanding communities as a whole may allow for insights into the forces driving 
overall network structure. Associations of interconnectivity with demographic descriptors (age, 
race/ethnicity) and syphilis diagnostic site may aid in identifying indicators of heightened 
interconnectivity that could guide resource allocation within the syphilis network without 
requiring complex network analyses in real time.  
D. Aim 2 Extended Methods 
Study Design 
 We used surveillance data to identify two types of qualifying “network events” occurring 
between January 2013 and June 2017 among MSM in NC: being diagnosed with early syphilis, 
or being named as a recent sexual partner of a person diagnosed with HIV or early syphilis. We 
estimated prevalent and incident viral suppression among persons with a previous HIV 
diagnosis at the network event, and we assessed the effect of contact tracing services on six-
month cumulative incidence of viral suppression. Using linked prescription claims data, we also 
evaluated prevalent and incident PrEP use among HIV-negative network members. PrEP-




remote server submit. Viral suppression analyses with NC EDSS data alone were performed in 
R v. 3.5.0.187 
Study Population and Data Extraction 
 We first identified all persons becoming diagnosed with HIV or early syphilis in NC over 
the period January 2013 – June 2017 (inclusive) within NC EDSS. We then identified the sexual 
partners named by these persons during contact tracing. We defined a qualifying HIV/syphilis 
network event as receiving an early syphilis diagnosis or being named as a sexual contact by a 
person becoming diagnosed with HIV or early syphilis. Some persons experienced multiple 
network events during the study time frame; all such events were included and were linked 
during analyses. We further restricted our study population to include only persons who: 1) were 
≥18 years old on the date of the network event; 2) resided in NC at the time of the event; 3) did 
not self-identify as transgender; and 4) either self-identified as MSM or identified as male and 
were named as a sexual contact by a self-identifying male partner. Self-identified transgender 
individuals were excluded because gender identity was unavailable for persons diagnosed with 
syphilis during the study period, preventing subgroup analyses of transgender women. 
 We then identified sub-populations for viral suppression and PrEP use analyses. Viral 
suppression analyses were conducted only among persons with an HIV diagnosis ≥30 days 
before their network event. Persons diagnosed with HIV at the network event or <30 days prior 
were excluded because they could not yet have achieved suppression through ART. Incident 
viral suppression analyses included only previously HIV-diagnosed persons without prevalent 
viral suppression at the time of their network event. 
 PrEP use analyses were conducted only among persons with confirmed HIV-negative or 
unknown HIV status at the time of the network event and included only those persons in NC 
EDSS who matched to insurance claims data as described above in “Linkage of Data Sources” 




prevalent PrEP use analyses to those with continuous coverage over at least six months before 
the network event. Incident PrEP use analyses were restricted to those with continuous 
coverage over the sixty days prior to the network event and over the six months following the 
network event.  
 As most persons without a prior HIV diagnosis are tested for HIV at the time of a network 
event, persons without an HIV diagnosis on record in NC EDSS before or in the 14 days 
following the event were presumed HIV-negative. The impact of this assumption was 
interrogated in a sensitivity analysis limiting PrEP analyses to events among persons who 1) 
were reached by DIS at the time of the network event, consented to HIV testing, and had a 
negative result; OR 2) had an unrelated, documented HIV-negative test result in NC EDSS in 
the three months prior to the network event or ever following the network event, through 
December 2019. 
Prevalent and Incident Viral Suppression among Previously Diagnosed PLWH 
 HIV viral load is routinely measured during HIV clinical care visits to evaluate disease 
progression and treatment success. In NC, HIV viral load measures generated by all HIV care 
providers are mandatorily reported to NC DPH.127 We identified all viral load measures during 
the year prior to each network event among previously diagnosed PLWH to assess prevalent 
viral suppression. Using the measure collected closest to the event, we classified persons with 
viral load <200 copies/mL as virally suppressed according to the CDC definition for surveillance 
purposes.193 Persons with no viral load measures available during the year prior to the network 
event (20.6% of previously diagnosed PLWH without viral load <200 copies/mL) were assumed 
to be out of care and classified as not virally suppressed. Virally non-suppressed PLWH were 
subsequently assessed for six-month cumulative incidence of viral suppression, defined as ≥1 




analysis, we assessed the twelve-month cumulative incidence of viral suppression, defined 
analogously. 
Effect of DIS Services on Incident Viral Suppression 
 To assess the impact of current DIS services on viral load outcomes among previously 
diagnosed PLWH in our population, we estimated the effect of being reached by DIS in 
association with the network event on the six-month cumulative incidence of viral suppression 
thereafter. Previously diagnosed PLWH were classified as reached by DIS services if DIS 
interacted with them in any capacity, including contact tracing interviews for those diagnosed 
with early syphilis, re-interviews among those named as contacts of persons diagnosed with 
HIV, and contact interviews for syphilis screening among those named as contacts of persons 
diagnosed with early syphilis. We applied linear risk regression to estimate adjusted cumulative 
incidence differences (aCID) comparing incident viral suppression among those reached vs. not 
reached by DIS. 
 A generalized estimating equations (GEE) model with an autoregressive correlation 
structure was used to account for the presence of multiple observations for some persons.194 
Under this condition, standard regression methods would underestimate standard errors 
because of correlation between repeated observations from a single individual. Repeated 
observations in our study population are valuable and cannot be discarded because they 
capture the reality of HIV and early syphilis contact tracing programs in NC – many individuals 
do experience multiple network events in close succession. GEE addresses this condition by 
down weighting within-subject observations according to the degree of correlation between 
residuals and the number of correlated observations for parameter estimation.194 First, a 
standard linear regression model assuming that all observations are independent is applied. 
Residuals are calculated from this model and are used to estimate a working correlation matrix. 




individuals by weighting each observation (
1
1+(𝑥−1)∗𝑅
), where x is the number of within-subject 
observations and R is the correlation between residuals. This process is repeated until 
estimates converge.194  
 The Quasi-likelihood under Independence model Criterion (QIC) is applied with GEE for 
model selection.195 The QIC sums the log quasi-likelihood for all observations under the 
independence model, or the inaccuracy of the fitted model to the observed data, plus a 
covariance penalty term.195 Confounders were singly assessed to identify optimal functional 
form via estimation of the QIC of a model with the confounder as the independent variable and 
the outcome variable as the dependent variable. The QIC was estimated for such models under 
all relevant correlation structures and the functional form that minimized QIC across all 
correlation structures was selected for each confounder.195 
 Plausible confounders of the possible effect of DIS services on reported incident viral 
suppression were identified following a comprehensive literature review and assessed using a 
directed acyclic graph (DAG)196 [Figure 3.5]. Network event status, age, and time since HIV 
diagnosis may affect prioritization of DIS services, while the event date may affect the size of 
the DIS caseload at that time. SES and perceptions of public health/willingness to engage with 
health services may create uncontrolled confounding that cannot be addressed with the 
available data. Confounders were then evaluated to identify optimal functional form, resulting in 
nominal coding of event year (2013, 2014, 2015, 2016, 2017), network event status (syphilis 
diagnosis, HIV contact, syphilis contact), and age at network event (18-24, 25-34, 35-44, ≥45 
years), and restricted cubic splines to represent years since HIV diagnosis. This adjustment set 
was included in the linear risk GEE model to estimate an aCID with robust standard errors using 
the sandwich estimator. GEE models were repeated with twelve-month cumulative incidence of 




 We evaluated several potential correlation structures because the pattern of correlation 
between multiple observations from a single individual in our study population is not known. If all 
within-subject observations are equally correlated regardless of other factors, an exchangeable 
correlation structure is appropriate. However, if correlation of within-subject observations is 
influenced by the number of network events between observations, an autoregressive 
correlation structure should more closely approximate the true covariance matrix. The 
Correlation Information Criterion (CIC) is the ratio of the robust covariance against the model-
based covariance, where a lower value indicates that the estimated covariance matrix more 
closely approximates the true covariance matrix.197 We selected the most appropriate 
correlation structure by comparing models with exchangeable and autoregressive working 
correlation structures for within-subject observations to an independent correlation structure as 
a reference using the CIC.  
 We fit an identity-binomial (linear risk) regression model, where i is the subject ID, o is 
the observation number for a network event, DISio represents DIS services at that event, and 
X1, …,  Xn represent adjustment variables. Adjustment variable values may or may not differ by 
observation for a single individual. GEE models were fit and evaluated using the geepack198 R 
package as: E(Yio) = B0 + B1*DISio + B2X1io + … + BnXnio. 
Prevalent and Incident PrEP Use among HIV-Negative Persons 
 PrEP use, as measured by FTC/TDF prescription claims, was evaluated among 
confirmed or presumptive HIV-negative persons using an adaptation of a previously described 
algorithm for PrEP utilization.199 Persons prescribed FTC/TDF, also known as Truvada, for PrEP 
were identified via exclusion of FTC/TDF prescriptions for HIV or Hepatitis B virus (HBV) 
treatment or as HIV post-exposure prophylaxis (PEP) [Figure 3.6]. There is substantial overlap 
between PEP and PrEP users; even if a person had an excluded FTC/TDF prescription claim 




be classified as a PrEP prescription. PrEP prescriptions and exclusions199 due to prior or 
concomitant prescriptions and/or diagnoses were determined from International Classification of 
Diseases, Ninth and Tenth Revisions Clinical Modification (ICD-9/10-CM) codes and National 
Drug Codes (NDC) in insurance claims data [Appendix]. Claims records were queried from 
January 1, 2010 through 30 days after FTC/TDF prescription as an “all-available” lookback 
period to identify exclusions. We manually reviewed all records for each event with an FTC/TDF 
claim excluded due to prior HIV diagnosis, identifying and correcting erroneous ICD-9/10-CM 
codes for prior HIV diagnosis in two persons who tested HIV-negative at the network event and 
indicated to DIS that they were currently using PrEP. 
 We assessed prevalent PrEP use, defined as ≥1 PrEP prescription claim in the six 
months prior to the network event date, among those with continuous pharmacy insurance 
coverage during that period. We then assessed incident PrEP use following a network event 
among all persons with pharmacy insurance coverage over the sixty days prior to the event date 
and continuously for six months after the event date, excluding persons with documented PrEP 
use prior to the network event. Six-month cumulative incidence of PrEP use was defined as ≥1 
PrEP prescription claim in the six months following the network event. We described prevalent 
and incident PrEP use by age, self-identified race/ethnicity, HIV/syphilis network event status 
(syphilis diagnosis, HIV contact, syphilis contact), year of network event, insurance subscriber 
(self, parent, other), and apparent PrEP indication (defined below).  
PrEP Indication among HIV-Negative MSM  
 The CDC recommended indications for PrEP use by MSM include 1) adult man; 2) 
without acute or established HIV infection; 3) any male sex partners in the past six months; 4) 
not in a mutually monogamous partnership with a recently tested, HIV negative man; and either 
5a) any anal sex without condoms (receptive or insertive) in the past six months; or 5b) a 




adaptation of the CDC recommended indications among MSM to describe PrEP use by 
indication for PrEP. 
 PrEP indication at the time of the network event was defined as: 1) had ≥1 male sex 
partner in the prior six months documented in NC EDSS (named by a man diagnosed with HIV 
or syphilis as a sexual contact or named any male sexual contacts during the six months prior to 
the event date); AND either 2) reported any CAI (reported recent condom use frequency as 
anything other than “Always” in DIS interview); OR 3) became diagnosed with or reported a 
bacterial STI, including syphilis, gonorrhea, chlamydia, or chancroid, in the prior six months 
(self-reported a bacterial STI diagnosis, had a bacterial STI diagnosis recorded in NC EDSS, or 
became diagnosed with early syphilis at the relevant network event). Missing values for condom 
use frequency were treated as lack of consistent condom use and a proxy for CAI. We 
evaluated the impact of this “worst-case” assumption in a sensitivity analysis by imputing 
missing condom use values and identifying the PrEP-indicated population after imputation.  
 As condom use is binary in our analyses, we used multiple imputation by chained 
equations (MICE) to impute unobserved condom use values conditional on observed 
demographic, clinical, and risk behavior characteristics.200 Under MICE, a series of regression 
models are applied to model each variable with missing data conditional upon all other variables 
available. Each variable is modeled according to its distribution; binary variables such as 
condom use as defined here are modeled using logistic regression.200 First, observed values for 
condom use were regressed on all other variables. Missing values were replaced by predictions, 
or imputations, from this regression model. We repeated this process until the model 
coefficients converged and retained the final imputations as the variable values. We then 
repeated the imputation procedure to create 50 imputed datasets.200 All imputation was 
performed using the mice R package.201 
 Imputation was restricted to the first two events for each unique person; no persons in 




Data were transposed from long to wide to create a single record for each person across both 
events. We then applied MICE to impute condom use conditional on all available variables, 
including: age, self-reported race/ethnicity, network event status, county, ZIP code, event date, 
DIS services status, prior documented HIV negative status, STD laboratory confirmed 
diagnoses in the six months prior to the event, self-reported STD diagnoses in the six months 
prior to the event, documented sexual contact in the six months prior to the event, documented 
sexual contact with a diagnosed PLWH at the event, and naming case condom use status for 
contacts. If a person had at least two eligible events, data from the other event, including 
condom use if non-missing, were included in the imputation model. Condom use information 
was missing for 2% of persons diagnosed with syphilis, 69% of persons named as HIV contacts, 
and 91% of persons named as syphilis contacts.  
 We treated PrEP indication as a stratification variable rather than an inclusion criterion 
for PrEP analyses due to challenges in reliably assessing PrEP indication with surveillance 
data. In addition to challenges related to missing data on condom use frequency, the 
surveillance-based adaptation likely underestimates PrEP indication because we cannot reliably 
identify the number of male sex partners in the six months prior for persons named as contacts 
and instead must rely on information provided by naming cases or by these same persons at 
other network events within the time frame of interest. In addition, sexual contacts are only 
elicited for the three months prior to symptom onset among persons diagnosed with primary 









E. Aim 3 Extended Methods 
Study Design 
 We generated static contact networks with community structure and other critical 
network features drawn from the Aim 1 sexual network and varied initial HIV prevalence within 
communities. Then, we applied a simplified, stochastic transmission model to simulate HIV 
spread through these networks. We evaluated HIV incidence in each community by endemic 
community HIV prevalence and modeled the efficiency of community-prevalence-based vs. 
randomly allocated treatment and prevention interventions on overall HIV incidence within the 
known network over a range of initial overall network HIV prevalences and intervention 
coverage levels.  
Network Generation 
 Following other studies of network structure,13,14 we used an empirical network as a 
starting point and test case for simulations and comparisons. Network parameters were drawn 
from the largest connected component of the HIV and syphilis sexual contact tracing network 
among MSM in NC from 2015 through 2017. This network demonstrates strong modularity, or 
community structure, and was comprehensively characterized in Chapter 4. Empirical network 
parameters drawn from this network included the network size (N), modularity (Q), number of 
communities (K), and overall node degree, intracommunity node degree, and community size 
distributions.  
 The network modularity quality function Q evaluates edge density within and between 
communities. If all edges fall randomly between nodes without regard to community, Q = 0, 
while if all edges fall only within communities, Q = 1. We used a simplification of the 
generalized-Louvain algorithm175,190 discussed in the Aim 1 Expanded Methods for a single-layer 




modularity (Q) in our empirical network, treating the combined HIV and syphilis network as a 
single network layer. We also later applied this function to identify network communities within 
each generated network. With only a single layer, the expression discussed above for Aim 1 
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 This function sums the total edge weight observed, less the edges expected with the set 
resolution parameter 𝛾 under a null model assuming no community structure, within network 
communities. The sum is then divided by the total edge strength 2μ observed within the 
network. Adjacency Aij denotes edges between nodes i and j. The total edge strength for each 
node j is kj =  ∑ Aiji  and the total edge strength in the network, 2μ =  ∑ kj ,. The Kronecker delta 
δ(gi, gj) = 1 if the community assignments gi and gj of nodes i and j are the same and 0 if they 
differ.175 Modularity (Q) was estimated with 𝛾 = 0.25175 for concordance with community 
detection analyses of the empirical network conducted in Aim 1 using a publicly available script 
hosted at http://netwiki.amath.unc.edu/GenLouvain.190  
 Large, sparse networks like the empirical network assessed here tend to display strong 
modularity. To evaluate the departure of this network’s structure from expected modularity, we 
compared the observed modularity to modularity of largest connected components of the same 
size and density from random Erdos-Renyi networks. These random networks showed 
modularity (Q) = 0.914 (± SD: 0.0051).  
 To determine the appropriate distributions for additional network simulation input 
parameters, we fit the overall node degree, intracommunity node degree, and community size 
distributions from the empirical network against common distributions for network data, including 
uniform, Poisson, geometric, lognormal, and power law distributions. Lognormal and power law 




three distributions were then best fit by the lognormal distribution under the Vuong test [Figure 
3.8].203 Parameters (μ and σ) from these distributions were identified as input parameters for 
network generation.  
 We used these input parameters with the algorithm presented in Sah et al204 to generate 
100 static networks as modular random graphs using the randomized hierarchical configuration 
model (HCM*), which preserves the empirically observed community size distribution and 
distributions of node degrees within and between communities, but randomizes specific inter 
and intracommunity edges.14,204 The algorithm proceeds as follows: 
1. Assign N nodes to K communities. Community sizes sk are sampled for each of the K 
communities from the lognormal community size distribution such that ∑sk = N. N nodes 
are then arbitrarily assigned to communities under the sampled community size 
sequence. 
2. Assign overall degrees, d(vi), to each node vi. A degree sequence is sampled from the 
lognormal overall degree distribution. This sequence must verify the Handshake 
Theorem, or the requirement that the sum of degrees is even, and the Erdős-Gallai 
Criterion, which ensures that the sequence is able to be graphed. Under the Erdős-
Gallai criterion, the degree sequence is sorted from highest to lowest and then queried 
to ensure that there are sufficient degrees remaining among the nodes with a lower 
degree to satisfy the degree requirements of any chosen node. No node may be 
assigned a degree = 0. 
3. Assign an intracommunity degree (number of edges within the assigned 
community), dw (vi) to each node vi. The intracommunity degree sequence is sampled 
from the lognormal intracommunity degree distribution. Intracommunity degrees must 
satisfy four conditions.  
1. After sorting the degree sequence and the intracommunity degree sequence 




2. The intracommunity degree sequence must be realizable for each community Ck 
under the Handshake Theorem and the Erdos-Gallai criterion. 
3. The intracommunity degree sequence attains the expected mean, dw within a set 
tolerance εdw = 0.3. 
4. Each community achieves the expected mean intracommunity degree, dw, within 
a set tolerance εdw = 0.3. This is achieved as long as max[{dw(vi)}vi∈G] ≤ min[sk]. 
4. Assign an intercommunity degree (number of edges outside the assigned community), 
db(vi), to each node vi as db(vi) = d(vi) − dw(vi). 
5. Generate intercommunity edges using a modified Havel-Hakimi model and randomize 
them. Nodes are sorted by intercommunity degree from highest to lowest and the node 
at the top of the list is connected randomly with another node. For an edge to form, the 
two nodes may not be previously connected, must belong to different communities, and 
may not both have an intracommunity degree = 0. The list is then resorted and a new 
edge is formed, repeating until all intercommunity degrees are fulfilled. Edges are then 
randomized using double-edge swaps. Two intercommunity edges (a,b) and (c,d) are 
randomly chosen, removed, and then replaced by two new edges (a,c) and (b,d). Newly 
connected nodes cannot belong to the same community, and nodes are not permitted to 
form self-loops or connect to another node multiple times. This process is then repeated 
N/2 times to randomize all edges. If the full network is not a single connected component 
after this process, one edge within the largest connected component and one edge 
within the next largest component are swapped, repeating until the network is a single 
connected component. 
6. Generate intracommunity edges using the Havel-Hakimi model and randomize them. 
Within each community independently, nodes are sorted by intracommunity degree from 
highest to lowest. The node with the highest intracommunity degree is connected to the 




then resorted and the process repeats until all intracommunity degrees are satisfied. 
Edges cannot be formed if nodes are previously connected. Nodes are not permitted to 
form self-loops. Edges are then randomized using double-edge swaps as described in 
Step 5. If each community is not a single connected component after this process, one 
edge within the largest connected component and one edge within the next largest 
component are swapped, repeating until each community is a single connected 
component. 
 We adapted publicly available scripts204 to generate networks under this algorithm in 
Python 3.7 (Python Software Foundation, https://www.python.org). Network adjacency matrices 
were then exported to MATLAB 9.3 (The MathWorks Inc., Natick, MA) for community detection 
via optimization of the quality function described above.175,190 Generated networks replicated 
critical features of our empirical network: 1) network size (N) = 2,350 persons; 2) modularity (Q) 
= 0.96; 3) mean node degree = 2.1; 4) mean community size = 112 members. 
HIV Transmission Model 
 Simple transmission models are widely used to evaluate fundamental network properties 
and potential intervention strategies.13,14 We applied a highly simplified HIV transmission model 
to simulate endemic infection spread across a sexual contact network, specifying a modified SI 
structure with one additional compartment for persons protected from HIV infection and another 
for persons who are rendered non-infectious via effective treatment [Figure 3.8]. Persons in the 
model may be “susceptible” to HIV (S), “protected” (P) via PrEP for HIV, infected and 
“infectious” (I), or “virally suppressed” (V) from highly adherent ART use. Transmission was 
modeled within HIV-discordant dyads, or those in which one person is at state I and one person 
is at state S. Transmission could not occur from persons who were in state V or to persons who 




states could not revert to the I or S states, respectively. In each daily time step, transmission 
occurred within each discordant dyad with probability 1 − (1 −  𝑝)c where 𝑝 was the per-act 
transmission probability associated with condomless anal intercourse (CAI) between HIV-
discordant partners and c was the act rate per partner per day. We simulated transmission 
within each discordant dyad in each time step using a draw from a Bernoulli distribution with a 
probability parameter equal to the daily transmission probability.  
 Act rate per partner per day and per-act transmission probability were drawn from the 
literature. We specified a fixed daily act rate per partner of 0.22, based on a large internet 
survey of US MSM in which the mean annualized number of sex acts with the most recent male 
sexual partner in the previous year was reported to be 80.6.205 We also specified a fixed per-act 
transmission probability of 0.0076, representing the midpoint between meta-analysis estimates 
of 0.0011 and 0.0140 for receptive and insertive anal intercourse, respectively, in the absence 
of viral suppression, PrEP, and condom use.206,207  
 We first simulated a series of nine intervention-free scenarios in which we varied the 
starting overall network prevalence from 0.10 to 0.50 at increments of five percentage points. 
For each overall endemic prevalence, we seeded each of the 100 generated networks with that 
prevalence at the start of each transmission simulation. To achieve this overall endemic 
prevalence while maximizing variability in prevalence across communities, we assigned unique 
prevalences between 0% and 100% to each community at time zero using random draws from a 
beta distribution with a mean equal to the specified overall endemic prevalence and a fixed α 
parameter of 2 [Figure 3.10]. Persons were then randomly sampled within each community and 
assigned to be in state I at the start of the simulation to fulfill assigned community-level endemic 
prevalences. No persons were initially seeded in the P or V states, nor did any persons move to 
the P or V states over time (PrEP and ART assignment under varying intervention scenarios are 




 We then simulated HIV transmission within all 100 networks over 1000 days for each 
overall endemic HIV prevalence, estimating the HIV incidence rate within the full network as 
incident infections per susceptible person-year. HIV incidence rates across all 100 networks 
were used to estimate the mean HIV incidence rate and 95% confidence intervals at each 
overall endemic prevalence. We also assessed the relationship between endemic community-
level HIV prevalences and community-level HIV incidence rates at each overall endemic HIV 
prevalence. Transmission simulations were conducted in R v. 3.5.0187 with the R EpiModel208 
package using the Longleaf computing cluster at UNC-CH. 
Intervention Scenarios 
 We simulated two types of interventions: ART, which instantaneously moved persons 
from state I to state V at simulation start, and PrEP, which instantaneously moved persons from 
state S to state P at simulation start. For each intervention, we modeled three sets of allocation 
schemes: one in which interventions were distributed randomly (i.e., without regard to 
community structure), one in which interventions were distributed preferentially to persons in 
communities with higher endemic HIV prevalences, and one in which interventions were 
distributed preferentially to persons in communities with lower endemic HIV prevalences. Within 
each of these three allocation schemes, we modeled intervention coverage levels of 10%, 30%, 
and 50% for each intervention, for a total of six intervention scenarios (three for ART, three for 
PrEP) per allocation scheme. Under the random allocation scheme, 10%, 30%, or 50% of 
eligible persons (i.e., persons who would otherwise start in the “S” or “I” state) were randomly 
allocated at time 0 to PrEP or ART, depending on the intervention being modeled. Under the 
preferential allocation schemes, the probability of an eligible person receiving an intervention 
was linearly related (directly for the high-to-low scheme and inversely for the low-to-high 




 The sample function with the prob argument in R was applied to achieve weighted 
sampling without replacement for intervention assignment, sampling from persons in state S for 
PrEP interventions and from persons in state I for ART interventions. Under high-to-low 
community-level endemic prevalence intervention allocation schemes, the probability applied 
was the initial community HIV prevalence for each eligible person, normalized to sum to 1 
across all persons in state S for PrEP interventions or across all persons in state I for ART 
interventions. Under low-to-high intervention allocation schemes, the probability applied was 1 – 
initial community HIV prevalence, normalized in the same manner. The prob argument samples 
from the specified population, where each person is selected with the normalized probability 
given. The sampled person is then removed from the population and all probabilities are re-
normalized to sum to 1, with the process repeating until the sample of desired size (in our case, 
intervention coverage level) is achieved. 
 Preferential allocation schemes were probabilistic, rather than deterministic, to mirror the 
practicalities of public health interventions: although some persons or populations within a 
network may be prioritized for enhanced PrEP or viral suppression support, public health 
personnel will typically attempt to reach all relevant persons with interventions. Under such an 
approach, not all persons in prioritized populations will initiate PrEP or achieve viral suppression 
under any intervention, while some persons not prioritized will start PrEP or become virally 
suppressed. 
 Each of the six intervention scenarios (ART at 10%, 30%, and 50% coverage; PrEP at 
10%, 30%, and 50% coverage) was modeled according to each of the three distribution 
schemes (random, low-to-high, high-to-low) within each of the nine overall endemic HIV 
prevalence scenarios, for a total of 162 intervention scenarios. The HIV incidence rate in each 
scenario was estimated as the mean number of new HIV infections per susceptible or protected 
person-year across the 100 networks over the full 1000-day simulation. We estimated the 




in comparison to the incidence rate at the same overall endemic HIV prevalence under no 
intervention.  
 Comparisons of ART vs. PrEP strategies based on intervention effect may be misleading 
because the absolute number of persons reached with an intervention at a given percent-
coverage level varied across the two interventions, with the extent of the difference depending 
upon the distance between 0.5 and the overall endemic HIV prevalence. To account for this 
discrepancy and allow for direct comparison of interventions, we defined a measure of 
intervention efficiency that adjusted for the number of persons reached by a given intervention. 
We estimated overall intervention efficiency for each intervention scenario as the percentage 
reduction in the HIV incidence rate per person reached with the intervention, compared to the 
mean incidence rate under the no-intervention model at the same overall endemic network 
prevalence.  
 We pursued two distinct objectives: 1) compare the effect and efficiency of ART vs. 
PrEP interventions under a set scenario (intervention coverage level and overall endemic HIV 
prevalence); and 2) compare the effect and efficiency of a given intervention type (ART or PrEP) 
across the three allocation schemes under a set scenario. Direct comparison of ART and PrEP 
interventions was conducted to identify optimal allocation of limited intervention resources under 
each starting scenario, while ART and PrEP interventions were tested across intervention 
allocation schemes to evaluate if differential allocation by community-level endemic prevalence 
provided added value in comparison to a random allocation scheme, which is simpler to 
implement. 
 We hypothesized that the impact of intervention allocation scheme on intervention effect 
and efficiency would decrease with increasing intervention coverage because differential 
sampling becomes increasingly similar to random sampling as greater proportions of eligible 
persons are sampled. Conversely, we hypothesized that the impact of intervention allocation 




variation in community-level endemic prevalence under our infection seeding procedure [Figure 
3.10]. At low overall endemic prevalences, most communities have low endemic prevalences 
and very few have high endemic prevalences, creating little variation for a preferential allocation 
scheme to exploit. At high overall endemic prevalences, community-level endemic HIV 
prevalences are more normally distributed, and there are both communities with low and high 
endemic prevalences from which persons can be sampled for intervention under high-to-low or 





























































Figure 3.2 Data flow for North Carolina (NC) Division of Public Health (DPH) – Cecil G. Sheps  
Center for Health Services Research at the University of North Carolina at Chapel Hill (UNC-


















Figure 3.3 Network interconnectivity vs. overlap 
 
CAPTION: The top row provides a high-level visualization and the bottom row illustrates this 
concept in a mock network. Example networks in panels A and B have the same number and 
proportion of overlapping nodes (3/15), but divergent levels of interconnectivity (12.5% vs. 
50%). Members of the HIV network only are shown in blue, members of the syphilis network 
only are shown in red, and members of both the HIV and syphilis networks are shown in yellow. 
Nodes within the HIV network that contribute to the observed percentage increase in node 
degree among syphilis network members upon combination with the HIV network are 
distinguished with bold borders. A. Network with comparatively low interconnectivity of the 
syphilis network with the HIV network. Members of both networks are clustered together, 
bridging distinct HIV and syphilis networks, and a large portion of the syphilis network is 
relatively insulated from the HIV network. B. Network with comparatively high interconnectivity 
of the syphilis network with the HIV network. The HIV network is embedded within the syphilis 




Figure 3.4 Example multilayer network
 
CAPTION: Two independent networks are shown in separate boxes. Nodes that are present in 
both layers are shown in white and nodes that are distinct to one layer are shown in black. Each 
node may be connected by an edge to any other node within a given layer (solid lines) and/or to 

























Figure 3.5 Causal diagram used to select confounders of the association between contact tracing interview by disease intervention 
specialists (DIS) and incident viral suppression 
 
CAPTION: Directed acyclic graph assessing the effect of DIS interview during contact tracing on the six month cumulative incidence 
of reported viral suppression. Age, event date, network event status, and years since HIV diagnosis were identified as potential 
confounders of the association of interest and are highlighted in red. Factors that may create additional uncontrolled confounding that 





Figure 3.6. Algorithm for identification of individuals prescribed emtricitabine and tenofovir 











Figure 3.7 Power law and lognormal distribution fits to empirical network data 
 
CAPTION: Power law and lognormal distribution fits to the A. observed node degree; B. intra-community node degree; and C. 
community size distributions from the largest connected component of the combined HIV/syphilis contact network in the Aim 1 
network. Empirical data are represented by circles and fitted distributions are represented by lines. The power law fit to the data is 





Figure 3.8 Adapted SI transmission model 
 
CAPTION: Under no intervention, susceptible (“S”) nodes become infected and infectious (“I”) 
through HIV acquisition, which is a function of contact rates and transmission probabilities within 
HIV-discordant dyads.  In intervention scenarios, susceptible nodes may become fully protected 
(“P”) against HIV acquisition through sustained and adherent PrEP use and infectious nodes 
may become virally suppressed (“V”) and fully non-infectious through sustained and adherent 













Figure 3.9 Beta distributions for sampling of community-level endemic HIV prevalences 
 
CAPTION: Beta distributions for sampling of community-level endemic HIV prevalences at each 
overall endemic HIV prevalence 0.10 to 0.50. Beta distributions were generated with mean = 




Table 3.1 Match process for linkage between North Carolina (NC) Electronic Disease 
Surveillance System (EDSS) and insurance claims data 
Match Matching variables 
Unique people 
in NC EDSS 
Single matches in 
insurance data 
Multiple matches 
in insurance data 
1 
First name, last name, date 
of birth, gender, ZIP code 
1000 968 32 
2 
First name, last name, date 
of birth, gender, ZIP code 
within +/- 50 miles 
487 470 17 
3 
First name, last name, date 
of birth, gender 
301 274 27 












































Table 3.2 Selected partition statistics considered in selection of the final resolution parameter 𝛾 





communities with ≥30 








0.45 34 26 144 0.9641 0.919 
0.40 33 24 171 0.9658 0.911 
0.35 32 24 164 0.9675 0.919 
0.30 29 24 191 0.9692 0.965 
0.25 26 21 229 0.9711 0.965 




























CHAPTER FOUR: NETWORK INTERCONNECTIVITY AND COMMUNITY DETECTION IN THE 
HIV/SYPHILIS SYNDEMIC AMONG MEN WHO HAVE SEX WITH MEN 
 
A. Introduction 
 Due to both biological117 and behavioral8 synergies, the interacting HIV and syphilis 
epidemics each exacerbate the impact of the other to form a syndemic.8 In the US, HIV and 
syphilis constitute substantial public health burdens, particularly among MSM.104 In the US in 
2017, 25,748 and 17,736 MSM were newly diagnosed with HIV209 and syphilis,210 respectively. 
Although estimated HIV incidence has decreased among US MSM overall in recent years, HIV 
incidence has remained steady among Black MSM and is rising among Hispanic/Latino MSM.209 
Syphilis diagnoses increased steadily from 2013 through 2017 within all populations in the US, 
with the largest increases also observed among minority MSM.210 Novel intervention strategies 
are needed to curtail the ongoing HIV/syphilis syndemic, particularly among MSM of color.  
 Although numerous studies of HIV and STD networks have been undertaken to guide 
prevention and treatment efforts for a single infection,148,142 few analyses have generated 
combined networks containing persons diagnosed with HIV or syphilis and their sexual contacts. 
Each of the existing combined-network analyses10,136,169,170 primarily evaluated the union of the 
two networks as a single network, rather than interrogating how the networks interact. New 
approaches that assess the relationship between HIV and syphilis contact networks could 
inform the design of interventions deployed through these networks. For example, identification 
of populations in which the syphilis network is highly interconnected with the HIV network may 




 We conducted a statewide, network-based evaluation of the HIV/syphilis syndemic 
among MSM in NC, a setting where the burden of both infections is high.15,113 Using 
surveillance-based diagnosis and contact tracing data for both infections, we sought to 
characterize the independent and combined HIV and syphilis networks and identify populations 
wherein these networks are highly connected. We devised a simple measure to quantify the 
amount and distribution of overlap across two networks; we termed this measure 
“interconnectivity” and posited that interconnectivity between HIV and syphilis contact-tracing 
networks could allow infection transmission to cross networks. We then identified distinct 
network communities, or groups of densely connected nodes,12 in which the syphilis network 
showed comparatively heightened interconnectivity with the HIV network. Detection of these 
communities may: 1) highlight key populations disproportionately burdened by the syndemic; 
and 2) guide resource allocation to portions of the syphilis network that experience elevated 




 All data were drawn from the NC EDSS, which is operated by the NC Division of Public 
Health. NC EDSS captures demographic, medical, and intervention data for all reportable 
communicable diseases in NC, including HIV and syphilis.179 Contact tracing data in NC EDSS 
are collected by DIS who interview all persons newly diagnosed with HIV and early syphilis in 
NC to identify recent sexual and injection drug use contacts. Sexual contacts are elicited for the 
twelve months prior to DIS interview for persons newly diagnosed with HIV127 and for the twelve, 
six, and three months prior to symptom onset for persons diagnosed with early latent, 




these three phases of early syphilis).128 DIS then attempt to trace and screen all named contacts 
for both HIV and syphilis.  
 Data were extracted from NC EDSS using SAS 9.4 (SAS Institute Inc., Cary, NC), and 
all analyses were conducted in R v. 3.5.0187 and MATLAB 9.3 (The MathWorks Inc., Natick, 
MA). The Non-Biomedical Institutional Review Board at UNC-CH approved this study (IRB 
Number: 18-3110).  
Independent and Combined Contact Network Generation 
 We defined a network event as receiving an HIV or early syphilis diagnosis between 
2015 and 2017, or being named as a sexual contact by someone receiving one of these new 
diagnoses. Each network event was assigned a network event status: HIV diagnosis, early 
syphilis diagnosis, HIV contact, or early syphilis contact.  
 All new HIV and early syphilis diagnoses among persons diagnosed in NC between 
2015 and 2017 who self-identified as cisgender MSM aged ≥ 18 years were included as HIV 
and syphilis diagnosis events, respectively. Adult, cisgender men named as sexual contacts at 
these diagnosis events were included as experiencing HIV and early syphilis contact events, 
respectively. Some persons experienced multiple or repeat network events during the study 
period; all such events were included for network generation. We excluded diagnosis events 
among newly diagnosed persons not reached for – or not willing to provide information about 
recent contacts in – DIS interview, as the absence of information about contacts precludes any 
contribution to network construction. Newly diagnosed persons who consented to interview but 
named no sexual contacts during the relevant time frame were included as isolates. Events 
among self-identified transgender persons were excluded because gender identity was not 
collected for persons diagnosed with syphilis during the study time frame, preventing analyses 




 We generated an independent HIV network comprising persons diagnosed with HIV and 
their contacts, with sexual relationships reported between these persons during HIV contact 
tracing as edges. We generated an analogous independent syphilis network comprising persons 
diagnosed with syphilis and their contacts, linked by edges representing sexual relationships 
reported during syphilis contact tracing. Finally, we generated a combined HIV/syphilis network 
comprising all persons and edges from both independent networks.  
Network Description 
 We calculated descriptive statistics for the combined network population and by network 
event status, summarizing the number and percentage of network events according to age and 
self-identified race/ethnicity. We also described the diagnostic site for persons diagnosed with 
early syphilis, categorizing sites as 1) primary care physician’s office or health maintenance 
organization (HMO) provider; 2) STD clinic, including STD clinics housed within city and county 
health departments; 3) other clinics; 4) emergency department; and 5) other (inpatient care, 
correctional facility, blood bank, etc.). 
 We calculated standard network parameters, including number of nodes, number of 
edges, component sizes, node degrees, and homophily143 for the combined and independent 
networks. Methodological details about these measures are provided in Chapter 3.  
Network Overlap and Interconnectivity 
 We used a traditional measure of network overlap, the Jaccard node similarity, to 
quantify the direct overlap between the independent HIV and syphilis networks. We calculated 
this measure as the number of nodes belonging to both independent networks (intersection) 
divided by the number in the combined network (union).172 We calculated the Jaccard edge 




union. For both measures, a value of 1 represents complete overlap and a value of 0 represents 
no overlap.  
 The Jaccard node and edge similarities do not fully describe the potential for HIV to 
propagate across the syphilis network, as opportunities for transmission of HIV through the 
syphilis network are dependent not only on the amount, but also the distribution, of overlap 
[Figure 3.3]. If the HIV network overlaps with only a distinct segment of the syphilis network, 
limited numbers of persons within the syphilis network are directly connected to the HIV 
network. However, if the HIV and syphilis networks are more widely interwoven, a larger 
proportion of syphilis network members may be directly connected to the HIV network. To reflect 
this phenomenon, we devised a simple measure of interconnectivity that accounts for both the 
proportion of overlapping nodes and the distribution of this overlap.  
 More specifically, we conceptualized interconnectivity as the relative percentage 
increase in mean node degree (mean number of persons to whom each person is connected by 
an edge) following combination of an index network with a second network. To estimate 
interconnectivity of the syphilis network with the HIV network, we thus compared the mean node 
degree among syphilis network members in the independent syphilis vs. combined HIV/syphilis 
networks. If there were no interconnectivity between the syphilis network and the HIV network, 
we would expect to observe no increase in mean node degree; higher relative increases 
represent greater interconnectivity. This measure is similar to the approach proposed by 
Dickison et al.173 for evaluation of coupled, disjoint network systems, but our simpler measure 
allows for nodes and edges to be shared between partially overlapping networks. Further, this 
measure does not require that networks’ degree distributions demonstrate an internal scale, a 






Community Detection  
 Community detection identifies clusters of nodes within a network that are more densely 
connected to each other than to the remainder of the network.12 We employed community 
detection to identify clusters of persons within the combined HIV/syphilis network among whom 
the syphilis network was highly interconnected with the HIV network, suggesting greater 
potential for exogenous HIV entry into the syphilis network. We applied a generalized Louvain 
method for community detection, including the independent HIV and syphilis networks as 
distinct network layers.177 This method maximizes a quality function Q, also termed the 
modularity of the network, to identify the set of community assignments that produces the 
highest concentration of edges within network communities. Larger values of Q (maximum 
possible value = 1) indicate that more edges occur within communities (rather than between 
communities), while Q = 0 indicates that edge occurrence is uncorrelated with community 
labels. The quality function and its application in this study are detailed in Chapter 3. Community 
detection analyses were restricted to the largest connected component in the combined network 
to ensure sufficient network density. 
Heterogeneity of Syphilis/HIV Network Interconnectivity by Network Community 
 We repeated our analysis of syphilis network interconnectivity with the HIV network in 
each community to assess heterogeneity of interconnectivity. As the distribution of node degree 
increases was non-normal within communities, we restricted this analysis to network 
communities containing ≥30 members of the syphilis network to allow for reliable estimates of 
the mean percentage increase in node degree under the central limit theorem.192 
 To characterize potentially distinguishing features of highly interconnected communities 
that could aid in intervention development and deployment, we applied simple linear regression 




and community-level interconnectivity (relative percentage increase in syphilis network node 
degree following combination of the syphilis network with the HIV network). Independent 
variables included median age of community members at first network event; proportion of 
community members who self-identified as Black, non-Hispanic; proportion of persons with 
syphilis diagnoses who received their diagnoses at STD clinics in each community; and 
proportion of community members who were members of both the HIV and syphilis networks. 
With the exception of syphilis diagnosis site, we included all members of each community in the 
calculation of these community descriptors because understanding communities as a whole 
may allow for insights into the forces driving overall network structure. Associations of 
interconnectivity with demographic descriptors (age, race/ethnicity) and syphilis diagnostic site 
may aid in identifying indicators of heightened interconnectivity that could guide resource 
allocation within the syphilis network without requiring complex network analyses in real time.  
C. Results 
Network Populations  
 There were 2,090 and 3,419 HIV and early syphilis diagnoses, respectively, that met our 
inclusion criteria between 2015 and 2017 in NC [Table 4.1]. These diagnosis events produced 
2,439 eligible HIV contact events and 3,545 eligible syphilis contact events, for a total of 11,493 
network events among 8,020 unique network members. Most network events were among 
persons who self-identified as Black, non-Hispanic (60%) or White, non-Hispanic (29%) and the 
median age at the first eligible network (diagnosis or contact) event during the study period was 
28.7 (interquartile range [IQR]: 24.2-36.8) years. Age at first diagnosis or contact event was 
lower for HIV vs. syphilis network members (median age 27.7 years vs. 29.0 years), and HIV 
diagnosis and contact events were more likely than syphilis diagnosis and contact events to 




diagnosed with early syphilis were most commonly diagnosed by a primary care physician or 
HMO provider (36.8%) or at an STD clinic (36.2%).  
Independent and Combined Network Characteristics 
 The largest connected component in the syphilis network comprised 13% of all syphilis 
network members, whereas the largest connected component in the HIV network comprised 9% 
of all HIV network members [Table 4.2, Figure 4.1]. In the combined network, edges in each of 
the independent networks bridged disconnected components across the other independent 
network, creating a largest connected component containing 2,350 persons (29% of all 
combined network members). Similar proportions of persons were identified as isolates in the 
HIV, syphilis, and combined networks (19.0%, 19.8%, and 19.6%, respectively). The overall 
mean node degree, including isolates, in the combined HIV/syphilis network (1.49; 95% CI: 
1.45, 1.53) was greater than that observed in the independent HIV (1.24; 95% CI: 1.19, 1.28) 
and syphilis (1.34; 95% CI: 1.30, 1.38) networks, while levels of homophily were similar across 
all three networks. In the combined HIV/syphilis network, the median difference in age between 
persons diagnosed with HIV and/or syphilis and their named contacts was 5.3 years and 70% of 
case-contact pairs shared concordant racial and ethnic self-identities. 
 We observed minimal direct overlap between the independent networks according to 
Jaccard node and edge similarities, with 15% of persons and 6% of edges included in both the 
HIV and syphilis networks, including isolates. The mean node degree among members of the 
syphilis network increased by a relative 26.0% following combination with the HIV network (1.34 
vs. 1.69; interconnectivity = 26%).  
Network Communities 
 We identified twenty-six distinct network communities within the largest connected 




maximum value of 1.0. Twenty-one communities comprising 2,268 persons (97% of persons in 
the largest connected component) contained ≥ 30 members of the syphilis network each and 
were thus evaluated for interconnectivity. The mean relative increase in node degree among 
members of the syphilis network following combination with the HIV network spanned 15.2% to 
72.2% across communities, demonstrating heterogeneity in interconnectivity by community. 
 Our measure of interconnectivity incorporates overlap between networks, and 
consequently, we observed an association between the percentage of community members 
who were members of both the HIV and syphilis networks and interconnectivity. Across 
communities, an absolute increase of one percentage point in the percentage of community 
members belonging to both networks, compared to the lowest observed value, was associated 
with an absolute increase of 2.0 (95% CI: 1.4, 2.6) percentage points in interconnectivity (i.e., in 
the relative increase in node degree in the combined vs. independent syphilis networks within a 
community. We also identified an association between syphilis diagnostic site and 
interconnectivity: a ten-percentage-point absolute increase in the percentage of persons 
diagnosed with syphilis at STD clinics, compared to the lowest observed value, was associated 
with an absolute increase of 2.5 (95% CI: -1.7, 6.7) percentage points in interconnectivity. 
 We observed associations between demographic identifiers and interconnectivity as 
well. A one-year absolute decrease in the median age of community members, compared to the 
highest observed value, was associated with an absolute increase of 1.7 (95% CI: -0.4, 3.8) 
percentage points in interconnectivity. A ten-percentage-point absolute increase in the 
percentage of persons who self-identified as Black, non-Hispanic, compared to the lowest 
observed value, was associated with an absolute increase of 3.2 (95% CI: 0.7, 5.7) percentage 
points in interconnectivity. Age and race/ethnicity within communities were also associated with 
each other: communities with a younger median age tended to show a higher proportion of 





 Despite the persistent HIV/syphilis syndemic among MSM and nuanced scientific 
understanding of the biological interaction between the two infections,117 the relationship 
between HIV and syphilis contact networks has not been well characterized. Improved 
understanding of interactions between these networks may allow for development of efficient 
intervention approaches, including HIV prevention strategies prioritizing sub-populations in 
which the syphilis network is highly interconnected with the HIV network. In this study, we 
devised and applied a simple measure of network interconnectivity in a statewide HIV/syphilis 
syndemic as an initial step toward such an approach. 
 Our application of community detection is a novel strategy for identifying network 
subsets with potentially increased risk of infection entry. Network community structures have 
been widely observed across biological, neural, computational, and social networks, including 
contact networks in human and animal populations.175,176 Our network showed extremely high 
modularity, or concentration of edges within network communities, of 0.97. A high modularity of 
0.85 was also observed in an analysis of a sexual contact network of PLWH in Cuba under a 
different community detection algorithm that identified distinct network communities 
characterized by HIV transmission risk group.176 High modularity is associated with explosive 
transmission within communities and rare transmission from one community to another.175 The 
high modularity that we observed in the HIV/syphilis network among NC MSM suggests that 
specific sub-populations belonging to communities in which the syphilis network is particularly 
interconnected with the HIV network are potential priorities for interventions to prevent HIV 
transmission. 
 Homophily can contribute to the formation of network community structure,211 and in the 
combined HIV/syphilis sexual contact network among MSM in NC, homophily by age and 




population, younger median age and greater self-identification as Black, non-Hispanic among 
community members were associated with heightened interconnectivity of the syphilis network 
with the HIV network. This finding is congruent with prior studies illustrating the role of racial 
homophily, alongside existing racial and ethnic disparities in HIV prevalence and treatment, in 
driving HIV incidence among Black MSM.154,155 As most transmissions within highly modular 
networks occur within communities,175 community structuring derived from homophily211 may 
also drive transmission within vulnerable demographic sub-groups. This effect likely contributes 
to disparities in HIV incidence and HIV/syphilis coinfection among young, Black MSM.115 If 
enhanced HIV prevention interventions must be prioritized within the syphilis network due to 
resource constraints, young MSM of color appear to be optimal recipients due to their increased 
membership in network communities with heightened interconnectivity of the syphilis network 
with the HIV network. Persons diagnosed with syphilis at STD clinics, many of which are housed 
in city and county health departments, may also experience substantial exposure to the HIV 
network. Enhanced HIV prevention services for persons receiving a syphilis diagnosis at these 
sites and for their partners may be particularly beneficial as well. 
 Beyond the detection of specific network communities with elevated interconnectivity 
and potentially heightened risk of HIV exposure among syphilis network members, we observed 
interconnectivity between the HIV and syphilis networks overall. This interconnectivity, in 
conjunction with increased coverage of the largest connected component in the combined vs. 
independent networks, suggests that the syphilis network may be treated as largely interwoven 
with the HIV network during intervention planning. That is, in the absence of constraints 
necessitating more focused interventions, HIV prevention interventions that attempt to reach the 
full combined network have the potential to make a strong impact. For example, NC and other 
jurisdictions have recently expanded HIV prevention services to include referrals for pre-




 Our analysis is limited to assessment of network interconnectivity and does not attempt 
to quantify individual HIV risk, as our networks aggregated sexual partnerships over several 
years and did not capture the time-course of individual infection statuses or the spread of 
infection within or across networks. Instead, we aimed to evaluate the HIV/syphilis syndemic 
from a network perspective by identifying populations in which the syphilis network is more likely 
to be interconnected with the HIV network, irrespective of individual syphilis network members’ 
HIV statuses. With this exploratory inquiry, we aim to spark future research on network 
interconnectivity and community detection in public health. 
 We acknowledge that persons diagnosed with HIV and syphilis and their named 
contacts do not represent the complete HIV and syphilis transmission networks in NC. Network 
membership was subject to selection bias because members were identified via self-reported 
sexual orientation and gender identity, and our networks only included persons receiving 
infection diagnoses or being named as contacts.163 Further, contact tracing data were limited to 
sexual contacts, were self-reported, and can suffer from social desirability bias and recall 
error.163 Our networks were also retrospective and static, ignoring some important complexities 
of sexual partnerships for analytical tractability. Although these factors limit generalizability 
beyond the reported network population, our findings are highly germane to the development of 
MSM-focused HIV treatment and prevention interventions for deployment within the existing HIV 
and syphilis contact tracing infrastructure. Future analyses may extend these methods to 
additional populations, transmission modes, and contact networks to more fully capture the 
entire transmission network.  
 Sexual contact networks containing HIV and syphilis are interconnected among MSM in 
NC, and the sexual network of known HIV and syphilis cases and contacts offers an efficient 
platform for deployment of intensified HIV prevention interventions. Limited HIV prevention 




reach populations in which the syphilis network is highly interconnected with the HIV network. In 
an era where “Ending the HIV Epidemic” campaigns are being mounted across the US,178 this 
type of information may be helpful in the design and deployment of interventions against 










CAPTION: Blue indicates persons diagnosed with HIV 2015-2017, red indicates persons 
diagnosed with early syphilis 2015-2017, gold indicates persons diagnosed with HIV and early 
syphilis 2015-2017, and gray indicates persons not diagnosed with HIV or early syphilis in the 
study period. Shape indicates network event status. Circular nodes were diagnosed with HIV or 
early syphilis 2015-2017, square nodes were named as sexual contacts of persons diagnosed 
with HIV or early syphilis, and triangular nodes were diagnosed with HIV or early syphilis and 
named as contacts. A. Largest connected component in the independent HIV network (N=334), 
including persons diagnosed with HIV 2015-2017 and their named sexual contacts. B. Largest 
connected component in the independent syphilis network (N=672), including persons 
diagnosed with early syphilis 2015-2017 and their named sexual contacts. C. Largest connected 
component in the combined HIV/syphilis network (N=2,350), including persons diagnosed with 







Figure 4.2 Network communities  
 
CAPTION: A. Network communities in the largest connected component of the HIV/syphilis network. Communities are distinguished 
by color. B. HIV/syphilis network membership by network community. Each network community containing ≥30 members of the 
syphilis network in the largest connected component of the two-layer network is represented by a pie chart. Pie chart area is 
proportional to the community size and colors reflect community members’ network membership. Communities not included in 
interconnectivity analyses (due to syphilis network membership <30) are shown in gray. Lines connecting communities represent ≥1 
edge between members of the two communities. Communities are laid out under the force-directed Fruchterman-Reingold algorithm. 





Figure 4.3 Demographic characteristics of network community members 
 
CAPTION: Demographic characteristics of the twenty-one network communities containing ≥30 
members of the syphilis network in the largest connected component of the combined 
HIV/syphilis network. The relative percentage increase in mean node degree among members 
of the syphilis network following combination with the HIV network in each community is 
indicated by color and community size is represented by point size. The percentage of 
community members who self-identify as Black, non-Hispanic on the y-axis is compared to the 








Table 4.1 Individual characteristics by network event status within the combined HIV/syphilis network among men who have sex with 
men in North Carolina 2015-2017 
                                                                
                                        
                                       








































Age at network event       
   18-24 3342 (29.1) 741 (35.4) 774 (31.7) 872 (25.5) 955 (26.9) 
   25-34 4643 (40.4) 822 (39.3) 1047 (42.9) 1319 (38.6) 1455 (41.0) 
   35-44 1871 (16.3) 251 (12.0) 383 (15.7) 612 (17.9) 625 (17.6) 
   45+ 1637 (14.2) 276 (13.2) 235 (9.6) 616 (18.0) 510 (14.4) 
Race/ethnicity      
   White, non-Hispanic 3339 (29.0) 533 (25.5) 601 (24.6) 1082 (31.6) 1123 (31.7) 
   Black, non-Hispanic 6865 (59.7) 1266 (60.6) 1581 (64.8) 2011 (58.8) 2007 (56.6) 
   Hispanic 814 (7.1) 211 (10.1) 126 (5.2) 263 (7.7) 214 (6.0) 
   Asian, non-Hispanic 76 (0.7) 14 (0.7) 7 (0.3) 32 (0.9) 23 (0.6) 
   Other 121 (1.0) 19 (0.9) 22 (0.9) 31 (0.9) 49 (1.4) 
   Missing 278 (2.4) 47 (2.2) 102 (4.2) 0 (0.0) 129 (3.6) 
Syphilis diagnostic site      
   STD clinic --- --- --- 1090 (36.2) --- 
   Private physician/HMO --- --- --- 1110 (36.8) --- 
   Other clinic --- --- --- 405 (13.4) --- 
   Emergency room --- --- --- 117 (3.9) --- 
   Other --- --- --- 293 (8.6) --- 








Table 4.2 Network parameters for the combined HIV/syphilis and independent HIV and syphilis sexual contact networks among men 










                                               
                       
                               
                  
IQR; interquartile range. 95% CI; 95% confidence interval 
 
Network parameter  Combined network HIV network Syphilis network 
Network size (nodes) 8020 3928 5283 
Number of unique edges 5984 2439 3545 
Isolates (N, %) 1572 (19.6) 779 (19.8) 1003 (19.0) 
Component size (N, %)    
   Dyad 883 (63.6) 468 (57.0) 642 (61.4) 
   Small (3-9) 473 (34.1) 318 (38.7) 365 (34.9) 
   Medium (10-29) 30 (2.2) 31 (3.8) 30 (2.9) 
   Large (≥ 30) 2 (0.1) 4 (0.5) 8 (0.8) 
   Total 2960 1596 2048 
Largest connected component (N, %) 2350 (29.3) 334 (8.5) 672 (12.7) 
Node degree (mean, 95% CI) 1.5 (1.5, 1.5) 1.2 (1.2, 1.3) 1.3 (1.3, 1.4) 
Homophily    
   Age in years: |age1 – age2| (median, IQR) 5.3 (2.2, 7.8) 4.9 (2.1, 7.4) 5.6 (2.4, 8.1) 
   Race/ethnicity: homophilic preference (mean, 95% CI) 0.7 (0.7, 0.7) 0.7 (0.7, 0.7) 0.7 (0.7, 0.7) 
Jaccard node similarity 0.15 --- --- 





CHAPTER FIVE: HIV VIRAL SUPPRESSION AND PRE-EXPOSURE PROPHYLAXIS IN HIV 
AND SYPHILIS CONTACT TRACING NETWORKS: AN ANALYSIS OF DISEASE 
SURVEILLANCE AND PRESCRIPTION CLAIMS DATA 
 
A. Introduction 
 Despite the development of highly effective HIV prevention modalities, HIV incidence is 
steady or increasing in many populations.1 Available interventions, including ART for PLWH and 
PrEP among HIV-negative persons, can substantially reduce HIV transmission.2-5 However, 
ART and PrEP uptake and adherence are widely suboptimal,6,7 preventing these interventions 
from reaching their full potential at the population level. New strategies are needed to increase 
ART and PrEP use for improved clinical and prevention outcomes.  
 For both epidemiological and practical reasons, sexual networks containing persons 
diagnosed with HIV and/or syphilis may be efficient platforms for HIV prevention interventions. 
HIV and syphilis are syndemic, particularly among MSM,8 and HIV-uninfected members of these 
networks experience heightened HIV risk.9,10 Among persons with a previous HIV diagnosis and 
unsuppressed viremia, being diagnosed with early syphilis or named as a sexual contact of a 
person diagnosed with HIV or early syphilis suggests potential for ongoing HIV transmission 
risk.10 Because contact tracing for HIV and syphilis is routine in the US,11 existing public health 
infrastructure can serve as a conduit for reaching HIV-positive and HIV-negative network 
members with ART and PrEP, respectively.  
 Estimates of HIV viral suppression and PrEP use within HIV/syphilis networks are 
required to identify resource needs and coverage gaps for enhanced intervention design. Using 





prevalent and incident viral suppression and PrEP use in the HIV/syphilis contact tracing 
network among MSM in NC.  
B. Methods 
Data Sources and Study Population 
 We identified our study population within NC EDSS, which is maintained by NC DPH.179 
NC EDSS hosts personal, laboratory, medical, and contact tracing data for reportable 
communicable diseases in NC, including HIV and syphilis.179 Contact tracing data in NC EDSS 
are collected by DIS who interview persons diagnosed with HIV or early syphilis (primary, 
secondary, or early latent) to identify recent sexual and injection drug use contacts. DIS elicit 
contacts during the twelve months before DIS interview for persons newly diagnosed with HIV127 
and during the three, six, and twelve months before symptom onset for persons diagnosed with 
primary, secondary, and early latent syphilis,128 respectively. DIS trace and test named contacts 
for both infections if possible. 
 We first identified all persons becoming diagnosed with HIV or early syphilis in NC over 
the period January 2013 – June 2017 (inclusive) within NC EDSS. We then identified the sexual 
partners named by these persons during contact tracing. We defined a qualifying HIV/syphilis 
network event as receiving an early syphilis diagnosis or being named as a sexual contact by a 
person becoming diagnosed with HIV or early syphilis. Some persons experienced multiple 
network events during the study time frame; all such events were included in analyses. We 
further restricted our study population to include only persons who: 1) were ≥18 years old on the 
date of the network event; 2) resided in NC at the time of the event; 3) did not self-identify as 
transgender; and 4) either self-identified as MSM or identified as male and were named as a 





excluded because gender identity was unavailable for persons diagnosed with syphilis during 
the study period, preventing subgroup analyses of transgender women. 
 We then identified sub-populations for viral suppression and PrEP use analyses. Viral 
suppression analyses were conducted only among persons with an HIV diagnosis ≥30 days 
before their network event. Persons diagnosed with HIV at the network event or <30 days prior 
were excluded because they could not yet have achieved suppression through ART. Incident 
viral suppression analyses included only previously HIV-diagnosed persons without prevalent 
viral suppression at their network event.  
 For analyses of prevalent and incident PrEP use, persons with confirmed HIV-negative 
or unknown HIV status at the time of the network event were first linked to insurance claims 
data from a single large, commercial insurer in NC181 by an honest broker at the Cecil G. Sheps 
Center for Health Services Research at UNC-CH [Table 3.1]. We included only those individuals 
linked who were enrolled in a commercial insurance plan with prescription coverage over the 
relevant time frames (specified below). As most persons without a prior HIV diagnosis are 
tested for HIV at the time of a network event, persons without an HIV diagnosis on record in NC 
EDSS before or in the 14 days after the event were presumed HIV-negative. The impact of this 
assumption was interrogated in a sensitivity analysis limiting PrEP analyses to events among 
persons who 1) were reached by DIS at the time of the network event, consented to HIV testing, 
and had a negative result; OR 2) had an unrelated, documented HIV-negative test result in NC 
EDSS in the three months before or ever following the network event, through December 2019. 
 Data were extracted from NC EDSS using SAS 9.4 (SAS Institute Inc., Cary, NC) and 
analyses were conducted in SAS 9.4 and R v. 3.5.0.187 The Non-Biomedical Institutional Review 








Prevalent and Incident Viral Suppression among Previously Diagnosed PLWH  
 HIV viral load is routinely measured during HIV clinical care visits to evaluate disease 
progression and treatment success. In NC, HIV viral load measures generated by all HIV care 
providers are mandatorily reported to NC DPH.127 We identified all viral load measures during 
the year prior to each network event among previously diagnosed PLWH to assess prevalent 
viral suppression. Using the measure collected closest to the event, we classified persons with 
viral load <200 copies/mL as virally suppressed according to the CDC definition for surveillance 
purposes.193 Persons with no viral load measures available during the year prior to the network 
event (20.6% of previously diagnosed PLWH without viral load <200 copies/mL) were assumed 
to be out of care and classified as not virally suppressed. Virally non-suppressed PLWH were 
subsequently assessed for six-month cumulative incidence of viral suppression, defined as ≥1 
viral load measure <200 copies/mL in the six months following the event. In an ancillary 
analysis, we assessed the twelve-month cumulative incidence of viral suppression, defined 
analogously. 
Effect of DIS Services on Incident Viral Suppression  
 To assess the impact of current DIS services on viral load outcomes among previously 
diagnosed PLWH in our population, we estimated the effect of being reached by DIS in 
association with the network event on the six-month cumulative incidence of viral suppression 
thereafter. Previously diagnosed PLWH were classified as reached by DIS services if DIS 
interacted with them in any capacity, including contact tracing interviews for those diagnosed 
with early syphilis, re-interviews among those named as contacts of persons diagnosed with 
HIV, and contact interviews for syphilis screening among those named as contacts of persons 





incident viral suppression among those reached vs. not reached by DIS. A generalized 
estimating equations (GEE) model with an autoregressive correlation structure was used to 
account for the presence of multiple observations for some persons194  
 Plausible confounders of the possible effect of DIS services on incident viral suppression 
were identified through a comprehensive literature review and assessed using a DAG [Figure 
3.6].196 Confounders were then evaluated to identify optimal functional form, resulting in nominal 
coding of event year (2013, 2014, 2015, 2016, 2017), network event status (syphilis diagnosis, 
HIV contact, syphilis contact), and age at network event (18-24, 25-34, 35-44, ≥45 years), and 
restricted cubic splines to represent years since HIV diagnosis. This adjustment set was 
included in the linear risk GEE model to estimate an aCID with robust standard errors using the 
sandwich estimator. GEE models were repeated with twelve-month cumulative incidence of 
reported viral suppression as the outcome. Further GEE modeling details are supplied in 
Chapter 3. 
Prevalent and Incident PrEP Use among HIV-Negative Persons  
 PrEP use, as measured by FTC/TDF prescription claims, was evaluated among HIV-
negative persons using an adaptation of the CDC algorithm for PrEP utilization.199 Persons 
prescribed FTC/TDF, also known as Truvada, for PrEP were identified via exclusion of 
FTC/TDF prescriptions for HIV or Hepatitis B virus treatment or as HIV PEP [Figure 3.7]. PrEP 
prescriptions and exclusions due to prior or concomitant prescriptions and/or diagnoses were 
determined from ICD-9/10-CM codes and NDC in insurance claims data199 [Appendix]. Claims 
records were queried from January 1, 2010 through 30 days after FTC/TDF prescription as an 
“all-available” lookback period to identify exclusions. We manually reviewed all records for each 
event with an FTC/TDF claim excluded due to prior HIV diagnosis, identifying and correcting 
erroneous ICD-9/10-CM codes for prior HIV diagnosis in two persons who tested HIV-negative 





 We assessed prevalent PrEP use, defined as ≥1 PrEP prescription claim in the six 
months before the network event date, among those with continuous pharmacy insurance 
coverage during that period. We then assessed incident PrEP use following a network event 
among all persons with pharmacy insurance coverage over the sixty days before the event date 
and continuously for six months after the event date, excluding persons with documented PrEP 
use before the network event. Six-month cumulative incidence of PrEP use was defined as ≥1 
PrEP prescription claim in the six months following the network event.  
 We described prevalent and incident PrEP use by age, self-identified race/ethnicity, 
HIV/syphilis network event status (syphilis diagnosis, HIV contact, syphilis contact), year of 
network event, insurance subscriber (self, parent, other), and apparent PrEP indication. We 
defined PrEP indication at the time of the network event as: 1) having ≥1 male sex partner in the 
prior six months documented in NC EDSS; AND either 2) reporting condom use during the 
contact tracing period as anything other than “Always”; OR 3) becoming diagnosed with or 
reporting a bacterial STI in the prior six months. PrEP indication assessment is detailed in 
Chapter 3. 
C. Results 
 We identified 3,963 eligible early syphilis diagnoses and 8,456 HIV/syphilis contact 
events under our inclusion criteria [Figure 5.1]. Of these network events, 4,959 occurred among 
2,970 previously diagnosed PLWH and 6,975 occurred among 5,245 confirmed or 
presumptively HIV-negative persons. Previously diagnosed PLWH were older (median age: 
31.1 vs. 27.3) and more likely to identify as Black, non-Hispanic (71% vs. 54%) than HIV-
negative persons, who were more likely to be reached by DIS following a network event (85% 
vs. 68%). 





 Approximately half (52.6%; N = 2,609/4,959) of all events among previously diagnosed 
PLWH occurred among persons who were virally suppressed according to surveillance records 
[Table 5.1]. Incident viral suppression in the six months after the event was then documented for 
35.4% (831/2,350) of events among previously diagnosed PLWH without prevalent viral 
suppression. Among events without incident viral suppression, 38% had a documented viral 
load > 200 copies/mL in the six months following the event and 62% had no documented viral 
loads during this time frame. After adjustment for event year, network event status, age at 
network event, and years since HIV diagnosis, the six-month cumulative incidence of viral 
suppression among persons reached by DIS was 13.1 (95% CI: 8.8, 17.4) absolute percentage 
points higher than that observed among persons not reached by DIS. Twelve-month cumulative 
incidence of viral suppression was documented for 49.1% (1,154/2,350) of events among 
previously diagnosed PLWH without prevalent viral suppression. The aCID comparing twelve-
month incident viral suppression among those reached vs. not reached by DIS was 6.7 (95% CI: 
2.1, 11.3) absolute percentage points. 
PrEP among HIV-Negative Persons 
 Of the 5,245 unique HIV-negative persons in our dataset, 1,788 (34.1%) were 
successfully linked to insurance claims data with any coverage in the period January 2010 – 
December 2017. Among these persons, 441 HIV/syphilis network events occurred among 372 
persons with pharmacy coverage at and during the six months prior to the event for analyses of 
prevalent PrEP use. No FTC/TDF prescriptions were excluded as treatment for HIV or HBV or 
as PEP. We identified prevalent PrEP use for 5.4% (24/441) of these network events. Our 
assessment of incident PrEP use was conducted with 411 network events among 360 persons 
who were not prevalent PrEP users and had pharmacy coverage during the sixty days prior to 
the event and continuously for six months after the event. No FTC/TDF prescriptions were 





month cumulative incidence of PrEP use following an HIV/syphilis network event was 4.1% 
(17/411).  
 Small increases in prevalent and incident PrEP use were observed from 2013 to 2017, 
but PrEP use remained low throughout this period [Table 5.2]. Persons who self-identified as 
White, non-Hispanic and who were diagnosed with early syphilis were overrepresented within 
the population matched to insurance claims data, particularly among those with prevalent or 
incident PrEP use. Prevalent PrEP users at the network event were older than those without 
prevalent PrEP use (median age = 34.4 vs. 28.2 years), while incident PrEP users were 
younger than those without (24.9 vs. 28.1 years). Most network events among HIV-negative 
persons (82.7%; N = 5,768) occurred among those indicated for PrEP under our surveillance-
based definition, and most incident PrEP use (88%; 15/17) occurred among indicated persons. 
Six-month cumulative incidence of PrEP use among indicated persons was 4.5% (15/337).  
 In a sensitivity analysis restricting PrEP analyses to persons with documented HIV 
negative status to estimate upper bounds for PrEP use, the size of the initial population for PrEP 
analyses was reduced from 6,975 to 5,787 events. After matching to insurance claims data, 
44/441 (10.0%) persons were excluded from prevalent PrEP use analyses and 41/411 (10.0%) 
persons were excluded from incident PrEP uptake analyses. The prevalence of PrEP use was 
5.8% and the six-month cumulative incidence of PrEP uptake was 4.3% in this restricted 
population. In a sensitivity analysis imputing condom use for events with missing values, we 
observed only a slight decrease in PrEP indication (79% vs. 83%). 
D. Discussion 
 Combination ART and PrEP interventions with high levels of uptake and adherence are 
required to end the HIV epidemic,212,213 and sexual networks with prevalent HIV and syphilis are 
high-priority populations for such programming. However, current levels of coverage in these 





in this population, we evaluated prevalent and incident viral suppression and PrEP use among 
MSM diagnosed with early syphilis or named as sexual contacts of persons diagnosed with HIV 
or early syphilis in NC, finding low levels of all outcomes.  
 Presentation of viremic, previously diagnosed PLWH in the HIV/syphilis network is a 
critical opportunity to activate support for care engagement or re-engagement. An estimated 
70% of HIV transmissions in the US138 (and 77% in NC)139 arise from contact with previously 
diagnosed PLWH, highlighting the importance of reaching this population with suppressive ART 
for clinical and public health benefits. In our population, 31% of all early syphilis diagnoses and 
HIV/syphilis contact events occurring among previously diagnosed PLWH were among persons 
with unsuppressed viremia at the event and for at least six months thereafter. These events 
represent missed opportunities to leverage a syphilis diagnosis or HIV/syphilis contact event as 
a springboard to viral suppression.  
 Although estimated viral suppression incidence following a network event was low, 
existing public health services offer a potential route for improvement. We observed a significant 
increase in six-month cumulative incidence of viral suppression among persons reached by DIS 
in comparison to those who were not reached. DIS services may act as a “cue to action” for 
ART use under the Health Belief Model132 by reinforcing potential health, transmission, and legal 
consequences associated with unsuppressed viremia, as well as a channel to care engagement 
services. Because the highest-priority responsibilities of DIS are to interview newly diagnosed 
persons and screen their contacts for infection, only 59% of previously diagnosed PLWH with 
unsuppressed viremia in this study population were reached by DIS. Support for higher 
coverage of DIS services among previously diagnosed PLWH may facilitate attainment of 2020 
National HIV/AIDS Strategy targets of 90% care engagement and 80% viral suppression among 
diagnosed PLWH.214 
 PrEP is indicated for a large population on the basis of HIV exposure risk,54 but uptake 





were prescribed PrEP in 2018.7 In NC, just an estimated 2,500 persons were prescribed PrEP in 
2018.65 We observed very high levels of PrEP indication in our study population, but little PrEP 
use. However, prevalent and incident PrEP use trended upward from 2013 to 2017, reflecting 
increased PrEP awareness, interest, and access in this population since the introduction of 
Truvada in 2012.37 Persons with incident PrEP use following a network event were substantially 
younger than prevalent PrEP users, suggesting that the contact tracing network may be a 
valuable pathway for reaching at-risk young MSM with PrEP.  
 NC and several other jurisdictions have recently expanded HIV prevention services to 
include referrals for PrEP during contact tracing.133 Pilot programs offering PrEP care or 
referrals out of select county health departments in NC are also underway,215 allowing 
assessment of these existing providers’ potential to reach underserved populations and address 
financial barriers to care. Although copay and medication assistance programs can reduce the 
cost of Truvada, these programs do not include provider care and laboratory tests,79 leaving a 
coverage gap that can be addressed by existing public health infrastructure.80 County health 
departments are also efficient PrEP access points for HIV/syphilis network members already 
engaged with public health personnel. Even if linkage to PrEP care is not immediately achieved, 
contact tracing and syphilis diagnoses offer opportunities to intervene on earlier stages of the 
HIV PrEP continuum,35 including building PrEP awareness and support for PrEP use. 
 As demonstrated here, linkage of insurance claims and surveillance data offers a novel, 
useful approach to monitor and support PrEP use among key populations for HIV prevention. 
Surveillance data allowed identification of persons at high risk of HIV exposure within their 
sexual networks and linkage to insurance claims data enabled assessment of PrEP use in this 
population. Linkage further allowed detection of erroneous ICD-9/10 CM codes for HIV 
diagnoses in persons receiving FTC/TDF, highlighting the value of triangulating multiple data 





 Contact tracing data are subject to social desirability bias and recall error, preventing 
complete elucidation of the underlying network population.163 In addition, our analyses of DIS 
services and viral suppression may be subject to uncontrolled confounding by socioeconomic 
status and perceptions of public health services, which were unmeasured in our data source but 
could simultaneously affect both care-seeking behavior and being reached by DIS. We also 
note that some persons without a viral load measure in the year before the network event may 
have received care in another state; however, this number is likely small because we excluded 
persons without a NC address at the time of the network event. We were further unable to 
account for potential out-migration after a network event, potentially leading to underestimation 
of incident viral suppression. Despite mandatory viral load reporting to NC EDSS implemented 
in 2013, slow uptake by several providers delayed full statewide reporting until 2016 (Dr. Erika 
Samoff, NC DPH, personal communication 2020), creating another potential source of error in 
viral suppression estimates. Error may also have arisen from our assumption that all persons 
with unknown HIV status at the time of the network event were HIV-negative. However, HIV 
testing occurred in association with most network events and would have resulted in a recorded 
diagnosis if positive. Additionally, a sensitivity analysis requiring a negative HIV test in the three 
months before, at, or ever following the event showed only small increases in PrEP use 
estimates.  
 Insurance claims data provide estimates of medication dispensing but may not 
accurately reflect medication consumption. We also required only a single PrEP prescription 
claim for prevalent or incident PrEP use, preventing evaluation of long-term use. Observed 
PrEP use is generalizable only to network members with pharmacy coverage under a single 
private insurer in NC, a population which differs substantially from all HIV-negative network 
members; however, estimates may also be reasonably generalizable to the remainder of the 
privately insured population. Although uninsured and publicly insured individuals are critical 





with available data. We note, however, that in our population of persons with high HIV 
acquisition risk and access to PrEP under insurance coverage – a population in which PrEP use 
might be expected to approach an upper bound – we observed very little PrEP use overall. 
 In summary, although many HIV-negative members of the HIV/syphilis contact tracing 
network were indicated for PrEP, prevalent and incident PrEP use were low. Viral suppression 
among previously HIV-diagnosed persons in the network was also sub-optimal. Incident viral 
suppression among previously HIV-diagnosed, viremic network members was significantly lower 
among persons not reached by DIS, suggesting a need for increased support for DIS services in 
this population. These findings may inform expansion of health department PrEP services and 







Figure 5.1 Populations for analysis of prevalent and incident viral suppression and pre-exposure 
prophylaxis (PrEP) use in the HIV/syphilis contact tracing networks 
 
CAPTION: HIV/syphilis network events among adult, cisgender, North Carolina (NC)-residing 
men who have sex with men (MSM), January 2013 – June 2017, were identified from NC 
surveillance data. Previously diagnosed people living with HIV (PLWH) were evaluated for 
prevalent and incident viral suppression. HIV-negative persons were matched to insurance 
claims data and evaluated for prevalent and incident PrEP use. Some HIV-negative persons 
were eligible for both prevalent and incident PrEP use analyses. *Events among HIV-negative 
persons, defined as those with no HIV diagnosis on record in NC EDSS at any point before or in 
the 14 days after the event. +Events among previously diagnosed PLWH, defined as those with 
an HIV diagnosis on record in NC EDSS ≥30 days prior to the event. #Events among recently 
diagnosed PLWH, defined as those with an HIV diagnosis on record in NC EDSS <30 days prior 
to or ≤14 days following the event. ^Population for prevalent PrEP use analysis was restricted to 
events among persons with continuous pharmacy coverage over the six months prior to the 
network event. **Population for incident PrEP use analysis was restricted to events among 
persons with continuous pharmacy coverage over the sixty days prior to and the six months 





Table 5.1 Individual characteristics by HIV viral suppression at the time of an HIV/syphilis 
network event occurring January 2013 – June 2017 in North Carolina among men who have sex 




Not virally suppressed  
Incident viral 
suppression+ 
No incident viral 
suppression 
Years since HIV diagnosis 
(median, IQR) 
5.5 (2.4, 9.8) 4.2 (0.8, 8.2) 4.8 (2.1, 8.6) 
Age at network event 
(median, IQR) 
33.2 (27.6, 44.2) 29.8 (25.8, 38.3) 28.9 (24.9, 35.8) 
Race/ethnicity (N, %)    
   White, non-Hispanic 717 (27.5) 182 (21.9) 220 (14.5) 
   Black, non-Hispanic 1690 (64.8) 582 (70.0) 1233 (81.2) 
   Hispanic 144 (5.5) 44 (5.3) 41 (2.7) 
   Other 38 (1.5) 12 (1.4) 6 (0.4) 
   Missing 20 (0.8) 11 (1.3) 19 (1.2) 
Network event    
   Syphilis diagnosis 1165 (44.6) 289 (34.8) 425 (28.0) 
   HIV contact 537 (20.6) 260 (31.3) 555 (36.5) 
   Syphilis contact 907 (34.8) 282 (33.9) 539 (35.5) 
Reached by DIS# 1951 (74.8) 564 (67.9) 833 (54.8) 
Year    
    2013 200 (7.7) 87 (10.5) 242 (15.9) 
    2014 410 (15.7) 158 (19.0) 297 (19.6) 
    2015 820 (31.4) 229 (27.6) 428 (28.2) 
    2016 818 (31.4) 266 (32.0) 376 (24.8) 
    2017++ 361 (13.8) 91 (10.9) 176 (11.6) 
Total network events 2609 831 1519 
IQR; interquartile range                                                                                                           
* ≥1 viral load <200 copies/mL in the 12 months prior to the date of the syphilis diagnosis or the date 
named as an HIV or syphilis contact                                                                                                                                                
+≥1 viral load <200 copies/mL in the 6 months following the date of the syphilis diagnosis or the date 
named as an HIV or syphilis contact                                                                                                                  
#Disease Intervention Specialist; refers to DIS contact after a network event, not the time of the previous 
HIV diagnosis                                                                                                                                                  








Table 5.2 Individual characteristics by pre-exposure prophylaxis (PrEP) use at the time of an HIV/syphilis network event and in the 
subsequent six months among HIV-negative men who have sex with men in North Carolina, January 2013 – June 2017.  
IQR; interquartile range. DIS; Disease Intervention Specialist                                                                                        
*Defined as ≥ one insurance claim for emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prescribed for ≥30 days in the six months prior to 
the date of the event                                                                                                                                                  
+Defined as ≥ one insurance claim for emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prescribed for ≥30 days in the six months 
following the date of the event                                                                                                                                                                                                                                                                             
#Cell sizes <5 are not presented to prevent deductive identification.                                                                                                                                                                                                                                                                                            
**January 1, 2017 – June 31, 2017        
Individual characteristics 
All events among 
HIV-negative 
persons 
Prevalent PrEP use* Incident PrEP uptake+ 
Yes No Yes No 
Age at event (median, IQR) 27.3 (23.2, 35.3) 34.4 (26.8, 39.6) 28.2 (23.1, 38.0) 24.9 (20.6, 32.2) 28.1 (23.2,  38.1) 
Race/ethnicity (N, %)      
    White, non-Hispanic 2411 (34.6) 16 (66.7) 230 (55.2) 9 (52.9) 201 (51.0) 
    Black, non-Hispanic 3783 (54.2) 5 (20.8) 153 (36.7) 5 (29.4) 161 (40.9) 
    Hispanic 487 (7.0) <5# 16 (3.8) <5 14 (3.6) 
    Other  124 (1.8) <5 12 (2.9) <5 14 (3.6) 
    Missing 170 (2.4) <5 6 (1.4) <5 <5 
Network event status      
    Syphilis diagnosis 1839 (26.4) 9 (37.5) 123 (29.5) 8 (47.1) 113 (28.7) 
    HIV contact 2235 (32.0) <5 120 (28.8)  <5 117 (29.7) 
    Syphilis contact 2901 (41.6) 11 (45.8) 174 (41.7) 5 (29.4) 164 (41.6) 
Reached by DIS 5951 (85.3) 23 (95.8) 378 (90.7) 16 (94.1) 357 (90.6) 
Year      
    2013 938 (13.5) <5 43 (10.3) <5 46 (11.7) 
    2014 1282 (18.4) <5 88 (21.1) <5 94 (23.9) 
    2015 1968 (28.2) 6 (25.0) 125 (30.0) <5 98 (24.9) 
    2016 1827 (26.2) 11 (45.9) 101 (24.2) 9 (52.9) 94 (23.9) 
    2017** 960 (13.8) <5 60 (14.4) 6 (35.3) 62 (15.7) 
Insurance subscriber      
    Self --- 23 (95.8) 342 (82.0) 13 (76.5) 327 (83.0) 
    Parent --- <5 71 (17.0) <5 62 (15.7) 
    Other --- <5 <5 <5 5 (1.3) 
Indicated for PrEP 5768 (82.7) 18 (75.0) 337 (80.8) 15 (88.2) 322 (81.7) 





CHAPTER SIX: TRANSMISSION DYNAMICS AND CONTROL OF ENDEMIC INFECTION IN 
NETWORKS WITH STRONG COMMUNITY STRUCTURE 
 
A. Introduction 
 The increasing availability of infectious disease contact and transmission network data 
offers new opportunities for development of network-based disease prevention strategies.162,216-
218 Network community structure, or the presence of clusters of individuals densely connected to 
each other and comparatively sparsely connected to the remainder of the network,12 is one of 
many factors that influences infection transmission over contact networks.13,14 Newly introduced 
infection in networks with weak community structure (many connections between communities) 
typically experience explosive growth, whereas emerging epidemics in networks with strong 
community structure (few connections between communities) tend to exhibit greater variance in 
final epidemic size, peak prevalence, and duration.13,14 However, the effect of community 
structure on endemic infection dynamics has not been assessed.  
 In networks with strong community structure, most edges occur within network 
communities.12 Consequently, most opportunities for infection transmission occur within 
communities. When endemic infection is unevenly distributed across communities in these 
networks, susceptible persons may thus bear differential infection risks and experience variable 
benefits from different types of prevention interventions. For instance, susceptible persons in 
network communities with high infection prevalence are more likely to be exposed to infection 
than those in low-prevalence communities, and thus prevention interventions that reduce 
susceptibility of uninfected persons may be most efficient when preferentially deployed to 





low infection prevalence, preferential treatment of infected persons may allow for efficient 
protection of susceptible members of those communities.  
 Consideration of network community structure and both overall and community-level 
endemic infection prevalence may aid in selection of optimal intervention approaches and 
efficient allocation of limited public health resources. Using HIV transmission as an example, we 
examined infection incidence and intervention effects in simulated networks with strong 
community structure and unevenly distributed endemic infection across communities. Within this 
framework, we estimated: 1) the impact of endemic community-level infection prevalence on 
community-level infection incidence, and 2) the efficiency of prophylactic and treatment 
interventions under random intervention allocation vs. preferential allocation according to 
endemic community-level infection prevalence.  
B.  Methods 
Network Generation 
 Following other studies of network structure,13,14 we used an empirical network as a 
starting point and test case for simulations. Network parameters were drawn from the largest 
connected component of the HIV and syphilis sexual contact tracing network among MSM in NC 
from 2015 through 2017. This network demonstrates strong modularity, or community structure, 
and was comprehensively characterized in Chapter 4. Empirical network parameters drawn 
from this network included the network size (N), modularity (Q), number of communities (K), and 
overall node degree, intracommunity node degree, and community size distributions.  
 We used these input parameters with the algorithm presented in Sah et al204 to generate 
100 static networks as modular random graphs under a randomized hierarchical configuration 





distributions of node degrees within and between communities, but randomizes specific inter 
and intracommunity edges.14,204 The algorithm proceeds as follows:  
1. Assign N nodes to K communities according to the community size distribution. 
2. Assign overall degrees, d(vi), to each node vi according to the node degree distribution. 
Assign intracommunity degrees (number of edges within the assigned 
community), dw (vi), and intercommunity degrees (number of edges between 
communities), db(vi), to each node vi. 
3. Generate intercommunity edges using a modified Havel-Hakimi model and randomize 
specific placement between nodes across communities. 
4. Generate intracommunity edges using the Havel-Hakimi model and randomize specific 
placement between nodes within communities. 
 We adapted publicly available scripts to generate networks204 in Python 3.7 (Python 
Software Foundation, https://www.python.org) and identify network communities177,190 in 
MATLAB 9.3 (The MathWorks Inc., Natick, MA). Simulated networks replicated critical features 
of our empirical source network: 1) network size (N) = 2,350 persons; 2) modularity (Q) = 0.96; 
3) mean node degree = 2.1; 4) mean community size = 112 members. Additional details on 
input parameters, network generation, and community detection are provided in Chapter 3.  
HIV Transmission Model 
 Simple transmission models are widely used to evaluate fundamental network properties 
and potential intervention strategies.13,14 We constructed a highly simplified HIV transmission 
model to simulate endemic infection spread across a sexual contact network, specifying a 
modified SI structure with one additional compartment for persons protected from HIV infection 
and another for persons who are rendered non-infectious via effective treatment [Figure 3.8]. 
Persons in the model may be “susceptible” to HIV (S), “protected” (P) via PrEP for HIV, infected 





modeled within HIV-discordant dyads, or dyads in which one person is in state I and one person 
is in state S. Transmission could not occur from persons who were in state V or to persons who 
were in state P, reflecting an assumption of perfect intervention efficacy, and persons in these 
states could not revert to the I or S states, respectively. In each daily time step, transmission 
occurred within each discordant dyad with probability 1 − (1 −  𝑝)c where 𝑝 was the per-act 
transmission probability associated with condomless anal intercourse (CAI) between HIV-
discordant partners and c was the act rate per partner per day. We simulated transmission 
within each discordant dyad in each time step using a draw from a Bernoulli distribution with a 
probability parameter equal to the daily transmission probability.  
 Act rate per partner per day and per-act transmission probability were drawn from the 
literature. We specified a fixed daily act rate per partner of 0.22, based on a large internet 
survey of US MSM in which the mean annualized number of sex acts with the most recent male 
sexual partner in the previous year was reported to be 80.6.205 We specified a fixed per-act 
transmission probability of 0.0076, representing the midpoint between meta-analysis estimates 
of 0.0011 and 0.0140 for receptive and insertive anal intercourse, respectively, in the absence 
of viral suppression, PrEP, and condom use.206,207  
 We first simulated a series of nine intervention-free scenarios in which we varied the 
starting overall network prevalence from 0.10 to 0.50 at increments of five percentage points. 
For each overall endemic prevalence, we seeded each of the 100 generated networks with that 
prevalence at the start of each transmission simulation. To achieve this overall endemic 
prevalence while maximizing variability in prevalence across communities, we assigned unique 
prevalences between 0% and 100% to each community at time zero using random draws from a 
beta distribution with a mean equal to the specified overall endemic prevalence and a fixed α 
parameter of 2  [Figure 3.9]. Persons were then randomly sampled within each community and 
assigned to be in state I at the start of the simulation to fulfill assigned community-level endemic 





the P or V states over time (PrEP and ART assignment under varying intervention scenarios are 
described below).  
 We then simulated HIV transmission within all 100 networks over 1000 days for each 
overall endemic HIV prevalence, estimating the HIV incidence rate within the full network as 
incident infections per susceptible person-year. HIV incidence rates across all 100 networks 
were used to estimate the mean HIV incidence rate and 95% confidence intervals at each 
overall endemic prevalence. We also assessed the relationship between endemic community-
level HIV prevalences and community-level HIV incidence rates at each overall endemic HIV 
prevalence. Transmission simulations were conducted in R v. 3.5.0187 with the R EpiModel208 
package. 
Intervention Scenarios 
 We simulated two types of interventions: ART, which instantaneously moved persons 
from state I to state V at simulation start, and PrEP, which instantaneously moved persons from 
state S to state P at simulation start. For each intervention, we modeled three sets of allocation 
schemes: one in which interventions were distributed randomly (i.e., without regard to 
community structure), one in which interventions were distributed preferentially to persons in 
communities with higher endemic HIV prevalences (high-to-low allocation), and one in which 
interventions were distributed preferentially to persons in communities with lower endemic HIV 
prevalences (low-to-high allocation). Within each of these three allocation schemes, we 
modeled intervention coverage levels of 10%, 30%, and 50% for each intervention, for a total of 
six intervention scenarios (three for ART, three for PrEP) per allocation scheme. Under the 
random allocation scheme, 10%, 30%, or 50% of eligible persons (i.e., persons who would 
otherwise start in the S or I state) were randomly allocated at time 0 to PrEP or ART, depending 
on the intervention being modeled. Under the preferential allocation schemes, the probability of 





scheme and inversely for the low-to-high scheme) to the endemic HIV prevalence in that 
person’s community (see Chapter 3 for details). Preferential allocation schemes were 
probabilistic, rather than deterministic, to mirror the practicalities of public health interventions: 
although some persons or populations within a network may be prioritized for enhanced PrEP or 
viral suppression support, public health personnel will typically attempt to reach all relevant 
persons with interventions. Under such an approach, not all persons in prioritized populations 
will initiate PrEP or achieve viral suppression under any intervention, while some persons not 
prioritized will start PrEP or become virally suppressed. 
 Each of the six intervention scenarios (ART at 10%, 30%, and 50% coverage; PrEP at 
10%, 30%, and 50% coverage) was modeled according to each of the three distribution 
schemes (random, low-to-high, high-to-low) within each of the nine overall endemic HIV 
prevalence scenarios, for a total of 162 intervention scenarios. The HIV incidence rate in each 
scenario was estimated as the mean number of new HIV infections per susceptible or protected 
person-year across the 100 networks over the full 1000-day simulation. We estimated the 
intervention effect as the percentage reduction in the HIV incidence rate under each intervention 
in comparison to the incidence rate at the same overall endemic HIV prevalence under no 
intervention.  
 Comparisons of ART vs. PrEP strategies based on intervention effect may be misleading 
because the absolute number of persons reached with an intervention at a given percent-
coverage level varied across the two interventions, with the extent of the difference depending 
upon the distance between 0.5 and the overall endemic HIV prevalence. To account for this 
discrepancy and allow for direct comparison of interventions, we defined a measure of 
intervention efficiency that adjusted for the number of persons reached by a given intervention. 
We estimated overall intervention efficiency for each intervention scenario as the percentage 





mean incidence rate under the no-intervention model at the same overall endemic network 
prevalence.  
 We pursued two distinct objectives: 1) compare the effect and efficiency of ART vs. 
PrEP interventions under a set scenario (intervention coverage level and overall endemic HIV 
prevalence); and 2) compare the effect and efficiency of a given intervention type (ART or PrEP) 
across the three allocation schemes under a set scenario. Direct comparison of ART and PrEP 
interventions was conducted to identify optimal allocation of limited intervention resources under 
each starting scenario, while ART and PrEP interventions were tested across intervention 
allocation schemes to evaluate if differential allocation by community-level endemic prevalence 
provided added value in comparison to a random allocation scheme, which is simpler to 
implement. 
 We hypothesized that the impact of intervention allocation scheme on intervention effect 
and efficiency would decrease with increasing intervention coverage because differential 
sampling becomes increasingly similar to random sampling as greater proportions of eligible 
persons are sampled. Conversely, we hypothesized that the impact of intervention allocation 
scheme would increase with increasing overall endemic HIV prevalence because of heightened 
variation in community-level endemic prevalence under our infection seeding procedure. At low 
overall endemic prevalences, most communities have low endemic prevalences and very few 
have high endemic prevalences, creating little variation for a preferential allocation scheme to 
exploit. At high overall endemic prevalences, community-level endemic HIV prevalences are 
more normally distributed, and there are both communities with low and high endemic 
prevalences from which persons can be sampled for intervention under high-to-low or low-to-








 Community-level HIV incidence rates increased with endemic community-level HIV 
prevalences under our simplified HIV transmission model [Figure 6.1]. This relationship varied 
by overall endemic HIV prevalence, with the strongest effect observed at the lowest overall 
endemic prevalence tested. In intervention-free scenarios, estimated incident HIV infections per 
susceptible person-year within the full network ranged from 0.19 (95% CI: 0.19-0.20) to 0.64 
(95% CI: 0.62, 0.66) at overall endemic HIV prevalences of 0.10 to 0.50, respectively. [Figure 
6.2]. Modeled interventions reduced overall HIV incidence rates by 6.7% to 81.1% in 
comparison to no-intervention incidence rates.  
 We observed greater absolute and percentage reductions in the HIV incidence rate with 
PrEP versus viral suppression interventions for each three-way combination of intervention 
allocation scheme, coverage level, and overall endemic HIV prevalence. However, greater 
absolute numbers of persons were required to be reached with PrEP than with viral suppression 
to achieve the same coverage level at overall endemic HIV prevalences < 0.50. When we 
compared interventions on the basis of efficiency, which accounted for variation in number of 
persons reached across scenarios, we found that viral suppression interventions were more 
efficient than PrEP interventions at low overall endemic HIV prevalences, with this relationship 
reversing as overall endemic prevalence increased [Figure 6.3]. PrEP became more efficient 
than ART at lower overall endemic prevalence levels in scenarios with lower (vs. higher) 
intervention coverage levels.  
 PrEP interventions showed divergent intervention effects by intervention allocation 
scheme: prioritization of susceptible persons in communities with highest initial HIV prevalences 
(high-to-low allocation) demonstrated the greatest percentage reductions in HIV incidence rate 
and highest intervention efficiency across all overall endemic prevalences and intervention 





under random allocation, then by effects under low-to-high allocation. The impact of PrEP 
intervention allocation scheme increased with overall endemic HIV prevalence, with the greatest 
differences across allocation schemes observed at the highest tested overall endemic 
prevalence. This effect was most observable at 10% coverage of susceptible persons with PrEP 
and was dampened by heightened intervention coverage. In contrast, viral suppression 
interventions showed no significant differences in intervention effect or efficiency by allocation 
scheme. 
D. Discussion 
 HIV and other sexually transmitted infections are spread through discrete contacts within 
sexual contact networks, with infection risk among network members depending on network 
position and individual characteristics.10,159-161 One network feature known to play a critical role 
in infection diffusion over infection-naïve networks is community structure, or modularity.13,14 
However, despite strong community structure identified in sexual contact tracing networks,176 
including in Chapter 4, the role of network community structure in transmission of endemic 
infections like HIV has not been previously examined. We assessed the impact of network 
community structure on HIV transmission and HIV prevention intervention efficiency, finding a 
strong association between endemic community-level infection prevalence and infection 
incidence rates – as well as clear relationships between intervention type, allocation scheme, 
and overall endemic infection prevalence – that could potentially be leveraged in the design of 
prevention interventions. 
 We observed increasing community-level HIV incidence rates with increasing endemic 
community-level HIV prevalences across a wide range of overall endemic HIV prevalences. 
Strong community structure, as simulated here, allowed for heightened infection incidence 
within high prevalence vs. low prevalence communities. This effect was most observable at low 





overall prevalences, infection is largely contained within a few communities with comparatively 
higher endemic infection prevalences, and many communities have little or no infection. Most 
edges within a highly modular network link persons within the same community, and 
transmission principally occurs over intracommunity edges within the few communities with 
comparatively high endemic HIV prevalences. As overall endemic network prevalence increases 
and more communities host substantial numbers of infections, transmission occurs more 
frequently over the dense intracommunity edges in each community. In addition, opportunities 
for infection to enter low-prevalence communities via intercommunity edges increase with the 
number of communities with substantial HIV burden.  
 Longstanding racial and ethnic disparities in HIV prevalence have been attributed to 
homophily in sexual partnerships,154 differences in progression through the HIV care 
continuum,219 potential for stigma-associated transmission risk behaviors among persons of 
color,220 and variation in frequencies of the CCR5 genotype by racial and ethnic background.221 
However, in a recent agent-based model, these four factors accounted for only half of the 
disparity in HIV prevalence between black and white MSM in the United States.222 Homophily 
contributes to the formation of network communities with demographic commonalities among 
members,211 and strong community structure may have played a role in the establishment of 
historical disparities in HIV prevalence across racial and ethnic groups. However, most network 
transmission models do not explicitly model community structure.211 Generation of appropriate 
community structure in addition to local network properties in network transmission models may 
account for a portion of the previously unexplained disparity in HIV prevalence by race and 
ethnicity. 
 PrEP intervention efficiency was greatest under allocation scenarios prioritizing 
susceptible persons in high prevalence communities, as these persons were more likely than 
susceptible persons in lower prevalence communities to belong to discordant dyads and 





endemic prevalences, likely because these networks displayed greater variation in community-
level endemic prevalence under our infection seeding mechanism. At low overall endemic 
prevalences there was less variation in community-level endemic prevalence, dampening the 
utility of community-prevalence-based allocation schemes. The benefit of a high-to-low 
allocation scheme was also most observable at low PrEP coverage levels because most 
persons reached with PrEP under low coverage scenarios were members of high prevalence 
communities. Intervention sampling under the high-to-low and low-to-high allocation schemes 
more closely approximated sampling under the random allocation scheme as coverage 
increased, mitigating this effect. 
 We identified no clear efficiency gains from prioritizing PLWH for viral suppression by 
network community prevalence. We initially hypothesized that viral suppression interventions 
preferentially allocated to persons in low prevalence communities would be more efficient than 
viral suppression interventions under other allocation schemes because they could effectively 
remove endemic infection from some communities, largely protecting susceptible community 
members from exposure. However, all PLWH in a low prevalence community would need to be 
sampled for viral suppression intervention coverage to achieve this protection, which was 
extremely rare under our nondeterministic intervention assignment scheme. Although viral 
suppression interventions preferentially allocated to infected persons in low prevalence 
communities reached more persons in discordant dyads than were reached under other 
allocation schemes, some discordant dyads remained in nearly all communities. Susceptible 
persons thus still experienced the opportunity for transmission in dyads with persons who did 
not receive the intervention and in dyads with persons who became infected during the 
simulation.  
 This highly simplified analysis is a preliminary exploration of the role of community 
structure in endemic infection transmission and the potential impact of control efforts leveraging 





features of the empirical HIV/syphilis contact tracing network among MSM in NC, and these 
networks are subject to the limitations governing contact network analysis described in Chapter 
4.163 Static networks forced all partnerships to be concurrent and required partnership 
maintenance over the full study time frame, increasing network connectivity beyond that which 
would occur in a true contact network. Our empirical source network is also highly modular and 
results may not be generalizable to contact networks with lower modularity. In addition, we 
applied a highly simplified transmission model that does not account for medication adherence, 
maintenance in care, transmissibility by infection stage, condom use, positional preferences, 
and many other factors influencing HIV transmission.223 As a result of these limitations, 
estimated HIV incidence rates, intervention effects, and intervention efficiency do not reflect 
expected transmission within the empirical network from which we drew parameters. Rather, 
this model explores general trends in infection transmission and intervention utility in modular 
networks across a wide range of intervention scenarios. 
 Although this study was highly simplified and was not designed to provide actionable 
guidance about specific intervention approaches, our findings do provide some broad insights 
around network structure and intervention allocation that may be instructive from a public health 
perspective. Specifically, our results suggest that prioritization of susceptible persons in high-
prevalence communities for enhanced interventions supporting PrEP uptake and maintenance 
may prevent more HIV infections per person reached than other PrEP allocation strategies. Viral 
suppression interventions may be more efficient than PrEP interventions under all allocation 
strategies in network populations with endemic HIV prevalences <20%. Future research will be 
useful in clarifying any relationship between network position and ART intervention allocation 
and elucidating more realistic estimates of intervention effects under various strategies. Many 
practical factors – such as relative costs of reaching sub-populations of network members with 
enhanced ART vs. PrEP interventions, heterogeneity in ART or PrEP uptake and adherence 





will also be necessary considerations in any future translation of observed relationships to public 
health action. 
 We demonstrate a clear effect of endemic community-level infection prevalences on 
community-level incidence rates and assess the potential for community-based treatment and 
prevention interventions that incorporate network community structure. Consideration of network 
community structure in network models for transmission of endemic infections, including HIV, 
may improve existing models. Further study of network-based prevention interventions 
accounting for community structure and differential infection prevalences across communities 










Figure 6.1 Log-transformed community-level HIV incidence rate by endemic community-level HIV 
prevalence and overall endemic network HIV prevalence under no intervention 
 
CAPTION: Log-transformed community-level HIV incidence rate, defined as incident HIV 
infections per susceptible person-year, by endemic community-level HIV prevalence and overall 
endemic network HIV prevalence under no intervention. Points represent individual community-
level HIV incidence rates in a single simulation. Overall endemic network HIV prevalence is 
indicated by color and linear trend lines in each color illustrate the relationship between endemic 










Figure 6.2 Overall HIV incidence rate by initial overall endemic HIV prevalence, intervention allocation scheme, and intervention 
coverage level 
 
CAPTION: Overall HIV incidence rate, defined as mean incident HIV infections per susceptible or protected person-year, by initial 
overall endemic HIV prevalence, intervention allocation scheme, and intervention coverage level. The mean HIV incidence rate under 
a given scenario across 100 network simulations is represented as a point. Color indicates intervention allocation scheme, where 
individual nodes may be prioritized for intervention by endemic community-level HIV prevalence from highest to lowest prevalence, 
lowest to highest prevalence, or randomly. Point shape indicates intervention coverage among eligible persons, either protection via 
pre-exposure prophylaxis (PrEP) among susceptible persons or viral suppression of infected and infectious persons. Linear trend 
lines highlight the relationship between overall HIV incidence rate and overall endemic HIV prevalence within each intervention 









Figure 6.3 Intervention efficiency by overall endemic HIV prevalence, intervention allocation scheme, and intervention coverage level 
 
CAPTION: Intervention efficiency, defined as the mean percentage reduction in HIV incidence rate per person reached with the 
intervention, by overall endemic HIV prevalence, intervention allocation scheme, and intervention coverage level. The mean 
intervention efficiency under a given scenario across 100 simulations is represented as a point. Color indicates intervention allocation 
scheme, where individual nodes may be prioritized for intervention by endemic community-level HIV prevalence from highest to 
lowest prevalence, lowest to highest prevalence, or randomly. Point shape indicates intervention type, either protection via pre-
exposure prophylaxis (PrEP) among susceptible persons or viral suppression of infected and infectious persons. Locally estimated 
scatterplot smoothing (LOESS) trend lines highlight the relationship between intervention efficiency and overall endemic HIV 
prevalence within each intervention coverage level/allocation scheme pair. A. Intervention efficiency at 10% coverage of eligible 






CHAPTER SEVEN: DISCUSSION 
 Existing public health infrastructure for HIV and syphilis contact tracing can serve as a 
conduit to reach HIV-positive and HIV-negative persons with enhanced ART and PrEP 
interventions, respectively. However, the relationship between HIV and syphilis contact 
networks and the potential utility of network-based interventions in this population is poorly 
understood. This dissertation aimed to analyze existing HIV and syphilis surveillance data in 
novel ways to assess the need for and potential added value of supplemental ART and PrEP 
interventions deployed through HIV and syphilis sexual contact tracing networks among MSM. 
Innovative strategies are needed to increase ART and PrEP use for improved clinical and 
prevention outcomes to realize the objectives of “Ending the HIV Epidemic” campaigns 
nationwide.178 
 This dissertation pursued three specific aims: 1) evaluate interconnectivity of HIV and 
syphilis sexual contact networks among MSM in NC; assess viral suppression and PrEP use 
among MSM members of the HIV/syphilis sexual contact network in NC; and model the impact 
of treatment and prevention interventions in modular networks with differential endemic infection 
prevalence across network communities. 
A. Summary of Findings 
Aim 1 
 We generated independent and combined HIV and syphilis sexual contact networks 
among MSM, identified network communities, and assessed HIV and syphilis network 





the HIV network, with the magnitude of this interconnectivity varying across network 
communities. Heightened interconnectivity was associated with younger median age; higher 
proportions of persons self-identifying as Black, non-Hispanic; and higher proportions of 
persons diagnosed with syphilis diagnosed at STD clinics. 
 Strong network community structure is associated with explosive infection transmission 
within communities.175 The very strong community structure (Q = 0.97) detected in the 
combined HIV/syphilis network suggests that specific sub-populations within the syphilis 
network that tend to belong to communities that are particularly interconnected with the HIV 
network may be potential priorities for enhanced interventions to prevent HIV transmission. 
Strong homophily by age and self-identified race/ethnicity leads to the formation of network 
communities with demographic commonalities. This community structure may then drive 
transmission within some demographic populations, contributing to the maintenance of 
longstanding disparities in HIV prevalence222 and HIV/syphilis coinfection107 among young, 
Black MSM.  
Aim 2 
 We used NC surveillance data to identify persons diagnosed with early syphilis or 
named as a recent sexual partner of a person diagnosed with HIV or early syphilis. We 
estimated prevalent and incident viral suppression among persons with a previous HIV 
diagnosis at and after the network event, respectively, and we assessed the effect of contact 
tracing services on six-month cumulative incidence of viral suppression among persons who 
were not virally suppressed at the time of the event. Prevalent viral suppression among persons 
previously diagnosed with HIV was 52.6%, and the six-month cumulative incidence of viral 
suppression was 35.4%. Although incident viral suppression following a network event overall 





observed a significant increase in six-month cumulative incidence of viral suppression among 
persons reached by DIS for interview in association with the network event in comparison to 
those who were not reached (aCID = 13.1; 95% CI: 8.9, 17.4 percentage points). Increased 
support for DIS services among previously-diagnosed PLWH with unsuppressed viremia 
identified in the HIV/syphilis contact tracing network may facilitate attainment of viral 
suppression targets in NC. 
 Using linked prescription claims data, we evaluated prevalent and incident PrEP use 
among HIV-negative persons diagnosed with early syphilis or named as recent sexual partners 
of persons diagnosed with HIV or early syphilis. Although most network events among HIV-
negative persons occurred among persons indicated for PrEP, few HIV-negative persons 
showed prevalent (5.4%) or incident (4.1%) PrEP use. Persons with incident PrEP use following 
a network event were substantially younger than persons with prevalent PrEP use prior to a 
network event, suggesting that the contact tracing network may provide a useful mechanism to 
encourage PrEP use among young MSM. Linkage of insurance claims data and surveillance 
data offered a novel approach to evaluate PrEP use among a key population for HIV prevention, 
and extension of this process may support efforts to increase PrEP use in NC.   
Aim 3 
 We generated sparse, static contact networks with strong community structure, 
replicating key features of the largest connected component of the combined HIV/syphilis 
contact network characterized in Aim 1. We simulated HIV transmission over these networks 
using a simple transmission model, allowing persons to be susceptible to HIV infection, 
protected via PrEP, infected and infectious, or virally suppressed via ART. We first evaluated 
the community-level HIV incidence rate by initial community-level HIV prevalence under no 
intervention, finding a strong association that was particularly pronounced at low overall 





 We also estimated the effect and efficiency of community-prevalence-based vs. 
randomly allocated viral suppression and PrEP interventions across a range of initial overall 
network HIV prevalences and intervention coverage levels. Modeled interventions reduced HIV 
incidence rates across the full network by 6.7% to 81.1% relative to corresponding intervention-
free scenarios. Viral suppression interventions were more efficient than PrEP interventions at 
low overall endemic HIV prevalences, while PrEP interventions were more efficient at high 
overall endemic HIV prevalences. PrEP interventions were most efficient when preferentially 
deployed to susceptible persons in communities with higher endemic HIV prevalences, 
especially at high overall endemic HIV prevalences and low intervention coverage levels. ART 
intervention efficiency did not vary meaningfully by intervention allocation scheme.  
 This study was highly simplified and was intended as a preliminary exploration of the 
role of community structure in endemic infection transmission and the potential impact of 
infection control efforts leveraging community structure. Further study of network-based 
prevention interventions accounting for community structure and differential infection 
prevalences across communities under a more realistic model may inform new approaches to 
prioritize limited public health resources. 
B. Study Strengths 
 NC’s HIV and STI surveillance data are a valuable resource for research because each 
person is assigned a unique identifier that is universally applied across time, infections, and 
contact tracing experiences.179 In contrast, many other states and jurisdictions maintain 
separate identifiers for each infection and cannot not link contact tracing events to diagnosis 
events, even within a single infection. NC EDSS enables analyses like those performed in the 
course of this dissertation by allowing people to experience patterns of interaction with the 
public health system, rather than distinct events. Many people in NC have repeat interactions 





syphilis, and HIV and STI screening and treatment. We leveraged this rich data source in 
Chapters 4 and 5 to conduct analyses that would not be possible in most other jurisdictions. 
 The analysis conducted in Chapter 4 is the first to characterize an integrated statewide 
HIV/syphilis sexual contact network and to specifically interrogate how HIV and syphilis sexual 
contact networks interact. Few analyses have generated integrated networks containing 
persons diagnosed with HIV and syphilis and their named sexual contacts. All such analyses 
were restricted to small demographic or geographic sub-populations and primarily evaluated the 
union of the HIV and syphilis networks as a single network.10,136,169,170 We specifically sought to 
understand the relationship between the HIV and syphilis sexual contact networks among MSM 
in NC. Jaccard node and edge similarities were applied to estimate direct overlap between the 
HIV and syphilis networks and largest connected component sizes in the independent and 
combined networks were identified to evaluate bridging between the network populations. 
However, these methods could not fully quantify direct connectivity between two networks. We 
devised a simple new measure of interconnectivity between two partially overlapping networks, 
drawing from literature on interconnectivity within coupled, disjoint network systems.173 The new 
measure proposed here evaluates both the amount of overlap between nodes in each network 
and the distribution of this overlap. This measure may be applied to assess interconnectivity 
within a full network or within network subsets, such as communities. 
 We evaluate network community structure in Chapters 4 and 6 to assess the potential 
for differential HIV risk among HIV-negative persons within the combined HIV/syphilis network 
population. Although community detection is common in sociology, biology, and computer 
science,12 it has been applied to only a small number of empirical and simulated sexual contact 
networks.13,14,176,224 Community detection offers a useful mechanism to group persons into 
clusters within which most network edges,12 and thus most opportunities for transmission, occur. 
As explored in Chapters 4 and 6, community detection could be a novel tool for identification of 





Although network community structure has repeatedly been shown to impact disease spread 
across a network, all prior studies of this effect have been confined to newly introduced 
epidemics in a naïve network population.13,14 We extended this work to examine the impact of 
community structure on the spread of an endemic infection that is unevenly distributed within a 
network, using HIV as an illustrative example.  
HIV laboratory and prescription data are regularly monitored to evaluate HIV care 
engagement among PLWH under the Data to Care framework.102,225 We extended this 
framework by linking HIV/STI surveillance data and prescription claims data to assess PrEP use 
among HIV-negative MSM within the known HIV/syphilis sexual contact network in Chapter 5. 
Surveillance data allowed us to identify persons at heightened risk of HIV exposure within their 
personal sexual networks and linkage to insurance claims data enabled assessment of 
prevalent and incident PrEP use in this vulnerable population. Routine linkage of prescription 
claims or prescribing data, including data covering populations not included in this analysis, and 
surveillance data may offer a novel approach to monitor and support PrEP use among key 
populations for HIV prevention.  
C. Limitations 
 We chose to apply surveillance data in these analyses because NC EDSS offers the 
best representation of the HIV epidemic in North Carolina. However, surveillance data are also 
subject to several important limitations that required the use of strong assumptions in our 
analyses. NC EDSS captures all reported HIV and STI diagnoses and HIV-related laboratory 
values in NC, but not all persons seek testing or care at regular intervals. In addition, although 
viral load reporting to NC EDSS was mandated for all providers in NC in 2013, slow uptake by 
several providers delayed full statewide reporting until 2016 (Dr. Erika Samoff, NC DPH, 
personal communication 2020). Our estimates are reliant on these reported viral loads and likely 





dependent on the year of the network event. We included network event year in our GEE model 
in Aim 2 to adjust for any potential confounding by this underreporting in analyses of the 
association between DIS interview status and incident viral suppression. Some persons may 
also have been misclassified in analyses of prevalent and incident viral suppression as having 
unsuppressed viremia if care was sought outside of NC or if no care was sought but ART 
adherence was maintained. In Chapter 5, we also assumed that all persons with unknown HIV 
status at the time of the network event were HIV-negative, interrogating this assumption in 
sensitivity analyses that produced similar results to those of our main analyses. 
 We acknowledge that the complete HIV and syphilis transmission networks in NC cannot 
be fully reconstructed from data on persons diagnosed with HIV and syphilis and the named 
contacts of these persons. Network membership is subject to selection bias because members 
are identified via self-reported characteristics and were restricted by diagnosed infection or 
contact status.163 Persons who are infected with HIV or syphilis but are undiagnosed could not 
be included in our analyses, and diagnosed persons not reached by DIS for interview were 
excluded from analyses in Chapter 4 because they could contribute no information for network 
generation. Further, contact tracing data were limited to only MSM sexual contacts across all 
analyses, ignoring the contributions of heterosexual and IDU-related contacts to the network. 
We were unable to include marginal contacts, or persons for whom there were too little 
information for DIS to begin contact investigations. Contact data were also self-reported and 
may suffer from social desirability bias and recall error, leading to underreporting.163 
 We initially sought to characterize all PrEP use among HIV-negative persons diagnosed 
with syphilis or named as contacts of persons diagnosed with HIV or syphilis. However, PrEP 
data could only be obtained from a single private insurer in NC. Approximately one-third of all 
HIV-negative network members matched to insurance claims data, but only 441 and 457 
network events occurred among persons with continuous pharmacy coverage under BCBS NC 





Among matched persons, 309/1,788 (17%) were not covered by an insurance plan with 
pharmacy benefits, while the remainder of excluded persons did not have continuous insurance 
coverage. Estimates of prevalent and incident PrEP use are reasonably generalizable only to 
network members with pharmacy coverage under a private insurer, and this population differs in 
meaningful ways from the full population of HIV-negative HIV/syphilis network members. 
Although uninsured and publicly-insured persons are now being reached by existing NC public 
health infrastructure with PrEP referrals and care, we were unable to evaluate PrEP use in 
these vulnerable populations with the available data. 
 We restricted all analyses to self-identified adult, cisgender MSM with a documented NC 
address at the time of their HIV or syphilis diagnosis or contact event. Although these factors 
limit generalizability beyond this specific population, our findings are highly relevant to the 
development of interventions deployed through HIV and syphilis contact tracing networks to 
support ART and PrEP use among MSM. Our networks are also retrospective and static, 
ignoring several important complexities of sexual partnerships and resulting sexual networks. In 
Chapter 4, we aggregated sexual partnerships over a three year period. The resulting network 
displays an inflated mean node degree compared to the true network at any single point in time 
because our static network artificially created concurrency of all partnerships over the study time 
frame. This analysis also classified persons by network membership, rather than infection 
status, because of variability in diagnosed and undiagnosed infection during the study time 
frame. Assessment of HIV exposure among HIV-negative network members would require use 
of a dynamic network that allows formation and dissolution of partnerships and near-omniscient 
knowledge of infection status at all time points. Instead, we aimed to evaluate the HIV/syphilis 
syndemic from a network perspective by identifying individuals and populations within the 
syphilis network that are highly interconnected with the HIV network.  
 The largest connected component of the combined HIV/syphilis network identified in 





concurrency and maintenance of all relationships for the full duration of the simulation within this 
network may heighten transmission estimates produced in Chapter 6. This effect is in direct 
contrast to missing marginal and unreported contacts in the combined HIV/syphilis network. Our 
generated networks in Chapter 6 thus cannot be considered realistic sexual contact networks. In 
addition, we applied a highly simplified transmission model that does not account for medication 
adherence, maintenance in care, variations in transmissibility with infection stage, condom use, 
positional preference, and many other factors influencing HIV transmission. Estimated HIV 
incidence rates and intervention effects do not reflect expected transmission among MSM in the 
known HIV/syphilis sexual contact network in NC. Rather, this model aims to explore general 
trends in intervention efficiency in modular networks with endemic HIV infection.  
D. Future Directions 
Expanded Populations 
 We restricted analyses in Chapters 4 and 5 to adult, self-identified cisgender MSM 
diagnosed with HIV or early syphilis and their named sexual contacts. However, transgender 
persons, persons in heterosexual partnerships, and PWID are also critical populations for HIV 
prevention and contribute to the full transmission network. The analyses conducted in Chapter 4 
could be expanded to include additional populations and transmission modes. One prior 
analysis identified distinct network communities in the Cuban HIV contact tracing network that 
were characterized by transmission risk group.176 Assessment of transmission risk group within 
network communities in the combined HIV/syphilis network in NC may provide additional 
insights into the HIV/syphilis syndemic within each sub-population and bridging between sub-
populations. 
 In addition, all PLWH and persons at risk of acquiring HIV may benefit from increased 





could be extended to all persons diagnosed with HIV or early syphilis and the named contacts of 
these persons in NC. Stratified analyses evaluating viral suppression and PrEP use prior to and 
following a network event by sex, self-identified transmission risk group, and self-identified 
gender identity may be useful for identification of gaps in ART and PrEP coverage within the 
combined HIV/syphilis network population. Increased understanding of inequities in care 
utilization within this population may help NC DPH design enhanced intervention strategies to 
aid populations with comparatively lower incidence of viral suppression or PrEP use following a 
network event. Further, stratified analyses assessing the effect of DIS interview on incident care 
utilization may highlight populations for which current DIS services are particularly effective or 
ineffective and contribute to the design of adapted programming to fit the needs of all 
populations in NC. 
Routine Integration of PrEP Data  
 Our findings highlight very low prevalent and incident PrEP use among a population of 
persons at heightened risk of acquiring HIV with access to PrEP under their insurance 
coverage. Although NC DPH and partnering county health departments across NC have made 
great strides in increasing PrEP access for NC residents, NC does not currently measure PrEP 
use in a systematic manner. AIDS Vu provides estimates of PrEP use for each state using a 
nationally representative prescription database from Gilead linked to an insurance claims 
database.65 In 2018, AIDS Vu estimated that a minimum of 2,515 people in NC were prescribed 
PrEP. This minimum estimate does not include all sources of PrEP prescriptions and excludes 
persons with FTC/TDF prescriptions that have no or insufficient insurance claims data (28%) to 
confirm FTC/TDF use for PrEP.65 The AIDS Vu estimate is a useful metric for NC DPH to track 
statewide PrEP use over time, but additional measures within specific populations of interest 





 Following the end of the study period for analyses in Chapter 5, NC EDSS introduced 
new data fields to record PrEP indication, awareness, and use among persons diagnosed with 
early syphilis or named as contacts of persons diagnosed with HIV or early syphilis (known 
HIV/syphilis network members). Similar fields have also been added to NC Counseling, Testing, 
and Referral Services (CTRS) HIV test reporting forms. This data may be applied in conjunction 
with any available insurance claims data and prescribing records to regularly assess PrEP use 
within this critical population for HIV prevention. Specifically, NC EDSS data could be applied to 
identify the number of known HIV/syphilis network members within each geographic jurisdiction 
that are potentially indicated for PrEP. Indicated persons could then be matched to any 
available insurance claims data, including Medicare and Medicaid data, and PrEP prescribing 
records from NC county health departments and clinical partners to assess PrEP use in this 
population. If possible, this data may be supplemented with Gilead prescription assistance data 
or pharmacy dispensing data. Routine analyses could identify specific demographic and 
geographic subpopulations within the known HIV/syphilis contact network that require enhanced 
support for PrEP uptake and maintenance as NC expands PrEP distribution efforts, particularly 
in rural regions. Analogous analyses could also be conducted among persons testing for HIV 
captured in NC CTRS data. 
 Linkage with the data sources listed above may also facilitate additional analyses in this 
population, including efforts to assess the effect of insurance type (private, public, or uninsured) 
on PrEP uptake and maintenance. Linkage of prescribing and dispensing data may further allow 
for evaluation of the gap between prescribed medication and filled medication, allowing insights 
into a potential break-point in the HIV PrEP continuum. 
Longitudinal Trajectories of HIV/STI Risk 
 Trajectories of HIV/STI-related events, including HIV testing documented in NC 





gonorrhea, or chlamydia) documented in NC EDSS, and being named as a sexual contact of a 
person diagnosed with HIV or early syphilis, could be analyzed using group-based trajectory 
models.36,224 Time zero would be defined as the date of the first documented negative HIV test, 
STI diagnosis, or HIV/syphilis contact tracing event, depending on the starting population and 
outcome of interest. Longitudinal patterns of HIV/STI-related events could then be established, 
with each person in the analytical cohort having an estimated probability of “membership” in 
latent groups defined by each pattern. After identification of distinct trajectories, potential 
predictors of membership in consistently or increasingly high priority groups could be evaluated. 
Time to important HIV/STI-related outcomes within each starting population could also be 
compared using survival analyses. 
 Data on incident HIV infection by trajectory could also be combined with individual 
demographic, risk behavior, and sexual contact network features to evaluate the likelihood of 
future HIV diagnosis among persons who test negative for HIV, are diagnosed with a reportable 
STI, or are named as a contact of a person diagnosed with HIV or early syphilis. These data 
could be analyzed using a predictive model or machine learning algorithm to identify persons 
who are at greatest risk of HIV diagnosis and may experience the greatest benefits from 
enhanced support for PrEP linkage and adherence following interaction with public health 
programming. 
Sexual and Injection Drug Use Network Interconnectivity  
 We evaluated interconnectivity between HIV and syphilis sexual contact networks to 
identify populations within the syphilis network that are more likely to be interconnected with the 
HIV network. This type of analysis may be useful for assessment of other infections and network 
types, particularly for investigation of HIV and HCV. Sexual and IDU contact networks often 
partially overlap,227 and sexual network data from HIV and syphilis contact tracing investigations 





outbreak among PWID in western NC. Of the 96 persons investigated in association with this 
outbreak with diagnosis data available, 15% were ever diagnosed with HIV and 44% were ever 
diagnosed with HCV. A majority of diagnosed PLWH identified in the investigation were co-
infected with HCV (64%).228  
 Network interconnectivity could be applied to evaluate the relationship between sexual 
and IDU contact networks, rather than separate infection networks. These analyses would 
require extensive data on shared injecting equipment in a population that can be linked to HIV 
and syphilis contact tracing data. We would expect to identify some overlapping edges, known 
as multiplex edges, where some persons are connected via both sexual contact and shared 
injecting equipment. We would also expect to identify some overlapping nodes, where unique 
persons appear as IDU contacts of some persons and sexual contacts of other persons. 
Network communities in which the sexual and injection drug use networks are highly 
interconnected may be potential bridges for introduction of HIV from the known HIV/syphilis 
sexual contact network to the IDU contact network, and HIV negative persons within these 
communities could be ideal recipients for PrEP. In addition, all persons within these network 
communities may benefit from HCV testing and subsequent treatment, if necessary. 
Model Impact of Interventions Deployed through Contact Tracing Networks 
 The transmission model applied in Chapter 6 is a simplification of HIV transmission 
within a network with modularity and other network features drawn from the empirical contact 
tracing network generated in Chapter 4. However, as discussed previously, this network does 
not reflect the true underlying transmission network in NC. To model the potential impact of HIV 
prevention strategies deployed through the known HIV/syphilis contact tracing network with 
more realism, a different approach would be required. This model would begin with simulation of 
a large, dynamic sexual contact network using exponential random graph models208 that 





simulate HIV and syphilis transmission over this network and sample from infected persons to fit 
diagnosis rates in NC. Next, we would identify sexual contacts of these nodes with sampling 
reflecting contact tracing in NC and reconstruct contact tracing networks. Cumulative 
partnerships over time in the dynamic networks would be fit against an empirical contact tracing 
network to ensure that critical network features, including community structure, have been 
reproduced. Finally, we would simulate the deployment of ART and PrEP interventions to 
persons diagnosed with HIV or syphilis or named as contacts of persons diagnosed with HIV or 
syphilis.  
 A more realistic model would also allow for the introduction of additional features not 
included in our simple model presented in Chapter 6, including medication adherence, 
maintenance in care, variations in transmissibility with infection stage, condom use, positional 
preferences, and biological effects of syphilis infection on HIV acquisition and transmission. This 
type of interrogation could give credence to or disprove the findings of our model presented in 
Chapter 6. It would also allow the intervention strategies explored in Chapter 6 to be tested 
against simpler strategies using demographic proxies for community-level interconnectivity or 
HIV prevalence. 
E. Public Health Implications 
 In an era where “Ending the HIV Epidemic” campaigns are being mounted across the 
US,178 novel approaches are required to design and deploy interventions against persistent HIV 
incidence. Despite this lofty goal, resources for public health efforts are thinly stretched. New 
mechanisms are needed to identify populations at greatest risk of HIV transmission and 
acquisition, to reach these populations with HIV treatment and prevention interventions, and to 





 HIV and syphilis sexual contact networks are interconnected among MSM in NC, and 
the sexual network of persons diagnosed with HIV and syphilis and their named contacts offers 
an efficient platform for deployment of intensified HIV prevention interventions. Limited HIV 
prevention resources may be most efficiently utilized by leveraging existing contact tracing 
infrastructure to reach persons and populations within the HIV/syphilis network that are likely to 
acquire HIV. HIV-negative persons in populations within the syphilis network that are highly 
interconnected with the HIV network, including young MSM of color and persons diagnosed with 
syphilis at STI clinics, may experience heightened exposure to the HIV network and benefit 
disproportionately from enhanced PrEP interventions. In addition, we demonstrated a clear 
effect of community structure in transmission of endemic infection through a highly modular 
network and identified potential for community-based interventions to exploit this network 
structure. Further study of network-based interventions accounting for community structure and 
differential infection risk across communities may offer new avenues to prioritize limited public 
health resources for HIV prevention and control. 
 Contact tracing for HIV and syphilis provides a useful mechanism to identify previously 
diagnosed PLWH who are virally non-suppressed and may benefit from additional support for 
HIV care linkage and maintenance. Although the six-month cumulative incidence of incident 
viral suppression following a network event was low, existing DIS services significantly 
increased this outcome. However, previously diagnosed PLWH named as contacts of persons 
diagnosed with HIV currently receive the lowest priority for allocation of limited DIS resources 
and are often not reached for DIS interview. Increased resources for DIS and SBC could allow 
these services to reach additional virally non-suppressed, previously diagnosed PWLH and 
support engagement or re-engagement in HIV treatment at this critical juncture in their care. 
 Despite high levels of PrEP indication among HIV-negative members of the HIV/syphilis 
contact tracing network, prevalent and incident PrEP use in this population were low. NC and 





for PrEP by DIS during contact tracing.133 Pilot programs offering full-service PrEP care or PrEP 
referrals out of select county health departments in NC are also ongoing,75-78,215 allowing 
assessment of these existing providers’ potential to reach underserved populations and address 
financial barriers to care. These new programs offer critical pathways to enhance PrEP use 
among HIV negative HIV/syphilis network members specifically. Linkage of surveillance data 
with PrEP prescribing, insurance claims, and pharmacy dispensing data, as described 
previously, will be necessary to monitor the success of these offerings and to identify 
populations not adequately served by current programming. 
F. Final Remarks 
Contact tracing is a traditional tool in the public health arsenal because it allows for rapid 
identification of undiagnosed infection, interrupting onward transmission.124 However, the 
secondary benefits of the contact tracing process are also incredibly valuable: highlighting 
uninfected persons who may benefit from prevention interventions and identifying previously 
diagnosed persons who may require additional support for HIV care utilization. We used NC 
surveillance data to quantify a direct effect of DIS services for HIV and syphilis on incident viral 
suppression among virally non-suppressed, previously diagnosed PLWH identified in the 
HIV/syphilis network, and to estimate the size of the HIV-negative and HIV-positive populations 
that may benefit from enhanced PrEP and viral suppression services delivered during contact 
tracing, respectively. We also assessed HIV and syphilis contact tracing data using community 
detection to identify populations within the syphilis network that may be ideal recipients of HIV 
prevention interventions. 
Existing HIV treatment and prevention interventions have the potential to end HIV 
transmission in the US,212,213 but they cannot reach this potential without new intervention 





find novel solutions that connect with people where they are and when they are able to engage 
with the public health system. New intervention strategies bypassing geographic, social, and 
economic barriers are needed to reduce inequities in HIV incidence and care utilization and 
reach all persons who may benefit from ART or PrEP. The existing public health infrastructure, 
including DIS, SBC, and publicly funded STD clinics housed at county and local health 
departments, offers many potential avenues for enhanced support for ART and PrEP use. 
These services already reach critical populations for HIV prevention and treatment, and do so 
during HIV- and/or syphilis-related events that may act as cues to action for initiation of ART of 
PrEP use. Increased support for and extended utilization of these frontline services can only 





APPENDIX: TRUVADA EXCLUSION CRITERIA 
Table A.1 International Classification of Diseases, 9th and 10th revisions, Clinical Modification 
(ICD-9/10-CM) codes and National Drug Code (NDC) package codes applied to identify and 
exclude FTC/TDF prescribed as treatment for HIV or hepatitis B virus (HBV), or as post-
exposure prophylaxis (PEP) against HIV. All NDC are formatted as 5-4-2 with dashes and 
leading zeros stripped. 
Diagnosis or 
Prescription 
Code Code Type 
HIV diagnosis 042, 79.53, V08 ICD-9-CM 
HBV diagnosis 070.2, 70.3, 70.52, V02.61 ICD-9-CM 
HIV diagnosis B20, B97.35, Z21 ICD-10-CM 
HBV diagnosis B16.0, B16.1, B16.2, B16.9, B17.0, B18.0, B18.1, B19.10, B19.11 ICD-10-CM 
HIV treatment 
prescription 
50090098000, 70518034100, 53808020801, 15584010101, 
61958110101, 50090124800, 70518067700, 50090172400, 3364111, 
50090172300, 59676057530, 70518071400, 53808088701, 
50090131800, 70518067400, 61958120101, 49702020218, 
53808089501, 50090061000, 70518184700, 61958060201, 
61958060101, 173066200, 173066300, 49702020548, 49702020318, 
49702020413, 50090055000, 53808089301, 70518069100, 
50090087400, 49702020613, 49702021120, 49702021326, 
49702021248, 53808099001, 49702021718, 87667117, 87667217, 
87667317, 87667417, 87663241, 87663341, 87667117, 87667217, 
87667317, 87667417, 61958040301, 50090075400, 61958040601, 
61958040401, 70518054600, 61958040101, 61958040501, 3196401, 
3196501, 3196601, 3196701, 3196801, 49702022118, 49702022248, 
59676027801, 59676057001, 59676057201, 59676057101, 
49702022517, 70518048200, 56047030, 56047492, 56051030, 
597004660, 597004724, 597012330, 597000201, 597000302, 
6057143, 6057362, 4024451, 4024515, 55289094712, 74052260, 
70518009100, 74395646, 74679922, 74679930, 70518009102, 
70518009101, 53808027601, 53808101001, 49702020718, 
49702020853, 74333330, 74339930, 53808111901, 74194063, 
50090116200, 59676056301, 59676056201, 59676056401, 
59676056501, 50090149100, 70518148300, 59676056630, 
70518068900, 3362212, 3362412, 3363112, 3363810, 50090158100, 
50090100700, 70518072500, 70518068800, 70518046900, 
63010001030, 63010002770, 55289047727, 4038140, 50090148600, 
49702022318, 49702023508, 49702023755, 49702023308, 
49702022418, 6022761, 6047361, 6047761, 6308001, 6360360, 
6360361, 50090108501, 50090108500, 70518162101, 70518162102, 
70518162100, 76519113006, 68071211306, 50090108502, 
70518148700, 50090135501, 49702022813, 53808113001, 
50090135500, 49702022713, 49702022613, 527194748, 
70518200700, 54040713, 70518151900, 31722059730, 
31722059712, 68382069606, 65862068701, 65862068730, 
65862068799, 65862068705, 65162006132, 65162006106, 
60687042025, 70518108600, 60687036425, 74308228, 74006301, 
74006328, 74309301, 74309328, 59676080030, 59676080099, 






3161112, 3161212, 3161412, 61958040401, 50090075400, 
61958040601, 61958040301, 70518054600, 61958040501, 








52343014730, 52343014830, 60687021625, 68382092106, 
51991089633, 43547043615, 69097042602, 31722083330, 
31722083332, 31722083390, 31722083430, 31722083431, 
31722083432, 70771101903, 70771102001, 65162044603, 
65162044903, 42291026130, 65862084230, 49884054809, 
70771101909, 16729038810, 49884054709, 49884054811, 
43547043715, 43547043603, 43547043609, 51407006530, 
65862084190, 65862084199, 70771102003, 70771102004, 
51407006430, 65862084299, 16729038910, 49884054711, 
68382092001, 68382092016, 51991089590, 70771101904, 
43547043703, 70771101901, 68382092077, 31722083490, 
69097042605, 33342036210, 33342036257, 33342036207, 
69238154703, 69238154803, 69238154903, 69238152703, 
31722053510, 31722053530, 42385090150, 53808112801, 
60687036625, 69097053302, 69097053315, 60505466603, 
65862081930, 70518100201, 65862081903, 65862081830, 
70518215100, 65862082030, 42385090103, 31722053505, 
31722053501, 31722053560, 65862042130, 42291080030, 
65862081803, 65862082003, 16714082001, 93710456, 
70518100200, 64380071404, 33342009607,  68180028806, 
65862090030, 35573040230, 70518071500, 70771105309, 
42291011530, 70710104903, 70771105303, 69097036202, 
68180028809, 68180028833, 65862033530, 66993048230, 
70710104909, 65862033510, 93538256, 68180028607, 
68180028601, 68180028602, 33342036210, 33342036257, 
33342036207, 64330000101, 66993047860, 65862002510, 
60429035430, 70518206700, 70518207000, 60505325108, 
60505325208, 60505325006, 53808084301, 65862002560, 
65862002610, 64380071003, 64380071104, 33342000109, 
33342000207, 65862055330, 68180060306, 50742062360, 
50742062460, 65862005524, 65862055310, 904658304, 
70518163400, 70518044001, 61958050101, 42794000308, 
60505394703, 173066200, 173066300, 49702020318, 49702020548, 
53808089301, 49702020413, 50090055000, 61958230101, 4035009, 
4035730, 4036509, 4036530, 85113301, 85116801, 85435001, 
85435101, 85435201, 85129701, 85129702, 85129703, 85131601, 
85131602, 85132301, 85132302, 85137001, 85137002, 85137003, 





Truvada (61958070401, 61958070501, 63629758102, 50090087000, 
63629758101, 70518009700, 70518009702, 61958070101, 
35356007003, 61958070301, 70518009701, 68071211203, 
54868514100, 54569558800, 54569558802, 54569558803, 
67296123703, 53808080501, 52959096903, 69189070101, 
61919066902, 67296123704) + Raltegravir (6022761, 6047361, 
6047761, 6308001, 6360360, 6360361, 50090108501, 50090108500, 
70518162101, 70518162102, 70518162100, 76519113006, 
68071211306, 50090108502) OR Truvada + Dolutegravir 
(49702024613, 49702024213, 50090135500, 49702022713, 
49702022613, 70518148700, 50090135501, 49702022813, 
53808113001, 50090160600, 49702023113); OR Truvada + 
Darunavir (70518071400, 50090172300, 59676057530, 
59676056501, 70518148300, 59676056301, 59676056201, 
50090149100, 70518068900, 59676056401, 59676056630, 
59676080030, 59676080099) OR Truvada + Ritonavir 
(55289094712, 74052260, 70518009100, 74395646, 74679922, 








53808111901, 50090116200, 74194063, 74339930, 74333330, 
70518200700, 54040713, 70518151900, 31722059730, 
31722059712, 68382069606, 65862068701, 65862068730, 
65862068799, 65862068705, 65162006132, 65162006106, 
60687042025, 70518108600, 60687036425, 74308228, 74006301, 
74006328, 74309301, 74309328, 61958110101).  
 
FTC/TDF prescription duration <30 days with ≥30 day fill gap 
between prescriptions and concomitant Raltegravir, Dolutegravir, 
Darunavir, or Ritonavir. One additional claim was treated as PEP with 





Truvada (61958070401, 61958070501, 63629758102, 50090087000, 
63629758101, 70518009700, 70518009702, 61958070101, 
35356007003, 61958070301, 70518009701, 68071211203, 
54868514100, 54569558800, 54569558802, 54569558803, 
67296123703, 53808080501, 52959096903, 69189070101, 
61919066902, 67296123704).  
 
Prescription duration ≥30 days or <30 days with <30 day fill gap 
between prescriptions, totaling ≥30 days. No concomitant Raltegravir, 
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